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iABSTRACT
Reproductive tract inflammatory diseases (RTID) of dairy cows are common
worldwide and have been associated with a decrease in reproductive
performance. The aims of this thesis were: (1) to quantify the effect of RTID on
reproductive performance using data from 80 dairy herds across England and
Wales, and from the University of Nottingham Dairy Centre; (2) to determine the
effect of endometritis on the normality of post-partum milk progesterone profiles;
(3) to investigate the association between endometritis and luteal vasculature
and protein expression of steroidogenesis enzymes ex vivo; (4) to determine the
expression of LPS-associated receptors including TLR4, CD14 and MD-2 in bovine
CL using multiplex PCR; (5) to investigate the dose dependent effects of LPS on
luteal endothelial cell vasculature in vitro and protein expression of
steroidogenesis enzymes.
Data analysis of 59118 cows from 80 dairy herds across England and Wales
showed 12% prevalence of RTID from 2000-2007 (P<0.001). Cows with RTID
had significantly longer intervals from calving to both first service and to
conception by about 5 days (P<0.001) and 22 days (P<0.001), respectively.
Moreover, cows with RTID had a lower conception rate to 1st service by 14%
(P<0.001) and required more services per conception about 1 service more
(P<0.001). In addition, they were 1.2 times more likely to be exited from the
herd (P<0.001), and had higher 305d milk yield (P<0.01). Furthermore, this
study analysed data from 708 cows at Nottingham dairy centre showed about
15% of prevalence of RTID form 2008-2014 (P<0.001). Similar effects were
observed in the Nottingham dairy centre. However, only the day to 1st service
was significant (P<0.001). The association between endometritis and milk
progesterone profiles was investigated to establish the importance of
endometritis on postpartum ovarian activity. Endometritis increased the incidence
of atypical progesterone profile with prolonged luteal phase being the most
affected.
In the ex vivo study, there was a negative association between presence of
endometritis with luteal vasculature, CL size, luteal progesterone content and
quantification of steroidogenic enzyme expression. Endometritis caused
significant inhibition in the degree of luteal vasculature, progesterone content
and protein expression of steroidogenic enzymes by corpora lutea.
ii
LPS has been implicated in influencing ovarian function. Multiplex PCR showed
that LPS receptors (TLR4, CD14, and MD-2) are expressed in bovine CL at all
stages of CL development, indicating that CL could be a target for LPS action. A
physiological cell culture system was consequently utilised to examine the effect
of LPS on luteal endothelial cell network formation, progesterone (P4) production
by luteal cells and steroidogenic enzyme expression in vitro. Treatment with
VEGFA/FGF2 increased progesterone production by luteal cells (P<0.001).
Moreover, progesterone production increased significantly from day 3-9 of
culture. Under both basal condition and/or angiogenic stimulus (VEGFA/FGF-2),
LPS (0.01, 0.1, 1 and 10 µg/ml) had no effect on P4 production by luteal cells on
day 3, 5, and 9 of culture. LPS significantly inhibited luteal endothelial cells
network formation. This was due to inhibition of endothelial cell proliferation and
increasing endothelial cell apoptosis (P<0.001).
In summary, the adverse impact that endometritis has on dairy cow fertility was
identified by this work. This work offers a greater understanding of the effect of
endometritis on dairy cow’s reproductive performance, early luteal development
and function. In particular, this work provides evidence of a novel effect of
endometritis on bovine luteal development and adequacy. It also offers further
awareness into the role of LPS in terms of its negative effect on luteal endothelial
cell angiogenesis and steroidogenesis.
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1 Literature review
1.1 General introduction
Over the past few decades, reproductive performance has decreased in dairy
herds in the UK as well as across the globe. This has a negative impact on
production and profit of a dairy farm (Lucy 2000, Weigel 2006). Insufficient
reproductive performance is one of the most costly problems facing dairy farmers
today (Kasimanickam et al. 2004). The decline in fertility over the past 50 years
has occurred as milk production has increased (Walsh et al. 2011). The efficiency
of production can be assessed by the interval between two calvings. The
traditional is 365 days, and it has been estimated that longer than this period,
costs up to £3 per cow per day (National Animal Disease Information Service,
2016, Esslemont et al. 2001). In the UK, currently the average calving interval is
425 days.
On the cow level, this cost equates to about £120 per cow and for the UK dairy
industry £216 million per-annum. Currently, the dairy industry in the UK supports
just under 14,000 dairy herds, with a total of 1.8 million adult dairy cows
(DairyCo 2016). Calving interval depends on two components 1) interval from
calving to conception and 2) the length of pregnancy (gestation period). As the
pregnancy period is relatively constant at 280-285 days, the number of days
open (target: 80-85 days) is the main principal determinant of the calving
interval. Several factors contribute to this interval, which includes: 1) resumption
of ovarian activity; 2) detection of oestrus; 3) ability to conceive and establish
pregnancy; 4) abnormal ovarian cycles such as follicular cysts; and 5)
management decision when to resume breeding.
The conception rate at first service in the UK is less than 40% (DairyCo 2010),
and was estimated to be declining at a rate approaching 1 percentage point per
year (Royal et al. 2000). There are two main reasons contributing to the decline
of conception rates at first service: 1) ovarian and uterine inadequacy; 2)
selection of animals for increased milk production. In early lactation, the dietary
intake of cows does not meet their lactation requirements and consequently they
enter a period of negative energy balance (NEB). This has a negative effect on
both metabolic and endocrine systems. High yielding dairy cows are likely to
have extended NEB, which will have further adverse effects on fertility (Webb et
al. 2000). Reproductive performance in dairy cattle is dependent on the
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interaction between environmental, management (i.e. accuracy of heat detection,
use of proper insemination technique and herd health policies) and biological
factors. Biological factors include involution of the cervix and uterus post-partum
(Mateus et al. 2002, Zhang et al. 2010); age and parity (Hajurka et al. 2005,
Melendez et al. 2004); hormone concentrations, nutrition (Wagner and Hansel
1969, Zhang et al. 2010); season (Kasimanickam et al. 2004, Noakes et al.
2009), and uterine infection (Sheldon 2004, Melendez et al. 2004).
Many production diseases have negative influence on the reproductive system in
dairy cows. Uterine diseases are common after parturition in cattle and play a
role in the reduced fertility of dairy cows (Sheldon et al. 2008). Usually, the
uterus becomes contaminated with bacteria shortly after calving. In most cases,
these bacteria are eliminated, however in up to 20% of animals, they persist and
cause endometritis (Sheldon et al. 2009a). This then has a negative impact on
the farm economics due to the direct cost of treatment, sub-fertility and
decreased milk production. In the UK, the direct costs of uterine disease
treatments and reduced milk yield of a cow were estimated to be approximately
£72 per cow (Arnott et al. 2015). The prevalence of metritis/endometritis has
been reported to be higher in high-yielding than low-yielding cows (Opsomer and
de Kruif 2009). The exact cause for increased occurrence of uterine disease in
high-yielding dairy cows is unknown. However, it has been suggested that the
increased incidence is associated with greater NEB and the impaired neutrophil
function in high-yielding cows (Hammon et al. 2006). This is supported by the
observation of increased inflammatory response gene expression in the
endometrium two weeks after calving in cows with severe NEB (Wathes et al.
2009). These studies indicate that NEB results in disturbed immune function,
which leads to an inability of cows to eliminate bacteria from the uterus.
Uterine infection (i.e. metritis and endometritis) during the postpartum period is
regarded as a major health issue in dairy cows. It is demonstrated that uterine
disease of various forms contributes to declining fertility (Crowe and Williams
2012). It is likely that it has a direct effect on the uterus, but bacterial
endotoxins and immune mediators produced in response to bacterial infection
also inhibit pituitary LH secretion, suppress folliculogenesis (Sheldon et al.
2002b), reduce ovarian steroidogenesis and disrupt ovarian cyclicity (Opsomer et
al. 2000, Mateus et al. 2002, Huszenicza et al. 1999). Several bacteria are
recognised as uterine pathogens are E.coli, Trueperella pyogenes, Fusobacterium
CHAPTER ONE
3
necrophorum, Prevotella melaninogenica and Proteus species. These bacteria are
associated with endometrial inflammation and can cause severe clinical uterine
infection (Sheldon et al. 2002a, Williams et al. 2005).
Lipopolysaccharide is an endotoxin secreted from the outer layer of Gram-
negative bacteria such as E.coli. Both LPS and immune mediators can inhibit
pituitary LH secretion and suppress folliculogenesis, and reduce ovarian
steroidogenesis, (Huszenicza et al. 1999, Mateus et al. 2002, Opsomer et al.
2000, Sheldon et al. 2002b, Williams et al. 2007). It has been reported that post-
partum anoestrus and ovarian cysts were associated with uterine infection
(Williams et al. 2007, Mateus et al. 2002). A few studies have investigated the
relationship between progesterone profiles and clinical signs of uterine
inflammation. These have observed an association between uterine infection and
abnormal postpartum progesterone profiles (Huszenicza et al. 1999, Mateus et
al. 2002, Opsomer et al. 2000, McCoy et al. 2006). This might be related to the
ability of the uterine E.coli infection within the uterus to impair synthesis of the
luteolytic prostaglandin F2 (PGF2). Thus, it can prolong the luteal phase by
switching synthesis away from PGF2 towards luteotrophic PGE2 (Williams et al.
2008a, Herath et al. 2009).
One of the challenges is the correct identification of the inflammatory status in
the uterus, particularly in the field. The diagnosis of uterine infection can be
performed by different methods such as bacteriological, histological and
cytological examination. However, these methods are not always useful under
field conditions because diagnosis and effective remedies should be taken
immediately. For that reason, vaginal discharge examination is regarded as a
simple, non-invasive method is often used under field conditions (Sheldon et al.
2006, LeBlanc et al. 2002). Purulent vaginal discharge can accurately reflect
uterine infection and indicate presence of pathogenic bacteria in the uterus
(Dohmen et al. 1995, Williams et al. 2005). However, not all vaginal scoring
systems can differentiate between the different severities and are also limited to
one type of uterine infection such endometritis (Dohmen et al. 1995, Huszenicza
et al. 1999, Williams et al. 2005).
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1.2 Reproductive tract of the cow
1.2.1 Anatomy of the uterus
The uterus of the cow is bicornuate and is characterised by a small uterine body
(5cm) just anterior to the cervical canal and two long uterine horns (20-40cm
long). The uterine horns are separated by the septum; they curve downwards
and laterally, and then taper at the oviductal end. The uterus is suspended in the
body cavity by broad ligaments that also contain the uterine artery that supplies
the blood to the uterus (Fig.1.1).
Figure 1.1: The reproductive tract in the cow.
CHAPTER ONE
5
1.2.2 Histology of the uterus
1.2.2.1 Endometrium
Luminal epithelium
The inner layer of the uterus is called the endometrium (Fig.1.2). The luminal
epithelium of the endometrium is pseudostratified and/or simple columnar
epithelium, adjacent to the uterine lumen. The morphology of these epithelial
cells changes during the oestrus cycle. Namely, they become taller at oestrus and
are more cuboidal during the luteal phase (Bacha and Bacha 2000).
Glands
Endometrial glands are continuously extensions from the luminal epithelium and
penetrate deep into the endometrium. Thus, there are two types of endometrial
glands according to their location: superficial glands, which located near to the
luminal epithelium and deep glands which are located near to the myometrium.
Glands are simple, coiled and branched tubular glands that are lined with both
ciliated and non-ciliated simple, columnar epithelium and open out into the lumen
(Hafez 1993, Bacha and Bacha 2000).
Caruncle
Caruncles are a particular feature of the ruminant uterus. They are characterised
by oval or round thickenings in the uterine mucosa resulting from proliferation of
sub-epithelial connective tissue. Caruncles are visible in the non-pregnant uterus
(Fig.1.1). Furthermore, they are the sites that form attachments with fetal
membranes. There are about 70-120 caruncles in the cow, arranged in 4 or 5
rows.
Stroma
The stroma of the endometrium is composed of tightly packed fibroblasts, which
gives the structural support for the endometrium. The stroma also contain,
lymphocytes and blood vessels (Hafez 1993, Bacha and Bacha 2000). Immune
cells can also be detected in the stroma.
1.2.2.2 Myometrium
The myometrium is composed of two layers of smooth muscle layers of inner,
thick circular and outer longitudinal muscle cells. Vascular layer with large
CHAPTER ONE
6
arteries, veins and lymph is located between the two layers (Hafez 1993, Bacha
and Bacha 2000).
Figure 1.2: The bovine uterine horn cross section.
1.3 Bovine oestrus cycle
1.3.1 General overview
The reproductive cycle of non-primate female mammals is known as the oestrus
cycle. One oestrus cycle is the period of the time between two successive oestrus
(sexual receptivity) periods and the reproductive system is characterised by
numerous physiological changes. Cows in oestrus have many clinical signs such
as nervousness, standing to be mounted, vaginal mucus discharge, and
acceptance of the bull for mating. Other secondary signs include bellowing,
aggressiveness and restlessness (Senger 2003, Ball and Peters 2004). In the
cow, the average oestrus cycle lasts 21 days with range 18-24 days, with day 0
is designated oestrus. The oestrus cycle is can be divided into phases as follows:
(Noakes et al. 2009).
Pro-oestrus
Proestrus is the period just prior to oestrus, and typically occurs on days 17-20 of
the oestrus cycle. It is characterised by declining progesterone concentrations
due to corpus luteum regression and extends to the start of oestrus. The main
characteristic of this stage is the occurrence of the rapid growth of the pre-
ovulatory antral follicle, which is responsible for increasing circulatory oestradiol
concentrations. Oestradiol induces numerous changes in the female reproductive
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system in preparation for mating as well as induction of the behavioural changes
of oestrus (O'Connor 1993).
Oestrus
Oestrus lasts on average 9-12 hours in dairy cows (Noakes et al. 2009). It is a
very recognisable stage because of several clinical signs (e.g standing heat;
bellowing, restlessness; mucus discharge in the vagina, chin resting and back
rubbing) as well as physiological changes (e.g. luteinising hormone (LH) surge).
In the cow, ovulation (release of the oocyte for fertilisation) takes place on
average 28 hours after the LH surge, which occurs mid-oestrus (Noakes et al.
2009).
Metoestrus (post-ovulation)
It is the period after ovulation while the corpus luteum (CL) is forming. During
metoestrus both oestrogen and progesterone are relatively low (Noakes et al.
2009).
Dioestrus (Luteal)
Dioestrus is the longest stage of the oestrus cycle. It starts from day 5-17, when
the corpus luteum becomes functional and progesterone concentrations are rising
(Senger 2003). This stage lasts until the CL is regressed in the absence of a
pregnancy. High progesterone prepares the uterus to create a suitable
environment for the conceptus and establish pregnancy. In terms of ovarian
function, the oestrus cycle can also be divided into two phases: luteal phase and
follicular phase. The luteal phase is about 14-18 days in length and CL is the
dominant structure, and is characterised by high progesterone concentrations
(Forde et al. 2011, Aerts and Bols 2010). The shorter follicular phase lasts
approximately 4-7 days, when increasing pulsatile secretion of gonadotropin
hormones stimulate the final maturation of the antral follicle. Oestradiol is the
dominant hormone at this stage (Hafez 1993, Bearden and Fuquay 1992).
1.3.2 Hormonal control of oestrus cycle
Hormones are chemical substances that act as a messenger, and often convey
the message between organs by the bloodstream controlling their activity.
Hormones are secreted from various endocrine glands such as pituitary, thyroid,
and adrenal glands. The complex regulation of the oestrus cycle in cows involves
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interactions between the hypothalamus, pituitary gland, ovaries with an input
from the uterus. The oestrus cycle is regulated by hormones secreted from the
hypothalamus (gonadotrophin-releasing hormone; GnRH), anterior pituitary
gland (follicle stimulating hormone [FSH] and luteinising hormone [LH]), ovaries
(progesterone [P4]; oestradiol [E2] and inhibin) and uterus (PGF2). These
hormones exert their actions through a system of negative and positive feedback
that ultimately governs the oestrus cycle (Webb et al. 1991, Forde et al. 2011).
The interactions of these hormones are shown in Fig. 1.3.
GnRH is released from the hypothalamus in a pulsatile manner and is responsible
for the release of gonadotrophin hormones, FSH and LH from the anterior
pituitary gland (Conn and Crowley 1994). FSH stimulates antral follicle
Figure 1.3: The summary of the hormonal control of the ovarian cycle. Adapted from (Ball
and Peters 2004).
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recruitment, which occurs in wave throughout the cycle, typically 2 or 3 per cycle
(Fig. 1.4).
During pro-oestrus, the gonadotrophins stimulate final maturation of the pre-
ovulatory follicle, resulting in increased release of oestradiol. Oestradiol acts on
oestrogen receptors in the surge and tonic centres of the hypothalamus to trigger
the release of LH, when progesterone levels are low (Peter et al. 1985). The
action of LH, is mediated by a membrane G protein-coupled receptor (LHCGR)
present in the theca and granulosa cells of the ovulatory follicle (Ireland and
Figure 1.4: Hormonal changes during the bovine oestrus cycle. Follicle stimulating
hormone (FSH) stimulates antral follicle recruitment in waves. While pulses of luteinising
hormone (LH) stimulate the latter stages of (dominant) follicular development and is
responsible for increasing oestradiol (E2) secretion by the dominant follicle. Increasing E2
levels positively feedback on the brain to induce oestrus behaviour and increasing LH
pulse amplitude resulting in a surge of LH. This is the trigger for ovulation. Progesterone
(P4) is produced by the corpus luteum (CL) during the luteal phase and levels steadily
increase post-ovulation. In the non-pregnant cow, uterine derived prostaglandin-F2α 
(PGF2α) initiates CL regression and thus progesterone concentrations fall. This removes 
the negative feedback of progesterone on the hypothalamus enabling the cow to re-enter
pro-oestrus. Adapted from (Garnsworthy et al. 2008).
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Roche 1982). LH binding to the LHCGR activates a G-protein (Gibori 1993), which
leads to the production of cyclic AMP (cAMP) and phosphorylation of regulatory
intracellular proteins (Catt and Dufau 1976). The pre-ovulatory LH pulses
continue to stimulate the final development of the dominant follicle, which is
associated with further increased oestradiol production. Above a certain
threshold, positive feedback of oestradiol on the hypothalamic surge centre leads
to increased GnRH pulsatile release and ultimately an LH surge that causes
ovulation (Fig. 1.4). During the luteal phase of the oestrus cycle, the CL produces
P4 whose concentrations increase post ovulation before reaching a peak around
day 8-10. During the luteal phase, there is a negative feedback mechanism
through which progesterone inhibits LH secretion via suppression of GnRH. In
non-pregnant cows, the CL will regress as a result of PGF2ɑ production from the
uterus which causes a decrease in P4 concentration. This enables the final stages
of follicular maturation to occur and the animal to return to oestrus (Webb et al.
1991, Webb and Campbell 2006, Garnsworthy et al. 2008). It is important to
note that in the cow, both dominant follicles and CL can be present (at various
stages of their development) on the ovary at the same time.
1.4 Folliculogenesis
There are approximately 450,000 primordial follicles present in each bovine ovary
at birth, this number has declined to about 3000 when the cow reaches 15-20
years of age (Erickson 1966, Webb et al. 1991). The central dogma is that no
new primordial follicles are produced after birth. Each primordial follicle
composed of an oocyte (egg) surrounded by a single layer of flattened precursor-
of granulosa cells. The process of follicular development and growth is called
folliculogenesis (Fig. 1.5) and is controlled by gonadotrophins and local ovarian
factors. The earliest stages are gonadotrophin independent and appear to be
largely regulated locally.
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Figure 1.5: Schematic representation of the growth and maturation of the bovine follicle
throughout folliculogenesis.
A cohort of primordial follicles from the resting pool is stimulated by intra-ovarian
signals. This cohort will develop into primary (granulosa cells become cuboidal in
shape), then pre-antral (increasing numbers of granulosa cell layers and
recruitment of a theca layer from the stroma), and ultimately antral (formation of
an antral cavity) follicles. It is these antral follicles that become pre-ovulatory
and release the oocyte. In cattle, sheep and humans, this process takes about 6
months (Campbell et al. 2003). However, the majority of follicles will not develop
to pre-ovulatory size but will become atretic and be lost. The process of atresia
will involve apoptosis of both follicular cells as well as the oocyte (Chun and
Hsueh 1998, Quirk et al. 2004). It has been indicated that the development of
the pre-antral follicle is independent of gonadotropic stimulation, with paracrine
control mechanisms having a primary role (Gong et al. 1996). However, FSH
receptors (FSHR) have been detected in primary follicles and FSH stimulated
growth of medium-sized pre-antral follicles in vitro (Gutierrez et al. 2000, Webb
et al. 2002).
There are several factors that have been identified as important regulators for
the development of pre-antral and antral follicles including: fibroblast growth
factor 2 (FGF2), intra-ovarian peptides (activin and inhibin), epidermal growth
factor (EGF), stem cell factor (SCF or kit-ligand: KL), transforming growth factor
B (TGFB), bone morphogenetic protein-15 (BMP-15 or GDF-9B), vascular
endothelial growth factor A (VEGFA) and insulin-like growth factor 1 (IGF-1)
(Mihm et al. 2000, Berisha et al. 2000, Juengel et al. 2004).
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1.4.1 Antral follicle
As follicular growth continues, granulosa cells increase in number and once about
6 layers thick, follicles will undergo the transition to the antral phase (Braw-Tal
and Yossefi 1997). Follicles at this stage will develop a fluid-filled cavity known as
an antrum, which then surrounds the oocyte. Further follicular growth is
dependent on increasing granulosa cell number and follicular fluid volume.
Granulosa-derived factors generate an osmotic gradient which draws in fluid from
the thecal vasculature, resulting in the formation of follicular fluid and an antral
cavity (Rodgers and Irving-Rodgers 2010). Follicular fluid has a similar
composition to serum and is composed of steroid hormones, protein,
proteogylcans, peptide hormones, insulin like growth factors (IGF) and their
binding proteins and several other factors that determine the fate of the oocyte
and follicle (Bao and Garverick 1998, Webb et al. 1998, Fortune 1994, Rodgers
and Irving-Rodgers 2010). Moreover, it has been reported that follicles selected
to grow to ovulatory size possess a more advanced microvascular network
(Ferrara 2004).
1.4.2 Endocrine regulation of ovarian antral follicle
development in cattle
In cattle, antral follicle growth occurs in two different phases; the ﬁrst ‘slow’ 
growth phase spans the period from antrum acquisition to a size of roughly 3mm
and the second ‘fast’ phase which is gonadotrophin-dependent. This phase
includes cohort recruitment, selection and growth of dominant follicle, (DF)
(Mihm and Bleach 2003) (Fig. 1.5), and the complete acquisition of ovulatory
capacity (Mihm and Bleach 2003).
Increased circulating FSH concentrations constitute the essential stimulation for
recruitment of an antral follicle cohort and emergence of a follicular wave (in
bovine, two or three waves per cycle; (Adams et al. 1992, Fortune 1994). In
cows, only one follicle is selected which then exerts dominance over the other
antral follicles. It achieves that by secreting oestradiol and inhibin, which causes
a decrease in plasma FSH concentrations, that is still required for the growth of
any subordinate follicles (Ginther et al. 1996). In so doing, their support is
removed and thus subordinate follicles will undergo atresia. When LH binds to
LHCGR, it influences different types of activities in the follicle such as
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steroidogenesis, follicular growth, maturation of oocyte and ovulation (Hyttel et
al. 1997). For that reason, the presence of LHCGR on granulosa cells is essential
for continued folliculogenesis from the acquisition of follicular dominance as well
as ovulation (Beg et al. 2001, Ginther et al. 2001, Barros et al. 2009).
1.4.3 LH surge and ovulation
In the non-pregnant cow, uterine PGF2α initiates corpus luteum regression and a 
reduction in P4 concentrations. Subsequently it initiates the increased frequency
of GnRH pulsatile secretion, which in turn initiates the production of low
amplitude, high frequency LH pluses. These LH pulses support not only the
continued growth of the large follicle but continued oestrogen production. The
production of oestrogen is regulated under the activities of both LH and FSH.
Namely androstenedione production by theca cell is stimulated by LH; while, FSH
stimulates the aromatisation of androstenedione to oestradiol-17β act in 
granulosa cells. Subsequently, oestradiol acts on the hypothalamus to increase
the release of GnRH pulse frequency, which produces high level of FSH and LH
surge (Fig. 1.3). Furthermore, LH surge stimulates oocyte maturation and
ovulation of the dominant follicle (Gordon 1996).
1.5 Development of the corpus luteum
Following ovulation, the corpus luteum (CL) develops from the ruptured follicle
and forms a temporary endocrine gland. Critical to the formation of the CL is the
LH surge. Proper development of this gland is essential for the maintenance of
early pregnancy in mammals. Its main function is to produce and secrete
progesterone. This acts on the uterus to support embryo development and the
establishment of pregnancy (Mann et al. 1998, Mann and Lamming 2001, Green
et al. 2005).
The CL is composed of luteinising steroidogenic theca and granulosa cells called
small and large luteal cells, respectively. Immediately following ovulation, the
tissue of the collapsed follicle folds in and mainly consists of luteinising granulosa
cells adjacent to theca cells (Amselgruber et al. 1994). There are two major
simultaneous process involved in luteinisation: extensive remodeling of the tissue
leading to CL formation and the acquisition of luteal function. The first step
involves cell proliferation and hypertrophy of the steroidogenic cells. Theca cells
from the ovulated follicle undergoing proliferation and become small luteal cells
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(Farin et al. 1986). The basement membrane between the theca interna and
granulosa cells breaks down with the theca and vascular cells migrating into the
luteinising granulosa cell layers. Eventually, they will be completely dispersed
among luteinised granulosa cells. Simultaneously there is growth of an extensive
vascular network (Amselgruber et al. 1994). Formation of these blood vessels
occurs due to an increase of angiogenic factors, which are secreted form during
the ovulatory process (Niswender and Nett 1994).
Corpus luteum formation involves the proliferation of non-steroidogenic cell
populations such as endothelial cells (required for the formation of the luteal
vascular network) alongside other cells like fibroblasts, pericytes and
macrophages (Alila and Hansel 1984, Schams and Berisha 2004). On the other
hand, the luteinisation of granulosa cells yields large luteal cells, which generally
cease dividing but undergo massive hypertrophy (Alila and Hansel 1984, Schams
and Berisha 2004). Hypertrophy of luteinising granulosa cells results in an
increase in cellular size through altered expression of cytoskeletal components.
The resulting structure usually protrudes from the ovary and is red-tan in colour
(Peters and Ball 1995). Different studies have reported that the ability of
luteinising granulosa cells transiently change tubulin expression and acquire the
ability to express cytokeratin, vimentin and desmin (Khan-Dawood et al. 1996).
The mature CL is composed of about 30% steroidogenic cells and 30-40% are
endothelial cells (Devoto et al. 2002). In domestic ruminants, other cell types
have been identified including: fibroblasts, vascular smooth muscle cells,
macrophages, lymphocytes, leukocytes and pericytes (Hansel et al. 1990, O'Shea
et al. 1989). Pericytes are characterized as perivascular cells attached to
endothelial cells and their branched cytoplasm surrounds newly formed blood
vessels (Amselgruber et al. 1994).
In addition to the morphological changes seen during luteal development,
numerous biochemical changes occur during luteinisation (Niswender and Nett
1994). The cytoplasm of both large and small steroidogenic cells accumulate
abundant smooth endoplasmic reticulum and numerous mitochondria (Niswender
and Nett 1994). This is associated with the initial increase of circulating
progesterone (Niswender and Nett 1994). LH is the most important hormone that
stimulates synthesis of progesterone in the bovine CL (Niswender and Nett
1994). The inhibition of LH pulses during metoestrus caused inhibition of luteal
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development and reduced its ability to secrete progesterone. Both large and
small steroidogenic cells contain LHCGR, which increased during CL development.
However, only small luteal cells respond to LH in regards to progesterone
production (Quintal-Franco et al. 1999).
The large luteal cells produce large amount of progesterone in the absence of LH
stimulation (Quintal-Franco et al. 1999). However, LH is critical for progesterone
production from the CL (Hansel and Blair 1996). This is partially due to LH
stimulating the expression of cytochrome P450 side chain cleavage (CYP11A)
mRNA which is then maintained in the absence of cAMP-stimulating agents
(Juengel et al. 1994). Large luteal cell also highly express steroid acute
regulatory protein (STAR) mRNA. STAR expression was stimulated by IGF-1
(Amselgruber et al., 1994), through an autocrine and endocrine manner
(Sauerwein et al. 1992).
1.5.1 Cellular content of the corpus luteum
The array of different cell types in the CL interact together to achieve normal
function during growth, differentiation and regression of the CL (Niswender et al.
2000, Grazul-Bilska et al. 1997, Reynolds et al. 2000). These interactions are
mediated by both contact-dependent (e.g. via gap junctions) (Reynolds and
Redmer 1998), Notch signaling (Vorontchikhina et al. 2005) and contact-
independent mechanisms, e.g. secretion of growth factors (Schams and Berisha
2002). This section will provide basic knowledge on these different luteal cell
types.
1.5.1.1 Steroidogenic cells
Large luteal cells
Large luteal cells (LLC) range from 24 to 38 µm in diameter (O'Shea et al. 1989,
Lei et al. 1991) and represent about 40% of the total volume of the luteal tissue
(O'Shea et al. 1989). However, these cells only represent about 10% of the total
number of luteal cells (O'Shea et al. 1989). Morphologically, these cells are
characterised by a spherical shape with a spherical nucleus and contain extensive
rough and smooth endoplasmic reticula, abundant mitochondria and secretory
granules (Wiltbank 1994).
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Small steroidogenic cells
Small luteal cells (SLC) represent about 25-27% of the total number of cells and
about 20-30% of the luteal volume. These cells differ from large luteal by their
much smaller diameter (16-18 µm) (O'Shea et al. 1989). These cells also contain
abundant mitochondria and smooth endoplasmic reticulum, but contain less
rough endoplasmic reticulum and secretory granules compared to large luteal
cells (Wiltbank 1994). In addition, their nuclei are irregular with cytoplasmic
inclusions and more lipid droplets compared to large luteal cells (O'Shea et al.
1989).
1.5.1.2 Non-steroidogenic cells
Endothelial cells
Endothelial cells (EC) represent the vast majority of non-steroidogenic cells in the
CL (50% of the total cell number) (O’Shea et al., 1989). These cells express
neural cell adhesion molecule (NCAM), which could mediate interaction between
EC and LLC, which express NCAM. This functional adhesion between EC and LLC
has been suggested to stimulate progesterone production by large luteal cells
(Girsh et al. 1995). Endothelial cells are much smaller than large and small luteal
cell with a diameter of 10-11 µm. Morphologically, EC are characterised by an
elongated and slender shape, with a large nuclear to cytoplasmic ratio, small
number of organelles and a distinct basal lamina (Wiltbank 1994). The cells are
involved in vasodilation, vasoconstriction, angiogenesis and immune cell passage
into tissue (Michiels 2003).
Pericytes
Pericytes interact with EC through discontinuities in the shared basement
membrane. Morphologically, pericytes are composed of a cell body, prominent
nucleus, and small content of cytoplasm with many long processes. They are
located along the basement membrane of micro vessels (Mandarino et al. 1993).
Pericytes communicate with endothelial cells by direct physical contact and
paracrine signaling pathways. Pericytes stabilise newly formed endothelial tubes,
modulate blood ﬂow and vascular permeability as well as EC migration, 
differentiation and branching (Carmeliet 2003).
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In the CL, pericytes produce angiogenic factors such as vascular endothelial
growth factor A (VEGFA) (Redmer et al. 2001). Interestingly, ECs degenerate
during luteal regression but the number of pericytes remain high (Redmer and
Reynolds 1996). They play a role in both regulation of tissue remodeling and in
maintaining the integrity of large blood vessels by allowing structural luteolysis to
occur.
Vascular smooth muscle cells (SMC)
In contrast to pericytes, SMCs are not embedded in the basement membrane and
might not have direct contact the endothelium (Gerhardt and Betsholtz 2003).
During angiogenesis, SMCs exhibit very high rates of proliferation, migration and
synthesis of extracellular matrix components including: collagen, elastin and
proteoglycans that compromise a major portion of the blood vessel wall. At the
same time, these cells acquire contractile abilities (Owens et al. 2004). Likewise,
in response to a vascular wound, the SMC undergo a high level of cell
proliferation, migration, and synthetic capacity. Thus, they play a fundamental
role in wound and vascular repair (Owens et al. 2004).
Fibroblasts
Fibroblasts are 10-12 µm in diameter and represent about 6-9% of the luteal
volume and 10-20% of the total number of cells (O'Shea et al. 1989). These cells
play an important role in the maintaining the structural framework of the corpus
luteum.
Immune cells
Immune cells, lymphocytes and macrophages are all observed in the bovine CL
(Lobel and Levy 1968) particularly evident from 14 days onwards around the
time of luteal regression. The function of immune cells during CL regression is
thought to be destruction of the luteal tissue through different processes,
including phagocytosis (Paavola 1979). However, immune cells may have
another active role in controlling the lifespan and function of the CL (Adashi
1990). There has been specific attention to tumor necrosis factor α (TNFA), 
because it is cytotoxic for tumors cells. Similar processes occur during luteal
tissue regression (Ji et al. 1991). Indeed, TNFA has also been detected in the
bovine CL undergoing regression (Shaw and Britt 1995).
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1.6 Angiogenesis
Angiogenesis is defined as a complex process by which new blood vessels grow
from pre-existing ones. In addition, it is a physiological process involving the
proliferation and migration of endothelial cells, and plays an important role in
normal growth and tissue development (Klagsbrun and D'Amore 1991). In fact,
rapid CL growth is associated with intense vascular growth (Zheng et al. 1993).
Angiogenesis is a complex process, which requires the breakdown of walls of
existing blood vessels, which starts the migration, and proliferation of endothelial
cells to form the new blood vessels. For this to occur, the extracellular matrix
requires to be degraded (e.g by matrix metalloproteinases (MMPs)) that
consequently facilitates EC migration and proliferation (Klagsbrun and D'Amore
1991, Bendeck 2004).
New blood vessels are composed of endothelial cells with one or more
surrounding layers of supporting cells including pericytes or smooth muscle cells
(Chantrain et al. 2006). These supporting cells (pericytes) have actually been
found at the end tips of endothelial sprouts and once the new vessels are formed
these cells then start to extend along the length of these vessels and stabilize
them (Bergers and Song 2005, Hall 2006, Raza et al. 2010, Robinson et al.
2009). Angiogenesis also involves the creation of a capillary lumen and
differentiation of these newly formed vessels into arterioles or venules (Klagsbrun
and D’Amore 1991). Angiogenesis occurs infrequently in the normal adult, except
in the female reproductive system. This includes during follicular development,
the formation of the CL, and in the placenta during pregnancy. It also occurs as a
part of the body’s repair process, for instance, wound healing which has parallels
to the ovulatory response. However, uncontrolled neovascularization is often
pathological. For example, in tumours, the growth of tissue depends on
neovascularisation while in diabetes, blindness can result from retinopathy and
vascularisation of the retina (Folkman 1972).
1.6.1 Angiogenesis and the function of corpus
luteum
During early luteal development, the blood flow starts slowly but new blood
vessels are highly permeable until a new basement membrane is formed and
pericytes cover the length of the proliferated endothelial cells (Amselgruber et al.
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1994). Capillary sprouting depends on the coordinated growth of both pericytes
and endothelial cells (Amselgruber et al. 1994).
The rate of vascular growth in the luteal tissue is greatest in metoestrus and by
the mid-luteal phase the mature CL is highly vascularized (Redmer and Reynolds
1996). Up to 85% of proliferating cells during luteal development are endothelial
cells (Redmer and Reynolds 1996). Vascular development of the luteal tissue
during its development has been quantified using immunlocalisation for von
Willebrand Factor (VWF) (Robinson et al. 2008). It has been observed that most
microvessels were found in the thecal-derived areas in the early CL but numerous
capillary sprouts were observed among luteinising granulosa derived
steroidogenic cells (Zheng et al. 1993). The mid-CL was composed of numerous
endothelial cells forming capillaries, which form a dense network surrounding
luteal steroidogenic cells (Zheng et al. 1993). Indeed, many luteal steroidogenic
cells were immediately adjacent to at least one capillary. Similar observations
have been reported in the marmoset CL (Young et al. 2000). However, Young et
al. (2000) also observed endothelial cell proliferation during luteal regression,
suggesting that these proliferate to from the large blood vessels in order to
remove away the cellular debris of regressed particles. They observed that luteal
angiogenesis did not change until functional regression was terminated and
progesterone concentrations have decreased to follicular phase levels (Young et
al. 2000).
Luteal angiogenesis is rapid, being established within days of ovulation
(Amselgruber et al. 1999) and is summarized in Fig. 1.6. After ovulation, the
blood vessels of the ruptured follicular wall rapidly grows in the CL, which
reaches its maturity from about 10 to 12 days. The main function of the CL is to
produce progesterone, with plasma progesterone concentrations used as an
indicator of luteal function (Niswender and Nett 1994, Reynolds et al. 1994). The
establishment and remodelling of a complex ovarian vascular system plays a
crucial role in the development and function of the CL (Robinson et al. 2009).
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This is critical for the supply of nutrients, oxygen, hormonal support and
facilitation of the release of steroid hormones (Robinson et al. 2009). In addition,
the vascular network will facilitate the transport of progesterone precursors to
Figure 1.6: Corpus luteum development and its vascularisation. A) In the pre-ovulatory
follicle, the extensive vascular network (endothelial cells, pericytes) is localised to theca
layer (arrow). The thecal micro-vessels are separated from the granulosa layer by a
basement membrane. B) Prior to ovulation, theca microvessels dilate, invaginate into the
basement membrane and expand into the granulosa layer. C) During ovulation, the
endothelial cell basement membrane degrades due to action of proteases. Pericytes start
to migrate from thecal area towards the granulosa region under the influence of
granulosa-derived growth factors. D) During CL development, pericytes stimulate
migration and sprouting of endothelial cells from thecal area (Reynolds et al. 2000, Fraser
and Wulff 2003, Robinson et al. 2009).
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the luteal cells (Reynolds et al. 1994). The differentiation and maturation of a
functional CL is based on a well-developed capillary bed (Amselgruber et al.
1994). During the early luteal phase, progesterone concentrations in the blood
mirror luteal blood flow increases (Acosta et al. 2003) which highlights the
importance of angiogenesis for CL function.
1.6.2 Stimulation of angiogenesis
Several studies have indicated that in many tissues (e.g tumours), hypoxia is the
stimulus for the synthesis of pro-angiogenic factors, in particular vascular
endothelial growth factor A (VEGFA). This then subsequently initiates
angiogenesis. However, there is evidence that luteal angiogenesis is, at least in
part, up-regulated by LH (Fraser and Wulff 2003, Berisha et al. 2006, Robinson
et al. 2009). For example, in cows, follicular fibroblast growth factor (FGF) 2
mRNA and protein concentrations were significantly increased after LH surge
(Berisha et al. 2006). In most in vitro studies, VEGFA production by granulosa
cells was stimulated by LH or hCG in cows (Schams et al. 2001) and primates
(van den Driesche et al. 2008, Martinez-Chequer et al. 2003). In addition, IGF-1
has also been shown to simulate VEGFA secretion by bovine granulosa cells
(Schams et al. 2002).
There are several factors that regulate angiogenesis with the FGF family (Presta
et al. 1989), VEGFA (Ferrara et al. 2003) and PDGF (Presta et al. 1989) being the
most important. However, other modulatory factors have also been shown to
stimulate angiogenesis including angiopoietins (ANGPT1 and ANGPT2), hypoxia-
inducible factor-1α (HIF1A), and inhibitory factors including TNFA and TGFB 
(Yancopoulos et al. 2000, Folkman and Shing 1992).
1.6.2.1 Fibroblast growth factor 2 (FGF2)
In the bovine CL, ﬁbroblast growth factor (FGF2) seems to be more dominant 
factor at stimulating endothelial cell growth and is most likely the major pro-
angiogenic factor (Klagsbrun and D'Amore 1991). Expression of FGF2 protein was
increased during follicular-luteal transition in the cows, suggesting that FGF2
plays a key role in the initiation of angiogenesis (Robinson et al. 2007). While
VEGFA expression was unaffected over the same time period. FGF2 has been
shown to induce angiogenesis by stimulating endothelial cell production of
collagenase and plasminogen activator (Klagsbrun and D'Amore 1991). The
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release of these proteases which are able to degrade the basement membrane
and induce migration of capillary endothelial cells. However, this factor is
different from most other angiogenic factors, in that FGF-2 is not a typical
secreted protein and must, therefore, be released by alternative mechanisms,
perhaps from cellular storage as a result of cell lysis (Klagsbrun and D'Amore
1991).
FGF2 has a fundamental role in the stimulation of endothelial cell sprouting and
formation of luteal EC networks in vitro (Laird et al. 2013). This was
demonstrated utilising an in vitro luteal angiogenesis culture system, in which
endothelial cell network formation was inhibited by adding FGF receptor inhibitor
(Woad et al. 2009). Furthermore, FGF2 was regulated during the follicular–luteal
transition, which localised in thecal endothelial cells and vascular pericytes before
the LH surge (Berisha et al. 2006). However, after the LH surge for about 2 days,
FGF2 was localised dominantly in the luteinising granulosa cells, this is may be
important for maintenance of granulosa cells (Berisha et al. 2006). The most
striking effect of angiogenesis was seen when VEGFA and FGF2 were used
together to induce angiogenesis in vitro (Pepper et al. 1992).
1.6.2.2 Vascular endothelial growth factor A (VEGFA)
Formerly, VEGFA was originally known as vascular permeability factor due to its
capability to cause leakage and induce fenestrations in the endothelial cells of
capillaries (Senger et al. 1983), vascular endothelial cell protease production,
proliferation and migration. Moreover, it is a potent stimulator of angiogenesis in
the follicle and CL in many species. Furthermore, VEGFA mRNA increased
dramatically during both normal and pathological angiogenesis such as wound
healing, fracture (Reynolds and Redmer 1998) and tumour growth (Ferrara and
Davis-Smyth 1997).
It has been demonstrated that the VEGFA mRNA expression was temporally and
spatially related to angiogenesis in the ovary (Phillips et al. 1990, Ravindranath
et al. 1992). It is a potent mitogenic for endothelial cells (Senger et al. 1993,
Connolly 1991). The action of VEGFA is mediated through two receptors, VEGFR-
1 and VEGFR-2. It has been shown that CL development is related to intense
angiogenesis which is influenced by VEGF-A and its receptor VEGFR-2 (Hünigen
et al. 2008). In the cow, local immunoneutralisation of VEGFA decreased luteal
development and progesterone production (Yamashita et al. 2008) and the
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inhibition of VEGFA signalling resulted in inhibition of the formation of endothelial
networks in vitro (Woad et al. 2009).
1.6.2.3 Influence of bacterial endotoxins
Bacterial lipopolysaccharides have been shown to induce angiogenesis in several
tissue systems. LPS directly stimulated endothelial cell sprouting and increased
angiogenesis in vitro through the activation of tumour necrosis receptor
associated factor-6 (TRAF6) dependent signaling pathways (Pollet et al. 2003).
Moreover, VEGFA protein and mRNA expression in macrophages was markedly
increased by LPS in cirrhotic patients (Pérez‐Ruiz et al. 1999). However, other
studies found that bacterial LPS causes downregulation of VEGFA in endothelial
cells and delayed wound healing (Power et al. 2001).
1.7 Progesterone synthesis
Progesterone is the principal steroid hormone produced by the bovine CL. There
are several source of cholesterol (the precursor of progesterone) within luteal
cells including free cholesterol found in the membrane (Wiltbank et al. 1990) and
esterified cholesterol deposited in cytoplasmic lipid droplets (Farin et al. 1986,
Rennert et al. 1993) (Fig. 1.7). Esterified cholesterol is delivered to the bovine
luteal cell via high density lipoproteins (HDL) and to a smaller extent via low
density lipoproteins (LDL) (Savion et al. 1982). The HDL/LDL cholesterol complex
attaches to specific receptors present on the outer membrane of the luteal cells
before entering them. Production and secretion of progesterone by the CL
involves two key enzymes and other regulatory proteins. The key rate-limiting
step in synthesis of progesterone is the conveyance of cholesterol from the outer
to the inner mitochondrial membrane. This is facilitated by steroid acute
regulatory protein (STAR). Cytochrome P450 side chain cleavage (CYP11A) is
located in the inner mitochondrial membrane and converts cholesterol to
pregnenolone. While, 3β-hydroxysteroid dehydrogenase (HSD3B), which is found 
in smooth endoplasmic reticulum, converts pregnenolone to progesterone
(Rekawiecki et al. 2008). In the cow, the luteal secretion of progesterone is
stimulated by LH and PGE2 in vitro (Rekawiecki et al. 2005). This was explained
by the increased STAR, CYP11A, and HSD3B protein expression after treatment.
Furthermore, LH is responsible for an increase in the number of intracellular
organelles including mitochondria, smooth endoplasmic reticulum and lipid
droplets (Gibori 1993).
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Figure 1.7: Progesterone synthesis pathway in a luteal cell. There are three sources of
cholesterol: A) High density lipoprotein (HDL), B) Low density lipoprotein (LDL), C)
Hydrolysis of stored cholesterol esters by cholesterol esterase. D) Free cholesterol then
transported to inner mitochondrial membrane, which is stimulated by steroidogenic acute
regulatory protein (STAR), E) cholesterol is converted to pregnenolone by cytochrome P-
450 chain cleavage enzyme, CYP11A before being transported back out of mitochondria,
F) In the smooth endoplasmic reticulum, pregnenolone is converted to progesterone by
3β-hydroxysteroid dehydrogenase (HSD3B); G) Then progesterone appears to diffuse 
from luteal cell. Adapted from (Niswender et al. 1994).
Steroid acute regulatory protein (STAR)
The action of STAR is mediated thorough the interaction between of its C-
terminus with the relatively sterol-rich outer mitochondrial membrane. This
causes cholesterol to pass from the outer membrane and transfer to inner
membrane (Fig. 1.7). STAR remains within the mitochondria during this process
therefore, continued synthesis of STAR is important and is required for sustaining
steroidogenesis (Alpy and Tomasetto 2005). In addition, it has been suggested
that post-or co-translational modification of STAR may increase the action of
newly formed STAR protein (Strauss et al. 2003). LH-induced increases in
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intracellular cAMP concentrations are important for protein kinase A (PKA)
activation and increasing STAR activity through phosphorylation of STAR and this
will lead to increased progesterone production (Rekawiecki et al. 2005).
Cytochrome P450 side chain cleavage enzyme (CYP11A)
The cleavage of the side chain from cholesterol to form pregnenolone on the
inner mitochondrial membrane is catalysed by CYP11A. CYP11A is induced during
luteinisation (Meidan et al. 1992) but its transactivation is repressed by
activation of the protein kinase C (PKC) pathway (Moore et al., 1990). PGF2α 
appears to inhibit secretion of progesterone by ovine large luteal cells in vitro
through the protein kinase-C (PKC) pathway (Wiltbank et al. 1989), Fig. 1.7.
3β-hydroxysteroid dehydrogenase (HSD3B) 
3β-hydroxysteroid dehydrogenase is located in the endoplasmic reticulum and 
mitochondria, where it catalyses 3β-hydroxysteroid dehydrogenation and Δ5- to
Δ4-isomerisation of the Δ5-steroid precursors (Lorence et al. 1990). Pregnenolone
formed by CY11A diffuses out of the mitochondria and then is transported to the
smooth endoplasmic reticulum (SER), where pregnenolone is converted to
progesterone by the action of 3β-HSD (Niswender et al. 1994), Fig. 1.7. 
1.8 Luteolysis
In the cow, luteolysis is initiated around day 16 of the oestrus cycle in the
absence of a sufficiently developed embryo. Oxytocin secreted from the CL
and/or posterior pituitary gland acts on oxytocin receptors (OXTR) in the
endometrium to induce pulsatile PGF2α secretion. Then, PGF2α enters the uterine 
vein, and as a result of counter current is transferred to the uterine/ovarian
artery and PGF2α diffuses to the ovary. It is then when it causes luteolysis 
(McCracken et al. 1999) by acting on large luteal cells (Wathes and Lamming
1994, Flint et al. 1994). Luteolysis involves apoptosis, the infiltration of immune
cells, and ultimately reduction in the blood flow to the CL (Niswender et al.
1994). There are some histological changes, which occur in the regressing CL
including thickening of the arterial wall, a decreased number of granules in the
cytoplasm and peripheral vacuolation of the large luteal cells. When the luteal
cells decrease in size, the CL decreases in size, becomes pale in colour and is
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known as a corpus albicans (Jainudeen and Hafez 1993). This is associated with a
rapid decline in progesterone concentrations.
1.9 Post-partum reproductive performance
The productivity and sustainability of any dairy cattle enterprise depends on
efficient reproductive performance (Radostits et al. 2006). To maintain this
enterprise, dairy cows should have regular oestrus cycles, conceive at an optimal
time and deliver a healthy calf each year (Hare et al. 2006). Any fertility and
other reproductive problems during the postpartum period are crucial factors in
cull making decisions (Radostits et al. 2006). In the USA, about 20% of dairy
cows are culled yearly due to poor and inadequate reproductive performance
(McDougall 2006). Dairy herd reproductive performance indices provide an
indication of reproductive abnormality or problems and make it possible for
strategic treatments to be introduced (Radostits et al. 2006). Unfortunately,
reproductive performance indices and their targets vary from country to country
and local trends should be considered when interpreting reproductive targets in
dairy enterprises (McDougall 2006, Radostits et al. 2006).
Inadequate reproduction in dairy cows results in excessively long lactations
where milk production steadily declines, or prolonged periods with no milk
production at all. Such situations are costly to the dairy farmer, and may require
extensive replacement heifers to maintain a stable herd size (McDougall 2006,
Radostits et al. 2006). Establishing a successful reproductive monitoring
programme requires the veterinarian to work with the dairy producer. It also
requires intense monitoring of farm’s management e.g. feeding, housing, cow
comfort and keeping records (McDougall 2006, Radostits et al. 2006). The design
of this programme can generate successful breeding in cows and a diminished
involuntary culling rate due to reproductive inefficiency (Hare et al. 2006,
Radostits et al. 2006). There are numbers of indices been used to measure
fertility and reproductive efficiency of dairy enterprise, but the most commonly
been used is calving interval (Hare et al. 2006, Radostits et al. 2006).
1.9.1 Uterine and cervical involution
Involution of the uterus and cervix is the process of returning these structures to
a state capable of supporting a new pregnancy. The exact time required for
uterine involution is difficult to evaluate (Kindahl et al. 1999). Generally, it takes
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place within three weeks after calving, but usually it is not completed until 4-5
weeks postpartum. It can be assessed by rectal palpation and ultrasonography
(Kindahl et al. 1999). After calving, pregnancy re-establishment depends on the
system returning to its pre-gravid condition (Mateus et al. 2002). Delayed uterine
involution has negative impacts on the economy of dairy farms (Zhang et al.
2010). The activity of the ovaries during the postpartum period requires the
resumption of ovarian follicular activity. In dairy cows, a delay in resumption in
ovarian activity has adverse effects on the calving to conception interval
(Ramakrishnan and Dhami 2012). In contrast, a delay in uterine involution was
associated with the endometrial damage and a negative impact on the ability to
conceive (Gilbert et al. 2005). The mechanism of uterine involution varies among
domestic species and mainly depends on the type of placentation. The
placentation in cattle is cotyledonary (Hafez 1962). Several events happen after
uterine involution including continued contraction of the myometrium
(Hirsbrunner et al. 2002, Kindahl et al. 1999, Noakes et al. 2009), physical
shrinkage, atrophy of glandular tissue and muscle cells, tissue necrosis and
shedding it and regeneration of new endometrium (Levkut et al. 2002). The size
of the uterus rapidly decreases due to constriction of the blood vessels and
contractions of the myometrium (Leslie 1983). At the same time as uterine
involution, the uterus is often contaminated with bacteria (Azawi 2008). This will
stimulate the local innate immunity for clearing and repairing the uterine
infection.
Casida et al (1968) defined uterine involution as complete when the uterus
returned to its normal non-pregnant position and when the two horns were
similar in diameter and showed normal consistency and tone. However, for many
cows the uterus cannot be palpated easily during the first three weeks post-
partum, so diameter of the cervix may be a more useful indicator of the
involution process. The involution of the cervix is slower and it is completed by
day 30 postpartum (Leslie 1983).
1.9.2 Factors that delay uterine involution
It has previously been reported in many studies that the time of uterine
involution can be affected by several factors. Generally, uterine involution takes a
few days longer in multiparous cows than in primiparous cows (Hajurka et al.
2005, Leslie 1983, Melendez et al. 2004, El-Din Zain et al. 1995, Noakes et al.
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2009). However, the biggest factor is endometritis, which can have a large
negative impact on the time for uterine involution. This is discussed in more
detail in the following sections.
1.9.3 Pathogenic bacterial infection of the uterus
After calving, the uterine environment enhances the growth of a variety of
aerobic and anaerobic bacteria. However, the most pathogenic bacteria causing
uterine infection are believed to be Escherichia coli, Trueperella pyogenes,
Fusobacterium necrophorum and Prevotella species. It has been show that some
bacteria, including T. pyogenes, F. necrophorum and Prevotella act synergistically
to increase the severity uterine disease (Ruder et al. 1981, Olson et al. 1984).
The most prevalent pathogenic bacteria in the reproductive tract during
postpartum period in cows are E.coli (37%) and T. pyogenes, (49%) (Williams et
al. 2005). Often infections with E.coli appear to precede and pave the way for T.
pyogenes infection (Williams et al. 2007). The endometrial pathogenic E. coli are
different from diarrhoeic or extra-intestinal pathogenic E. coli (Sheldon et al.
2010). This is because these bacteria are more adherent and invasive for
endometrial epithelial and stromal cells, compared with E. coli isolated from the
uterus of clinically unaffected animals (Sheldon et al. 2010).
1.9.4 Contamination and elimination of bacteria
from the postpartum uterus
During pregnancy, the vulva, vestibule, and vagina and in particular the cervix
act as anatomical barriers to prevent bacteria entering the uterus. During
parturition, the cervix will dilate which allows for the entrance of bacteria into the
uterus (Sheldon 2004, Azawi 2008), for that reason, bacterial contamination of
the uterus postpartum is common. It has been reported that 80–100% of
animals have bacteria in their uterine lumen during the first 2nd weeks after
parturition. While immune responses increasingly remove the bacteria, still more
than 40% of animals still have bacterial infection in the 3rd week after parturition
(Sheldon et al. 2008).
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1.10 Postpartum uterine infection
1.10.1 Metritis
Metritis is the severe inflammation of all layers of the uterus (endometrium,
submucosa, muscularis and serosa). It is characterized clinically by delayed
uterine and cervical involution, pyrexia (≥39.5˚C) and a fetid watery purulent 
discharge. It occurs within the first 21 days postpartum (Sheldon and Dobson
2004). The incidence of metritis varies between studies often due to different
exact definitions of the disease. In North America, the incidence of metritis in
dairy cattle ranged from 10 to 20% (Dubuc et al. 2010, Overton and Fetrow
2008). The main risk factors for metritis included retained fetal membrane,
dystocia, stillbirth, twins, NEB, abortion, milk fever, and deficiency in hygiene
(Correa et al. 1993, Dubuc et al. 2010). Out of these, retained placenta was the
major risk factor with 30 to 50% of metritis cases also having retained placenta
(LeBlanc 2008). It is likely that the fetal membrane becomes necrotic and
provides an ideal media for bacterial growth, if it remains inside the uterus for
more than 24 hours (Sheldon 2004).
1.10.2 Endometritis
Endometritis is regarded as an inflammation of the superficial layers of the
endometrium, and only involves the epithelial surface and underlying glandular
tissues (Azawi 2008). Endometritis is often not associated with clinical systemic
signs (Gunduz et al. 2010). It can be further divided into (1) Clinical endometritis
which is characterized clinically either by the presence of purulent vaginal
discharge at three weeks or more postpartum, or mucopurulent discharge 26
days after calving (LeBlanc 2008, Sheldon et al. 2008); (2) Subclinical
endometritis has no clinical signs and is only diagnosed in the laboratory by
endometrial cytology (Sheldon et al. 2008). Namely, 21 to 33 days after calving,
when there is >18% of neutrophils detected in the endometrium or >10% of
neutrophils during 34-47 days post-calving. Both clinical and subclinical
endometritis are sequel to delayed uterine involution (Sheldon et al. 2008). In
terms of effect reproductive performance, endometritis has been shown to have a
negative on the calving to first service interval; from calving to conception
interval and decreased conception rates (Kasimanickam et al. 2004).
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The reported prevalence of endometritis varies between studies and countries.
For example, in the UK the prevalence of endometritis was 10% in dairy herds
(Borsberry and Dobson 1989). Similar rates have been reported in Denmark
[6.3%] (Bruun et al. 2002), Spain [2.6-4.5%] (Lopez-Gatius 2003) and Australia
[5.6-10.9%] (Moss et al. 2002). However, much higher prevalence has been
reported in Korea [47.6%] (Kim and Kang 2003) and the USA [53%] (Gilbert et
al. 2005).
1.10.3 Pyometra
The accumulation of the pus in the uterine lumen is called pyometra and is often
associated with a persistent CL (Sheldon et al. 2008). It mainly develops in cows
that have their first ovulation after calving before bacterial contamination of the
uterus has been eliminated. At the same time, the cervix is closed due to
progesterone production from the corpus luteum (Chapwanya et al. 2012, Földi
et al. 2006). It usually occurs from 3 weeks postpartum onwards.
1.10.4 Risk factors for uterine infection
It has been reported that the risk factors for uterine infection include retention of
the placenta, the calving environment, twins, dystocia, and nutrition. Retained
placenta is regarded as an important predisposing factor for uterine infection
(Potter et al. 2010). Moreover, retained placenta is related to a substantial
decrease in milk yield (Sheldon et al. 2004) and this can persist even after the
problem has been corrected.
1.11 Mechanism through which uterine
disease affects fertility
1.11.1 Uterine function
There is no doubt that a healthy endometrium is necessary to support the
development of the embryo and successful pregnancy. Indeed uterine infection
with pathogenic bacteria will drastically reduce conception. The embryonic
mortality rate is increased when uterine infection with pathogenic bacteria after
conception occurred (Semambo et al. 1991). The presence of microbes or
pathogen-associated molecules appears to provoke a considerable immune
response (Sheldon et al. 2008).
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The uterine immune response is mediated through immune cells infiltrating the
endometrial epithelial and stroma layers. Certainly, epithelial cells are the first
endometrial cells in the line of defense against microbes. In the genital tract, the
innate immunity is highly dependent on the expression of pattern recognition
receptors (PRR) to detect pathogen-associated molecular patterns (PAMPs). The
PRR family includes the Toll-like Receptors (TLR), which are highly conserved
across phyla and detect a range of PAMPs associated with bacteria, viruses and
fungi (Fig.1.8) (Beutler 2004, Akira and Takeda 2004, Akira et al. 2006). Binding
of PAMPs to PRR stimulates signal transduction pathways for mitogen-activated
protein kinase (MAPK) and the nuclear factor-kappa B (NFκB) transcription factor 
pathways. This results in altered secretion of prostaglandins, and cytokines such
as TNFA, IL6 and IL8 (Ghosh et al. 1998, Li and Verma 2002, Akira and Takeda
2004).
The bovine endometrial epithelial and stroma cells express Toll like receptor-4
(TLR4) and its co-receptor MD-2 and CD14. This complex, forms the innate
immune receptor for bacterial endotoxin lipopolysaccharide (LPS), the key PAMP
of the common uterine pathogen E.coli (Fig. 1.8) (Herath et al. 2006b). The
pathogen-associated molecules acting on uterine cells not only cause
inflammation but also affect endocrine function. The endometrium produces two
principle hormones PGF2α and PGE2, respectively. Endometrial explants and cells
treated with LPS, resulted in a shift towards PGE2 from PGF2α production (Herath
et al. 2009) (Fig.1.8E). This though was reversed when co-treated with oxytocin
(Herath et al. 2009). This switch in prostaglandin accumulation was associated
with an increased level of phospholipase A2 (PLA2) protein in epithelial cells
(Herath et al. 2009). This concept could provide a mechanism to explain
prolonged luteal phases that has been reported in animals with uterine disease.
Equally, PGE2 may play an important role in regulating inflammatory responses in
the endometrium (Herath et al. 2009).
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Figure 1.8: The molecular interplay between uterine infectious disease and ovarian
function. A) Toll-like receptor 4 (TLR4) detect pathogen-associated molecules (PAMPs)
such as lipopolysaccharide (LPS) when the endometrium is infected with E. coli. LPS
requires LPS binding protein (LBP) for it to be recognised by TLR4. Consequently, the
innate immune system is alerted stimulating the release of cytokines and chemokines and
then infiltration of immune cells and production of anti-microbial peptides(AMPs). B)
Polymorphonuclear neutrophils (PMNs) and macrophages to remove bacteria. C) LPS
inhibits secretion of gonadotrophin releasing hormone [hypothalamus] and luteinising
hormone (LH) [anterior pituitary] thereby decreasing the ability of the dominant follicle to
ovulate. Follicle stimulating hormone (FSH) concentrations are however, less affected thus
emergence of follicular waves still occurs in the first weeks post-partum. D) LPS can
accumulate in follicular fluid and interact with TLR4 in granulosa cells disturbing oestradiol
secretion through the downregulation of aromatase gene. Thus dominant follicle growth is
reduced by endometritis with a decreased likelihood of ovulation. E) There is also a shift in
prostaglandin secretion to prostaglandin E2 (PGE) rather than prostaglandin F2α (PGF)
which would disturb luteolysis and lead to an extension of the luteal phase. Adapted from
(Sheldon et al. 2009a).
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1.11.2 Uterine disease and ovarian function
1.11.2.1 Follicular function
Uterine infections not only cause subfertility by disrupting endometrial health but
also affect ovarian function. It is assumed that a follicle at ovulation needs to be
a minimal size, healthy and oestrogenic in order to establish a successful
pregnancy (Perry et al. 2005). Cows with uterine disease had slower growth of
first post-partum dominant follicle, and lower peripheral plasma oestradiol
concentrations at the time of maximal follicle diameter and plasma progesterone
levels were lower 7 days after ovulation (Sheldon et al. 2002b, Williams et al.
2007). Bacteria are rarely found in the ovary, thus the effects are likely to be
indirect. Indeed, LPS has been detected in the peripheral plasma as well as the
follicular fluid of postpartum cows with endometritis (Mateus et al. 2003, Herath
et al. 2007). The concentration of LPS in follicular fluid ranged from 0.04-
0.8μg/ml in animals with clinical disease but was not detected in normal animals 
(Herath et al. 2007). The reduced ovulation rate might be due to associated
effects of the uterine infection on hypothalamus, pituitary as well as ovary
(Fig.1.8). At the level of the hypothalamus and pituitary, LPS can suppress
hypothalamic GnRH secretion and plasma LH levels (Battaglia et al. 2000, Rivest
et al. 1993, Williams et al. 2001). However, not all studies have shown that LH is
impaired in animals treated with intrauterine infusion of LPS (Williams et al.
2008a). However, peripheral plasma FSH concentration profiles and ovarian
follicle wave emergence were not affected by uterine infection (Sheldon et al.
2002b), Fig.1.8.
Regardless of the follicular stage, LPS had no effect on cell survival or
androstenedione production by theca cell in vitro; however, oestradiol production
in granulosa cells from medium and dominant follicles was decreased by LPS
treatment (Herath et al. 2009). The additional evidence that LPS directly affected
granulosa cells included: 1) cell cultures were confirmed to be free from
contaminating leucocytes (Herath et al. 2007); 2) No immune cells are able to
cross an intact follicular basement membrane in vivo (Petrovská et al. 1996); 3)
Granulosa cells express TLR4, CD14, MD2 receptor complex required for binding
LPS (Herath et al. 2009, Bromfield and Sheldon 2013), and expression of
aromatase mRNA was reduced by LPS treatment of granulosa cells collected from
dominant follicles (Herath et al. 2007). This all provides evidence that there is a
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mechanism by which LPS can directly exert an effect on granulosa cells to disturb
follicular function and ovulation (Fig. 1.8D).
1.11.2.2 Corpus luteum
Prolonged luteal phase has been commonly observed in cows with uterine
infection, which might reflect attenuated luteolysis. Indeed, the switch in
endometrial PGs from PGF2ɑ to PGE2 would explain this since PGF is luteolytic,
while PGE is luteotropic in ruminants (Poyser 1995, Arosh et al. 2004, Sheldon et
al. 2009a). Another important aspect that is more obscure is how LPS effects
progesterone production by the CL. It has been reported that peripheral plasma
progesterone concentrations were lower in cows with high uterine pathogen
growth density than in cows with low uterine pathogen growth density (Williams
et al. 2007). The timing of the post-ovulatory rise in progesterone is important
for embryonic survival (Mann and Lamming 1999), and low progesterone
concentrations could lead to the loss of embryos. Bovine luteal cells treated with
LPS had increased progesterone production in vitro, however, cell survival was
decreased under higher concentration of LPS [3µg/ml] (Grant et al. 2007).
Whether LPS exerts its action directly on luteal cells, or indirectly (e.g. mediated
by cytokines) is unclear. It has been shown that the CL appears to have an
association with the immune system. For instance, in the bovine CL parenchyma
components of the antigen presentation pathway were expressed and these
aided interactions with T cells (Cannon et al. 2007). Furthermore, there is
evidence that macrophages and lymphocytes are present in the bovine corpus
luteum throughout the luteal phase, particularly at luteolysis (Townson et al.
2002, Bauer et al. 2001). These cells could play a major role in the immune
response of the CL to LPS and possible mediatory role for cytokines production
(Penny et al. 1999, Townson et al. 2002). It should be noted that endothelial
cells, could also have a role in any response to LPS (Faure et al. 2001). It has
been demonstrated that TLR4 expression by endothelial cells could be regulated
at the site of infection and inflammation, either directly by LPS or indirectly by
inflammatory cytokines such as TNFA and IFNG (Faure et al. 2001). It has been
recognised that LPS directly exerts action on endothelial cells. For example LPS
binding to endothelial cell surface increased expression of pro-inflammatory
cytokines, adhesion molecules and triggered endothelial cell apoptosis (Hack and
Zeerleder 2001). Also LPS-activated macrophages and monocytes stimulate the
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production of pro-inflammatory mediators that modulated endothelial cell
function (Aird 2003).
1.12 Bacterial endotoxin and their effects on
mammalian cells
1.12.1 Lipopolysaccharides
Bacterial lipopolysaccharides (LPS) are glycoproteins that form the major
component of the outer layer of the cell wall in Gram negative bacteria. These
give structural integrity and defense of the bacterial cell wall (Erridge et al.
2002). LPS also creates a negative charge to the cell membrane, and covers up
to 75% of the bacterial cell area (Le Brun et al. 2013). LPS is important for many
biological interactions between bacteria and the external environment including
adhesion and recognition. In addition, LPS are also endotoxins as once cell-
bound, they are secreted by the bacteria and, trigger the immune system in
many eukaryotic living organisms (Alexander and Rietschel 2001). In this way,
LPS plays a major role in the pathogenesis of Gram-negative bacterial infections.
It is important to clarify the chemical structure of LPS to understand its function.
LPS is an amphiliphic macromolecule consisting of three various structures (Fig.
1.9):
1- Lipid A (a lipophilic domain)
2- Core (sub-divided into inner and outer cores; hetero-oligosaccharide
denominated)
3- O-polysaccharide chain or O-chain (a hydrophilic hetero-
polysaccharide)
Structure of Lipid A
Lipid A (endotoxin) can cause severe fever and septic shock in mammals (Akira
et al. 2006). It is a glycolipid, directed towards the interior of the bacterial cell,
and it is the component responsible for its endotoxic activity (Kirikae et al. 1994,
van der Poll and Opal 2008, Alexander and Rietschel 2001). The lipid A molecule
from E.coli consists of a disaccharide backbone to which four fatty acid (acyl)
chains are attached (Alexander and Rietschel 2001). A further two fatty acid
chains are then added to these primary chains creating a total of six chains. The
disaccharide moiety is a β-1,6-linked glucosamine unit (Alexander and Rietschel 
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2001). Usually, lipid A consists of a mixture of glycoforms, which differ from both
acylation and phosphorylation pattern. The subtle variation of these chemical
structures is recognised as being responsible for different degrees of bacterial
virulence and their adaptation to the host environment.
Figure 1.9: Chemical structure of lipopolysaccharide: Abbreviation include: Hex=Hexose;
Gal=Galactose; Glc=Glucose; Hep=Heptose; Kdo= 2-keto-3-deoxyoctonate; AOAH=
Acyloxyacyl Hydrolase; PO4=Phosphate; GlcN= Glucosamine backbone.
Core-oligosaccharide
The core-oligosaccharide is divided into two regions, the inner core that attaches
to the lipid A and the outer core that attaches to O-chain side. The inner portion
of the core-oligosaccharide is structurally less similar and composed of 3-deoxy-
D-manno-octulosonic acid (Kdo) and peculiar monosaccharides like heptose (L-
glycero-D-manno heptose and D-glycero-D-manno-heptose). The outer core is
composed of hexose residues (e.g. D-glucose, D-mannose, D-galactose) and this
is bound to the last heptose residue in the inner core (Alexander and Rietschel
2001).
O-antigen (O-side, or O-polysaccharide)
The O antigen is the most variable part of LPS between bacterial species. It is
composed of many repeats of O units, typically between 10 and 25 units that are
attached to the core oligosaccharide. It is made up of 1-8 monosaccharide
constituents (Raetz 1990). It stimulates production of antibodies in the host that
are capable of identifying specific O-chains. The composition of the O chain varies
from strain to strain. This variation depends on the arrangement and composition
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of the sugars, as well as the binding between them within the O unit, and the
linkages between O units. There are more than 160 different O antigen structures
formed by different E.coli strains (Raetz and Whitfield 2002).
1.12.2 Toll-like receptors (TLRs)
Toll-like receptors (TLRs) are a class of proteins that have been identified in
mammals (Medzhitov et al. 1997). In mammals, the TLR family contains at least
10 members (Table. 1.1, Beutler 2004a). TLRs play major roles in the innate
immunity. Generally, TLRs are transmembrane glycoproteins and are composed
of two important domains: an extracellular domain containing leucine rich repeat
(LRR) motif and Toll/IL-1R (TIR) domain is the cytoplasmic (intracellular)
signaling domain (Fig.1.10). LRRs are an extracellular domain, known in all
structures to adopt an arc (horseshoe) shape of repeating molecular sequences
(Matsushima et al. 2007). These are rich in the hydrophobic amino acid, leucine.
The extracellular domain of TLR4 consists of 23 LRR and these play a central role
in the binding LPS as well as the co-receptor molecules, CD14 and MD-2
(Matsushima et al., 2007). The sequence of cytoplasmic TIR domain is similar
across many species and within the TLR family. It is characterised by docking
intracellular adaptor molecules, which define the specificity of downstream
signaling (Werling et al. 2009).
Figure 1.10: Structure of toll-like receptosr (TLRs): TLRs consists of an extracellular
domain of leucine rich repeats (LRRs), which are responsible for ligand recognition and
binding. There is an intracellular Toll/IL-1R (TIR) domain which acts as a downstream
adaptor molecule.
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Table 1.1: Overview of toll like receptors and their ligands
TLRs Location* Origin of ligand** Ligand**
TLR1 Cell membrane Bacteria and
mycobacteria
Tri-acyl lipopeptide
TLR 2 Cell membrane Gram-positive bacteria Lipoprotein/lipopeptides
TLR 3 Endosome Virus Double-stranded RNA
TLR 4 Cell membrane Gram-negative
bacteria; Virus
Lipopolysaccharides (LPS)
Heparin sulphate
Heat shock protein
TLR 5 Cell membrane Bacteria Flagellin
TLR 6 Cell membrane Mycobacteria Di-acyl lipopeptides
TLR 7 Endosome Synthetic compounds
Virus
Imidazoquinoline
Single-stranded RNA
TLR 8 Endosome Synthetic compounds;
Virus
Imidazoquinoline; Single-
stranded RNA
TLR 9 Endosome Bacteria and viruses CpG-oligodeoxynucleotides
TLR 10 Cell membrane Not defined
(Kannaki et al. 2011, Kawai and Akira 2010)*; (Chen et al. 2007)**
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1.12.3 TLR4
This study focused on TLR4 as it has been established that TLR4 is the
signaling receptor for LPS (Poltorak et al. 1998, Zhang and Ghosh 2000). In
addition, TLR4 also recognises the endogenous mammalian ligands, such as
heat shock proteins (HSP60 and HSP70) (Gao and Tsan 2003); fibronectin
(Okamura et al. 2001); heparin sulphate (Akbarshahi et al. 2011), but only at
high concentrations (Gao and Tsan 2003). Importantly, LPS does not bind to
the surface of cell by itself. Instead, there are different molecules involved in
the recognition of LPS by the cell including LPS binding protein and CD14.
LPS-binding protein (LBP)
LPS-binding protein (LBP) is an acute-phase protein that is the first host
protein involved in the recognition of LPS (Schumann et al. 1990). LBP is
produced primarily by hepatocytes as a 50-kDa protein, which circulates in
the bloodstream as a 58-kDa protein following glycosylation (Schumann et al.
1990). The primary role of LBP appears to be presenting LPS to the cell
surface, where it recognised by TLR4 through the amphipathic lipid A region
of LPS with high affinity. In so doing, it forms a ternary complex with the LPS
receptor molecule, CD14 (Schumann et al. 1990). This complex facilitates LPS
transfer to the signaling LPS receptor complex which is composed of TLR4 and
MD2 (da Silva Correia et al. 2001, Tobias et al. 1995; Fig 1.11). Additionally,
LBP serves to enhance LPS uptake in endothelial cells (Dunzendorfer et al.
2004).
Cluster of differentiation 14 (CD14)
CD14 is a glycoprotein that exists in two forms: The first form is a membrane-
bound glycosylphosphatidylinositol (GPI)-anchored protein (mCD14) that
functions in LPS mediated cell activation (Jersmann et al. 2001). mCD14 is
attached to the surface of myeloid cells through its GPI tail, enabling CD14 to
be proximal to the membrane proximal despite lacking a transmembrane
domain. The second form (sCD14) is a soluble proteolytic fragment without a
GPI anchor, and this is present in plasma where it aids to transfer LPS in cells
devoid of membrane-bound CD14, such as endothelial and epithelial cells
(Wright 1995, da Silva Correia et al. 2001; Fig 1.11). Thus sCD14 has to be
cleaved from mCD14 bearing cells such as macrophages and monocytes for
its activity in endothelial cells (Arditi et al. 1993).
There is though some evidence that CD14 is active in endothelial cells since
early passage human umbilical vascular endothelial cells (HUVECs) express
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functional CD14 on the cell surface and blockade of mCD14 with a specific
anti-mCD14 antibody prevented endothelial cell detection of LPS and
subsequent leukocyte recruitment (Jersmann et al. 2001, Lloyd and Kubes
2006). As CD14 lacks an intracellular domain, it is unlikely that CD14 could
induce an intracellular signal in response to LPS (Schumann et al. 1990), for
that reason, the complex of TLR4/MD-2 has a vital role in conveying
intracellular signaling.
TLR signaling
The intracellular TIR domain plays an important role in TLR4 dimerisation and
the binding of lymphocyte gene 96 (MD-2) to the ectodomain by facilitating
this homotypic interaction (Miguel et al. 2007). The binding of the ligand
(LPS) to TLR4 leads to stimulation of homodimerisation, and this causes
concerted structural alteration in the receptor leading to activation of the
cytoplasmic TIR signaling domain (Miguel et al. 2007). Following ligation of
TLR4, one of two cytoplasmic signaling pathways become activated,
depending on the identity of the specific adaptor molecule recruited to TIR
domain (O'Neill and Bowie 2007). Such adaptor molecules are: myeloid
differentiation 88 (MYD88), TIR-domain consisting of adaptor protein (TIRAP;
also known as My88 adaptor-like protein), TIR-containing adaptor inducing
IFNB (TRIF; also known as TICAM-1) and TRIF associated with adaptor
molecule (TRAM; also called TICAM-2) (Fig. 1.11).
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Figure 1.11: Proposed Toll-like receptor 4 (TLR4) signalling pathway events in
endothelial cells in MYD88- dependent pathway. Stimulation of endothelial cells with
lipopolysaccharide (LPS) activates tumour necrosis factor receptor associated factor-6
(TRAF6), resulting in the activation of several downstream signalling pathways,
including activation of Jun N-terminal kinase (JNK) and nuclear transcription factor-κB 
(NF-B) and subsequent production of pro-inflammatory molecules. TRAF6 activation
induces endothelial sprouting and leading to a proapototic state through JNK and NF-
B-dependent pathways. Abbreviations include interleukin-1 receptor-associated
kinase (IRAK). Adapted from (Dauphinee and Karsan 2006).
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1.13 Aims of the PhD thesis
The aims of this thesis were to investigate the mechanisms involved in the
failure of fertility in dairy cows during post-partum period with a particular
focus on the impact of endometritis. This thesis concentrated on four aspects:
1. The association between reproductive tract inflammatory disease
(RTID) and reproductive performance in a large-study retrospective
study that incorporated multiple commercial dairy herds across
England and Wales. This quantified the impact of RTID on dairy cow
fertility under field conditions.
2. A prospective study that investigated the association between uterine
infection post-partum, ovarian activity (resumption of postpartum
cyclicity and subsequent progesterone profiles) and reproductive
performance at the University of Nottingham dairy centre. This study
provided insights into how endometritis affected ovarian activity and
thus fertility.
3. Ex vivo investigation to characterise progesterone production,
steroidogenic enzyme protein expression and vascularization of the
bovine corpus luteum in cows with endometritis. It also investigated
the presence of mRNA encoding TLR4 and it co-receptors in the bovine
CL throughout the oestrus cycle.
4. Determination of the dose-dependent effects of E.coli
lipopolysaccharide (LPS) on bovine luteal endothelial cell network
formation and steroidogenesis in vitro.
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2 The association between uterine
disease and subsequent reproductive
performance in commercial UK dairy
herds
2.1 Introduction
Good reproductive performance in dairy cows is a crucial part of any
successful farming enterprise. Numerous studies have determined reduced
reproductive performance as a major cause of impaired production efficiency
in the dairy industry, caused by greater costs of herd replacement, veterinary
intervention, and ultimately decreased milk yield per year. The reproductive
performance of dairy herds can be monitored using different measurements
and indicators. Time interval measurements are frequently used as
reproductive performance indicators and many of these indicators are based
around the cows’ individual calving date (e.g. day to first service (DFS) and
calving interval (CI)). The different parameters have various advantages and
limitations. For example, calving interval depends on two components 1)
interval from calving to conception (or days open), and 2) the length of
pregnancy which is relatively constant (~283 days). Thus, days open is the
main principal determinant of the calving interval and incorporates the number
of days from calving to first service (DFS), and services per conception (SPC).
However, this is also influenced by environmental factors, management
(accuracy of heat detection, use of proper insemination technique and
appropriate herd health policies) as well as biological factors. Biological factors
include involution of the cervix and uterus (Mateus et al. 2002, Zhang et al.
2010); age and parity (Hajurka et al. 2005, Melendez et al. 2004);
concentrations of key reproductive hormones, nutrition (Zhang et al. 2010,
Wagner and Hansel 1969); season of the year (Kasimanickam et al. 2004,
Noakes et al. 2009); uterine infection (Sheldon and Dobson 2004, Melendez et
al. 2004, Noakes et al. 2009).
Dairy cow subfertility has been associated with uterine infection. As well as a
direct effect on the uterus, infection has been shown to cause disturbance in
the hypothalamus, anterior pituitary and ovary. Moreover these effects can
persist even after clinical resolution of the disease (Sheldon and Dobson
2004). Uterine diseases such as metritis and endometritis are highly prevalent
in high yielding dairy cows. Often, these diseases are combined with cervicitis
and vaginitis and collectively termed reproductive tract inflammatory disease
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(RTID). The incidence of metritis affects about 25-40% of cows in the first 14
days after calving (Sheldon and Dobson 2004). The observed variation is likely
to be due to different diagnostic methods and time of examination relative to
calving. The prevalence of clinical endometritis is about 20% within a herd
(McDougall et al. 2007, Goshen and Shpigel 2006). Among all types of uterine
disease, subclinical endometritis is the most prevalent one, which affects up to
50% of the animals with uterine disease (Sheldon et al. 2008, Gilbert et al.
2005, Kasimanickam et al. 2004). Numerous of aerobic and anaerobic Gram
positive and Gram negative bacteria have been detected in the uterus in more
than 90% of cows in the first 10-14 days post-partum (Földi et al. 2006,
Williams et al. 2005, Sheldon et al. 2002b). Vaginal discharge during the
postpartum period can accurately reflect uterine infection (Williams et al.
2005). However, vaginal scoring systems cannot accurately differentiate the
actual severity of the case and the actual location of the infection e.g.
endometritis vs cervicitis (Dohmen et al. 1995, Huszenicza et al. 1999,
Williams et al. 2005). It has been reported that there is not always agreement
between purulent vaginal discharge and endometritis as defined by cytology.
This questions the source of the pus in the vagina, and states that it is not
always from the uterus (Dubuc et al. 2010). Typically, the risk factors for RTID
include retained fetal membrane, assisted calving, stillbirth, vulval discharge
and parity (Potter et al. 2010). Various studies have characterised the effect of
uterine infection on reproductive performance in dairy herds. However, this
study could be the first large scale, multi-herd study to characterise the effect
of uterine infection on a variety of reproductive parameters. Namely, this
chapter incorporates 80 dairy herds from England and Wales.
2.1.1 Aim
To quantify the association and potential influence of reproductive tract
inflammatory disease (RTID) on various reproductive performance parameters
in multiple commercial dairy herds across England and Wales.
2.1.2 The objectives of the study were:
In order to achieve this aim, the following objectives were developed:
1. To quantify the prevalence of reproductive tract inflammatory disease
in different commercial herds across England and Wales
2. To compare various reproductive performance between cows that
experienced RTID during their lactation and control cows. The
parameters chosen included the following parameters:
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a. Day to first service (DFS)
b. Calving to conception interval (CCI)
c. Number of services per conception (SPC)
d. Conception rate at first service
e. Calving interval (CI)
f. Milk yield 305d
3. To assess the prevalence of animals exiting the herd (e.g. due to
culling) between cows that had or did not have RTID, on a herd level
and between calving years.
2.2 Materials and methods
2.2.1 Experimental animals
The database was kindly provided by Dr Chris Hudson, University of
Nottingham as previously described (Hudson et al. 2012). The retrospective
data were collected from routine dairy herd records. This was inputted and
managed the herd manager. No personal data was stored as part of this
project and all herds were coded anonymously by a number. This study
incorporated 80 commercial Friesian-Holstein dairy herds from England and
Wales. The data was collected from 2000 to 2007 and contained 59,118
lactations from 29,157 cows. The average parity was 3. There were a number
of cows (n=12,805) within a particular lactation that exited the herd. The
exact reason is unknown but the most likely cause was culling. Animals that
exited the herd were included in the analysis where possible. All animals were
classified into two experimental groups according to their uterine health
status. This was determined by the vet(s) assigned to that particular herd. The
first group included 52,014 control lactations (i.e. no reported clinical signs of
endometritis or vaginal discharge). The second group involved 7,104
lactations where clinical uterine infectious disease was reported by the herd
manager. In this study, cases of vulval discharge and endometritis (as defined
by the on-farm veterinarian) are considered together under one category that
was called RTID. Animals were diagnosed with RTID were treated by the
veterinarian in charge as deemed appropriate for that individual case.
2.2.2 Dependent variables/ Reproductive
performance indices
The definitions of the reproductive parameters are described in Table 2.1.
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2.2.3 Data management
Data for these parameters was calculated in Excel based on the reported
insemination, pregnancy and calving dates. While the majority of the data
values were in the expected ranges (Table 2.2), there were data values that
did not fit these ranges. These were considered non-physiological or atypical
management and were excluded for that particular end-point only.
The prevalence of RTID in the UK dairy herd
Data from each herd, calving year and lactations number were entered and
stored in Microsoft Excel 2010 (Microsoft Corporation, 2010). Dichotomous
Fertility traits Definition
Day to first service
(DFS)
Number of days from calving to the day of first
insemination after calving
Calving to conception
interval (CCI)
Number of days from calving to subsequent first
reported conception (based on positive pregnancy
diagnosis) after calving
Number of services per
conception (SPC)
Number of inseminations required for a cow to become
pregnant defined by transrectal ultrasound/rectal
palpation
Conception rate at first
insemination
The number of cows at 1st insemination that become
pregnant divided by the total number of cows
inseminated.
Calving interval (CI) Number of days between two consecutive calvings.
Table 2.1: Definition of the key fertility parameters
Table 2.2: The accepted values for reproductive performance indices were used to
evaluate the postpartum reproductive performance of dairy cows in 80 commercial
dairy herds across England and Wales (2000-2007).
Independent
variables
Accepted
range
Number of
accepted
data points
Number of
excluded
data points
Total
Days to first
insemination (days) 20-150 46890 12228 59118
Number of services
per conception 1-12 46890 12228 59118
Calving to
conception interval
(days)
20-300 43049 16069 59118
Calving interval
(days) 305-585 40015 19103
* 59118
Milk yield 305d (Kg) 4000-20000 47266 11852 59118
*= Number of cows without CI due to exited =3233; number of cows with no
data=12683; number of cows out of range=3187
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values were used to indicate lactation positive with RTID; however lactation
without RTID coded into “0”.
Comparisons between “control” cows with different reproductive
performance
In order to interrogate the fertility of the “control” cows, three sub-groups
were created depending: 1) on the cows’ day to first service (DFS) interval as
follows: <50, 50-60 or >60 DIM; 2) calving interval as follows: <400, 400-
425 and >425 DIM. For these sub-groups, reproductive parameters analysed
were calving to conception interval (CCI), conception rate at 1st service,
number of service per conception and 305d milk yield.
RTID and its association with subsequent reproductive performance
Data from each lactation were entered and stored in Microsoft Excel 2010
(Microsoft Corporation, 2010). Dichotomous values were used for pregnancy
outcome at 1st insemination, RTID status and RFM where “1” indicated they
were pregnant/had RTID and RFM or were coded into “0” when animals did
not conceive at 1st service and/or free from disease and RFM. Lactations with
with one case of RTID were coded as RTID1, those with two cases were coded
as RTID2 and those recorded 3 cases were coded as RTID3.
2.2.4 Statistical analysis
Before performing analysis, data were checked for normality and homogeneity
of variance using residual plots and Bartlett’s test, respectively. If the data did
not satisfy this, then it was transformed appropriately, usually by log
transformation. For all experiments P<0.05 was significant and all data are
quoted as mean±SEM
The prevalence of RTID
The prevalence of RTID between calving years, herds and lactation number
were analysed using logistic regression in GenStat 16th Edition (VSN
International Ltd, Hemel Hempstead, UK).
Comparisons between control cows with different reproductive
performance
In order to compare the reproductive performance of cows with different DFS
values (<50, 50-60, >60DIM), unbalanced one-way ANOVA was performed
with the DFS category as the factor to compare reproductive indices including
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(DFS, CCI, CI) and 350d milk yield between DFS categories. Logistic
regression was performed to compare the conception rate at 1st service
between these DFS categories. A non-parametric Kruskal-Wallis one-way
ANOVA was performed to compare SPC. Similarly, one-way ANOVA was
conducted to compare reproductive performance of cows with different CI
values (<400, 400-425 and >425 DIM). Logistic regression was performed to
compare the conception rate at 1st service between CI category. One-way
ANOVA was performed to compare SPC between CI categories.
The association between RTID and subsequent reproductive
performance
An unbalanced ANOVA was performed to determine the association between
RTID status (included as the factor) and reproductive performance (DFS, CCI,
SPC, conception rate at 1st service, and CI). Kaplan-Meier survival analysis
was performed to compare calving to conception interval between cows that
experienced RTID and those that did not. The proportion of non-pregnant
cows represented the survival probability, which was plotted against the time
(calving to conception interval). Only cows that became pregnant were
included in this analysis. Within the database the number of reported RTID
cases/incidences for a particular lactation was recorded within the
spreadsheet.
Influence of multiple RTID cases on subsequent reproductive
performance
An unbalanced ANOVA, followed by multiple comparisons, was performed to
determine the differences of reproductive performance (DFS, CCI, SPC,
conception rate at 1st service, and CI) between different RTID cases report
(including as the factor). RTID cases means that number of RTID has been
reported per each cows.
2.3 Results
2.3.1 Prevalence of RTID across England and
Wales dairy herds from 2000-2007
The overall prevalence of RTID increased over the time period (P<0.001, Table
2.3). The mean prevalence of RTID over eight years was 12.0%. There was a
wide variation in the reported prevalence of RTID between herds, with a range
of 5-33% (Fig 2.1). Frequency distribution of prevalence of RTID between
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herds showed that out of 80 dairy herds, 47 herds had a low prevalence of
RTID (1-10%), 23 herds had a prevalence of 11-21% and 10 herds had 21-
≥33 (Fig 2.2). In addition, prevalence of RTID was much greater in cows with  
reported RFM compared to cows without RFM (P<0.001, Fig 2.3)
Year
Total
number of
calvings
Lactations with
RTID (n)
Lactations with
no RTID (n)
% of
RTID
2000 2352 183 2169 7.8
2001 2841 232 2609 8.2
2002 4159 431 3728 10.4
2003 6502 743 5759 11.4
2004 7275 922 6353 12.7
2005 11322 1303 10019 11.5
2006 11976 1481 10495 12.4
2007 12691 1809 10882 14.3
Total 59118 7104 52014 12.0
Table 2.3: The changes in the prevalence of reproductive tract inflammatory disease
(RTID) between years 2000 and 2007 in multiple-commercial dairy herds across
England and Wales (P<0.001).
Figure 2.1: Prevalence of reproductive tract inflammatory disease (RTID) in the
different 80 herds in England and Wales. The prevalence of RTID varied from 5-33%.
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Figure 2.2: Frequency distribution of the prevalence of reproductive tract
inflammatory disease (RTID) between the different herds. The majority (~45%) of
herds had relatively low prevalence but about 10% had a prevalence >20% RTID.
Figure 2.3: The impact of retained fetal membranes (RFM) on the prevalence of RTID.
Lactations that were RFM+ve had higher prevalence of RTID (50.0%) compared to
those that were RFM-ve (11.1%; P<0.001).
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2.3.2 Comparison of reproductive performance of
control lactations with reproductive indices
The overall mean DFS was 76.4 days, mean calving to conception interval was
124.1 days, mean number of services per conception (SPC) was 2.1 services,
mean calving interval was 405.6 days, conception rate at 1st service was
36.3% and mean milk yield was 8425 kg (Table 2.4).
Lactations with a low mean DFS (<50 days) had more services per conception
compared to lactations with mean DFS 50-60 day and >60 days by 0.1 and
0.4 services, respectively (P<0.001, Table 2.5). In addition, lactations with
mean DFS <50 days had shorter CCI compared to lactations with greater DFS
intervals (P<0.001, Table 2.5). However, the highest conception rate at first
service (P<0.001) and least services per conception (P<0.001) were observed
in the lactations with a DFS interval of >60days. This group of lactations also
had higher milk production compared to herds with mean DFS more than 50
days, 50-60 days groups (P<0.001; Table 2.5). Lactations with longest CI
(>425 days), not unexpectedly, had the longer DFS (P<0.001) and CCI
(P<0.001) than those the shortest CI (<400 days) (Table 2.6). However, large
differences between the groups were found regarding number of services per
conception (P<0.001) and conception rate at 1st service (P<0.001) with the
lactations in >425 day CI group having a conception rate at 1st service as low
as 12% and requiring 3.3 services per conception. Also this model found that
lactations with mean CI <400 days produced 348kg and 532kg less milk
compared to lactations with mean CI 400-425, >425 days groups, respectively
(P<0.001).
Table 2.4: Descriptive statistics for production variables for 59118 control lactations
in 80 commercial dairy herds across England and Wales.
Variable Minimum Maximum Mean SEM
Day to first service 20 150 76.4 0.1
Calving to conception interval
(days)
20 300 124.1 0.3
Service per conception (n) 1 12 2.14 0.01
Calving interval (days) 305 585 405.6 0.3
Conception rate at 1st service
(%)
- - 36.3% -
305d milk yield (L) 4000 20218 8425 0.3
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Table 2.6: Reproductive performance of lactations with differing calving intervals from
80 commercial dairy herds across England and Wales. Data are mean ±SEM.
Table 2.5: Reproductive performance of lactations with differing day to first service
intervals from 80 commercial dairy herds across England and Wales. Data are mean
±SEM.
Reproductive
performance
parameter
Days to first service P value
<50
days
50-60
days
>60
days
Days to 1st
service
41.6±0.3
n=5721
56.2±0.2
n=8235
87.1±0.1
n=32934
<0.001
Services per
conception (n)
2.77±0.03
n=5721
2.67 ±0.02
n=8235
2.48 ±0.01
n=32934
<0.001
Calving to
conception
interval (days)
98.0±0.8
n=4834
103.7±0.7
n=7072
129.3±0.3
n=27457
<0.001
Conception rate
at 1st service
(%)
29.4%±0.6 35.3%±0.5 37.1%±0.2 <0.001
Calving interval
(days)
381.4±0.9
n=4459
385.6±0.7
n=6529
410.6±0.4
n=25533
<0.001
305d milk yield
(L)
8244±24.19
n=5721
8367±19.6
n=8235
8572±10.8
n=32934
<0.001
Reproductive
performance
Calving interval (CI) P
value<400 400-425 >425
days days days
Days to 1st service 69.8±0.2
n=21047
86.6±0.2
n=5042
82.3±0.3
n=10432
<0.001
Services per conception
(n)
1.35±0.00
n=22224
2.17±0.02
n=5282
3.31±0.01
n=12509
<0.001
Calving to conception
interval (days)
81.4±0.2
n=22171
129.0±0.4
n=5277
196.0±0.3
n=12331
<0.001
Conception rate at 1st
service (%)
65.8%±0.3 25.8%±0.6 11.9%±0.4 <0.001
Calving interval (days) 361.0±0.2
n=20432
411.6±0.4
n=4625
481.0±0.3
n=10592
<0.001
305d milk yield (L) 7256±11.1
n=22224
7604±22.7
n=5282
7788±14.8
n=12509
<0.001
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2.3.3 The association between lactations
experiencing RTID and their reproductive
performance
2.3.3.1 Days to first service (DFS)
Lactations that experienced RTID had a longer mean DFS compared to control
lactations by 5 days (P<0.001; Fig 2.4A). The mean DFS for control lactations
was 75.9±1.0 days in comparison with 81.0±0.3 days for lactations that had
RTID (P<0.001; Fig 2.4A). The distribution of DFS between in these groups
can be seen in Fig 2.4B.
In addition, lactations with an increased number of RTID cases was associated
with an increased number of days to 1st service (P<0.001, Fig 2.5) with the
longest DFS observed in lactations with >3 reported RTID cases. Namely,
lactations with RTID 1, 2 and 3 cases had DFS longer by 3, 5 and 9 days,
respectively compared to control lactations.
Figure 2.4: The impact of lactations experiencing reproductive tract
inflammatory disease (RTID) on days to first service. (A) Days to first service in
control lactations was 5 days shorter than those lactations than those lactations
that experienced RTID (***;P<0.001). Data are mean±SEM (B) Box and whisker
plots comparing the variation in DFS for control lactations and experienced
RTID. The mid line within the box represents the median of DFS for control
lactations and lactations experienced RTID were 72 and 76 days, respectively,
the whiskers represent minimum and maximum values.
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2.3.3.2 Conception rate at first service
The 1st service conception rate was lower in the RTID group compared to the
control lactations by 14 percentage points (P<0.001, Fig.2.6).
Figure 2.5: The association between days to first service (DFS) and number of RTID
observations. Mean of DFS was significantly different (P<0.05) between lactations
with (RTID 0) and lactation with RTID 1, 2 and 3. Differences between lactations are
indicated by different letters a<b<c<d. Data are mean±SEM.
Figure 2.6: Comparison of conception rates at first service between control lactations
and those that experienced RTID. Control lactations had higher first service
conception rate (38.0±0.02) compared to lactations with RTID (24.4±0.06),
***;P<0.001. Data are mean.
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In addition, a higher number of RTID observations was associated with a lower
conception rate at 1st service (P<0.001, Fig 2.7). Namely, the conception rates
in the RTID 1, 2 and 3 groups were 12, 17.1 and 18 percentage points,
respectively lower than those found in control lactations (CR=38%).
2.3.3.3 Calving to conception interval (CCI; days open)
Lactations that experienced RTID took longer to establish a pregnancy by 22
days compared to control lactations (P<0.001, Fig 2.8A). This difference of
CCI between the groups was much bigger than that observed for DFS. Kaplan-
Meier survival analysis showed that the rate at which RTID positive lactations
became pregnant was lower than RTID negative lactations (P<0.001, Fig
2.8B). By 105 days in milk, half the control lactations were pregnant;
however, this was increased in cows that experienced RTID to 131 days.
Additionally, the CCI was affected by the number of RTID observations that
the lactations had, with increasing number being associated with longer CCI
(P<0.001, Fig 2.9). Namely, lactations with no RTID had shorter CCI
compared to those with RTID 1, 2 and 3 observations by about 19, 26 and 35
days, respectively.
Figure 2.7: The comparison of the conception rate at first service between lactations
with different number of incidence of RTID during that lactation. There was a difference
(P<0.001) in the conception rate at first service between lactations with different
number of RTID observations (P<0.05). Differences between lactations are indicated by
different letters c>b>a. Data are mean.
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2.3.3.4 Number of services per conception (SPC)
The lactations that experienced RTID required more services to become
pregnant (P<0.001; Fig 2.10A). The mean for control lactations was 2.0±0.01
services in comparison to 2.9±0.02 services for lactations positive for RTID
(Fig 2.10A). The variation in the distribution of SPC between control lactations
and lactations with RTID can be seen in Fig 2.10B. This showed that there was
a significant proportion of lactations in the RTID group took more than 3
services in order to become pregnant.
Figure 2.8: The association between lactations experiencing RTID and calving to
conception interval (CCI). (A) Lactations with RTID had longer CCI (144.0 days)
compared to control lactations (121.7 days; ***;P<0.0001). (B) Kaplan–Meier
survival curves for the proportion of animals that became pregnant over time.
Lactations positive for RTID during the lactation took longer to get pregnant compared
to lactations without RTID. Median days were 105 and 131 days for control and RTID
lactations , respectively (Log rank test: χ2= 384.2, P<0.001). Data are mean±SEM.
Figure 2.9: The association between calving to conception interval (CCI) and
incidence of RTID. Mean of CCI was different between lactations with (RTID 0) and
lactations with RTID 1, 2 and 3 (P<0.05). Differences between lactations are
indicated by different letters a<b<c<d. Data are mean±SEM
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Figure 2.10: The association between lactations experiencing RTID during lactation
and number of services per conception (SPC). (A) Service per conception in control
cows was 0.9 services lower than those cows that experienced RTID (***;P<0.001).
Data are mean±SEM. (B) Box and whisker plot comparing the variation in SPC for
control and cows that experienced RTID. The mid line within the box represents the
median of SPC and the whiskers represent minimum and maximum values.
Furthermore, a higher number of RTID cases were associated with an
increased number of services per conception (P<0.001, Fig 2.11). Lactations
in the RTID2 and 3 groups had similar number services per conception (~3.0
services) that was greater than both RTID 1 and control groups.
Figure 2.11: The association between number of services per conception (SPC) and
incidence of RTID. Mean of SPC was different (P<0.001) between lactations with (RTID
0) and lactations with RTID 1, 2 and 3 (P<0.05). Differences between lactations are
indicated by different letters a<b<c. Data are mean±SEM.
2.3.3.5 Calving interval (CI)
Lactations that experienced RTID during the lactation had a significantly
longer calving interval compared to control lactations (P<0.001, Fig 2.12A)
with 403.2 days for control lactations vs 425.6 days for lactations with RTID.
The difference between the groups was 22.4±0.6 days. The distribution of CI
in control lactations and lactations with RTID can be seen in Fig 2.12B and
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revealed that the 25% and 75% quartile were greater in the RTID group. A
higher number of RTID cases was associated with longer CI (P<0.001, Fig
2.13). Lactations with 1, 2 or 3 RTID cases had longer CI than control
lactations by 19, 26 and 38 days, respectively.
Figure 2.12: The impact of lactations experiencing RTID on calving interval (CI). (A)
Calving interval in control lactations was 22.4 days lower than those lactations that
experienced RTID (***;P<0.001). Data are mean±SEM (B) Box and whisker plot
comparing the variation in CI for control lactations and lactations experienced RTID.
The mid line represents the median CI which was 388 and 414 days for control and
RTID groups, respectively. The whiskers represent minimum and maximum values.
Figure 2.13: The association between calving interval and incidence of RTID. Mean
calving interval was significantly different between control (RTID 0) and those with
different number of RTID observations (P<0.05). Differences between lactations are
indicated by different letters a<b<c<d. Data are mean±SEM.
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2.3.3.6 Milk yield [305 day]
Lactations that had RTID during their lactation produced slightly more milk
over 305 days (173L) than control lactations (P<0.01, Fig 2.14A). There was
minimal difference in the distribution of milk yield in control lactations and
those that experienced RTID during the lactation (Fig 2.14B). When the RTID
lactations were split into their number of RTID cases, significance between the
groups was detected (P<0.01, Fig 2.15). This showed no difference between
the RTID groups, but that these were all greater than the control.
Figure 2.15: The association between 305d milk yield and number of RTID incidences.
Mean 305d milk yield was lower in control lactations compared with 1, 2 and 3
observations of RTID, (a<b; P<0.01). Differences between lactations are indicated by
different letters a<b. Data are mean ± SEM.
Figure 2.14: The association between lactations experiencing RTID on 305d milk yield.
(A) 305d milk yield in control lactations was lower than those that experienced RTID
(**;P<0.01). Data are mean±SEM (B) Box and whisker plots comparing the variation
in 305d milk yield for control and RTID groups. The mid line within the box represents
the median while the whiskers represent minimum and maximum.
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2.3.3.7 Exit rate from the herd
The overall herd exit rate was 21.7% per year (Table 2.7) and did not vary much
between years from 2000 to 2007. The exit rate in the 80 different herds ranged
from 5 to 35% (Fig 2.16). Lactations that experienced RTID exhibited a higher
exit rate compared to control lactations by about 4 percentage points (P<0.01,
Fig 2.17).
Figure 2.16: The variation in the exit rate between the 80 commercial dairy herds.
Table 2.7: The herd exit rate of lactations in 80 UK commercial dairy herds across
England and Wales from 2000-7.
Year of calving % of exiting rate Total number of
records
2000 20.4 2352
2001 21.9 2841
2002 17.8 4159
2003 21.1 6502
2004 20.2 7275
2005 19.6 11322
2006 24.4 11976
2007 21.9 12691
Total 21.7 59118
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When the RTID group was split into the number of reported RTID observations,
the data showed that an increased number of RTID cases was associated with a
higher exit rate (P<0.001, Fig 2.18). In those lactations with 3 RTID
observations, the mean exit rate was over 30%, which is approximately 10
percentage points higher than control lactations.
Figure 2.17: The herd exit rate in lactations that were positive or negative for RTID
during that lactation. Cows with RTID had a higher cow exit rate (24.9±0.4) compared to
control cows (21.2±0.2) (***;P<0.001). Data are mean.
Figure 2.18: The association between exiting rate and number of RTID incidences. Mean
exiting rate was different between lactations with (RTID 0) and lactations with RTID 1, 2 and 3
(P<0.001). Differences between lactations are indicated by different letters a<b<c. Data are
mean ± SEM.
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2.4 Discussion
2.4.1 Prevalence of RTID
The present study characterised the prevalence of RTID and their effects on
reproduction of Holstein Fresian dairy cows in commercial dairy herds across
England and Wales. This large-scale study is one of the few reports
investigating RTID in Holstein dairy cows in multiple commercial herds across
England and Wales. The mean prevalence of RTID in this study was 12%.
Moreover, cows diagnosed with RTID had increased DFS (5 days), calving-
conception interval (22 days), services per conception (about 1 service) and
exit rate (4%). This was associated with reduced conception rate at first
service. These results highlight the importance of having a sufficient health
program throughout the transition and post-partum period in high yielding
dairy cows.
The present study reported that the prevalence of RTID varied between herds
ranging from 5-33%. The large range probably reflects differences in
management between the herds analysed and the clinician’s exact diagnosis
definition. The overall prevalence of RTID in the current study was 12%
across 80 commercial dairy herds in England and Wales. This was similar to
Gautam et al. (2009), who reported 14.3% incidence of RTID during 29-
60DIM in Japan but slightly lower than the rate (15%) previously reported in
UK (Esslemont and Kossaibati 1996). It was 5 percentage points lower than
that reported by (LeBlanc et al. 2002) in North America who diagnosed by
vaginoscopy and cervical diameter from 20-33 DIM. Much higher prevalences
were reported in the UK dairy herds (Esslemont and Peeler 1993) and in two
Argentinean studies where the prevalence was 20-21% between 15-62DIM
based on manual examination (Madoz et al. 2008, De la Sota et al. 2008).
There are though a few studies reporting much higher rates of 29.4% in
Ireland (5751 cows; diagnosed by ultrasound, Mee et al. 2009) and 37.5% in
North America (975 cows, Ribeiro et al. 2013).
The difference in the prevalence of RTID in these studies are likely to depend
on several factors. The most significant reasons are likely to be the different
diagnostic methods employed and different times of RTID detection.
Additionally, different characteristics of the herds and their different
management practices will also have an influence (Kaneene and Miller 1995,
Lewis 1997, Heuwieser et al. 2000, LeBlanc et al. 2002). The present study
found that prevalence of RTID was significantly associated with retained fetal
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membranes. Cows with retained fetal membrane had 38% greater prevalence
of RTID than those without retained fetal membrane. The association between
the retention of fetal membrane and uterine disease has been previously
established (Kim and Kang 2003, Paisley et al. 1986, Potter et al. 2010). The
current hypothesis is that the retained fetal membranes provide favourable
medium and environment for bacterial growth.
2.4.2 Reproductive performance across all cows
To understand more about the management across the cows, the current
study investigated the reproductive performance of cows as a whole. Cows
with days to first service <50 DIM had an increased number of services per
conception; but shorter calving to conception interval, and shorter calving
interval compared to cows with days to first service 50-60 and>60 DIM. If
fertility is measured by the average number of services per conception or
conception rate at first service then fertility is clearly lower in cows bred prior
to day 60. This is consistent with several other previous studies which have
reported a lower conception rate at 1st service and a higher number of
services per conception in cows first bred before 60 days postpartum
(Williamson et al. 1980, Shannon et al. 1952, Dohoo 1983). However, the
same studies demonstrated that there was no justification to delay breeding
after 60 days postpartum, because cows served after 60 days had signifcantly
longer CCI. It is interesting to note that cows with a calving interval <400
DIM had shorter days to first service, shorter calving to conception interval,
higher conception rate at 1st service, lower number of services per conception
and more milk production compared to cows with CI >425 days.
Calving to conception interval is regarded as a function of many factors, but
of these, the management decision on when to start breeding following
parturition may be the easiest to influence. However, calving to conception
interval may not be a good indicator to measure reproductive status of the
herd. It is difficult to calculate calving interval for cows that have exited the
herd because there is no later calving; therefore, cows exiting the herd for
reasons such as failure to conceive, or delayed rebreeding do not contribute
to the herd's average CI value.
It is important to view the mean of the reproductive performance of animals.
The mean of the three intervals included DFS, CCI and CI in the present study
were 76.4; 124.1 and 405.6 days, respectively. Similar intervals were
observed in the previous study by (Biffani et al. 2003). Generally, some
factors have been attributed to extend these intervals such as, poor oestrus
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detection, inadequate nutrition, poor housing and pathological problems such
as uterine inflammation. In addition, the average number of services per
conception in this study was 2.14 services/conception. The present thesis
found that the conception rate at 1st service was 36.3%. A similar large-scale
UK study by Royal et al. (2000), found that conception rates were 39.7%
from 1995-98. While, Darwash et al. (1999) found that conception rate to any
particular service were 40% from 1994-1997. This would indicate that there
was a further decline in conception rates from the 1990s through to the
2000s. Though, the rate of this decline was less than previously predicted.
Not surprisingly, this study observed that cows with CI <400 days had better
reproductive performance than cows with >400 days in terms of DFS, CCI,
SPC and conception rate at 1st service. However, cows with calving interval of
more than 400 days had higher milk production. This is in agreement with
Smith and Becker (1996) who reported that cows with a calving interval >425
days produced more milk compared to cows with a calving interval <400
days. In contrast, Ratnayake et al. (1997) reported that extending the calving
interval from 15 to 18 months may have a positive influence on the
reproductive performance in terms of conception rate. It can be concluded for
these studies that cows with shorter CI exhibited better fertility over a variety
of indicators.
2.4.3 Impact of clinical RTID on reproductive
performance
To achieve a high pregnancy rate in cows within an adequate period of time,
there needs to be a successful and economically efficient reproductive
management (Dijkhuizen et al. 1985, Plaizier et al. 1997). For that reason, a
voluntary waiting period enables time for the ovarian cyclicity to be resumed
and the uterus fully involuted, devoid from inflammation. This should increase
the capability for conception, implantation and embryo survival. Generally, it
has previously been agreed that clinical RTID impairs subsequent reproductive
performance of dairy cows (LeBlanc et al. 2002, Sheldon et al. 2006).
An added level of complexity is that it is not only clinical RTID but also
subclinical RTID that could impair fertility (Kasimanickam et al. 2004).
Previously, it has been reported that RTID has a negative impact on fertility,
in spite of appropriate treatments with PGF2α or locally administered broad-
spectrum antibiotics (Sheldon et al. 2006). This large-scale study involving
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over 59,118 lactations from commercial herds also showed the negative
effects of RTID on subsequent reproductive performance.
In the current study, the mean days to first service was 5 days longer in cows
that experienced RTID compared to control cows. Similar extensions to DFS
were observed by LeBlanc et al. (2002) . However, other smaller scale studies
also found longer DFS in RTID-affected cows by 23.3, 3, and 9 days
respectively (Kim and Kang 2003, Williams et al. 2005, Gilbert et al. 2005).
However, in some other studies reported that days to first service were not
different (Dini et al. 2015). Moreover, this thesis found that there was a
further increase in the days to first service with increased observations of
RTID. The increased RTID observations are most likely the result of cows
having persistent infection and/or failing to respond to the treatments.
The underlying mechanism which results in extended DFS remains to be fully
elucidated. Cows with endometritis have lower peripheral plasma oestradiol
concentrations due to slower growth of the first (and subsequent) postpartum
dominant follicles which has been associated with lower peripheral plasma
progesterone concentration after ovulation (Sheldon et al. 2002a, Williams et
al. 2007, Battaglia et al. 1999, Peters et al. 1989). Cows which experienced
RTID had a greater degree of NEB (Galvão et al. 2010a) and cows with NEB
have lower circulating concentration of IGF-1 during the early postpartum
period (Lucy 2000, Wathes et al. 2009).
The bovine endometrium expresses the IGF system (Llewellyn et al. 2008),
which plays an important role in tissue repair, promoting proliferation and
healing during uterine involution. In addition, cows with severe NEB during
post-partum period had suppressed pulsatile LH secretion, suppressed ovarian
responsiveness to LH stimulation and also decreases in the functional
competence of the follicle characterized by low oestradiol production that
subsquently leads to delayed ovulation (Zaleha et al. 2013). Another
explanation for this, is that bacterial derived endotoxin lipopolysaccharide
and/or various mediator cytokines stimulated following bacterial infection
(e.g. tumour necrosis factor TNFA and interleukin (IL)-1) suppress the
secretion of GnRH from the hypothalamus (Rivest et al. 1995, Battaglia et al.
2000, Williams et al. 2007). It is worth noting that DFS is influenced by
management and VWP, thus the DFS does not necessarily reflect days to
onset of cyclicity.
In the current study, cows that experienced RTID took 22 days longer to
become pregnant than RTID-negative cows. This difference is much greater
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than observed for the DFS but is consistent with previous smaller scale
studies (Toni et al. 2015, Giuliodori et al. 2013, Fourichon et al. 2000, Lincke
et al. 2006, De la Sota et al. 2008, Mosquedq et al. 2011). However, it was
much lower compared than (Gilbert et al. 2005) who showed that cows with
RTID became pregnant 88 days later than cows without RTID. Increased
freguency of RTID within the lactation had further detrimental effects on
calving to conception interval. One explanation for this, is that RTID delays
uterine involution resulting in delayed breeding time.
The likely effects of RTID on fertility are decreased oestrus behaviour which
then may be missed by the farmer or an affect on the CL such that it does not
produce enough progesterone to maintain pregnancy. Furthermore, animals
with RTID need to be detected and treated efficiently as soon as possible to
prevent problems later on. On dairy farms however, RTID diagnosis is
performed by the veterinarian, often only during routine herd health checks.
This means that in several cases, early warning signs of RTID go unnoticed
until such time that the disease is in its full clinical stage. At this time, it has
become chronic and much more difficult to treat.
The major contributor to impaired reproduction in RTID positive cows was a
severe reduction in conception rate at 1st service. This study demonstrated
that the 1st service conception rate was significantly higher in RTID-negative
cows (38%) than RTID-positive cows (24%). These results are in agreement
with a previous report by Gilbert et al. (2006) which demonstrated that cows
with RTID had a lower conception rate (26%) compared to cows without RTID
(36%). The meta-analysis by Fourichon et al. (2000) summarized the impact
of RTID on reproductive performance from 24 studies in intensively housed
conditions. The effect of RTID on reproductive performance was quantified as
a 20 percentage point decrease in conception at 1st service. Moreover, the
increased number of RTID recordings was associated with further detrimental
effects on 1st service conception rates.
The reduction in 1st service conception rate might be associated with
prolonged uterine tissue repair, attenuated uterine re-epithelisation and
delayed uterine involution (Sheldon et al. 2003, Shrestha et al. 2004a) and/or
decreased steroid production by the ovary (Green et al. 2011), and
disturbance of ovarian cycles (Opsomer et al. 2000, Sheldon et al. 2002b,
Herath et al. 2009). Alternatively, persistent bacterial infections could impair
conception by changing the uterine environment resulting in impairment of
sperm transport, the death of sperm and/or creatation of a hostile
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environment to the subsequent embryonic development (Rahman et al.
1996).
In a similar manner, the number of services per conception increased to 2.9
for cows which experienced RTID (vs. 2.1 for control cows). In accordance to
previous findings (Gilbert et al. 2005, Fourichon et al. 2000, LeBlanc et al.
2002) which reported that cows with endometritis had a greater number of
inseminations per conception than cows without endometritis. The present
study reported that RTID has a negative impact on calving interval. Cows
experiencing RTID had a longer (426.4 days) calving interval than control
cows (403.2 days) with a difference of 22.3 days. These results were different
from the findings of Mosquedq et al. (2011) who reported that cows with RTID
had longer calving interval by 38 days. Abnormally lengthened calving
intervals due to RTID have been shown to be related to low productivity and
lead to serious economical implications for the herds as productivity of the
livestock farm is decreased severely (Lee and Kim 2007, Tayebwa et al.
2015).
The present study demonstrated that cows with RTID produced slightly more
milk in 305d compared to cows without RTID. Thus is in accordance with a
study by Gröhn et al. (1990) who reported that milk yield increased the risk of
metritis, retained placenta, days to calving interval and ovarian cysts. The
reasons beyond this increase are unknown, but it might be due to cows with
RTID having prolonged calving to conception interval, and thus have a longer
lactation curve. However, cows with uterine infection had lower milk
production for the first 100 days in milk (Bell and Roberts 2007). They
suggested this was due to reduced daily dry matter intake. There is a clear
association between high milk yield and increased risk of negative energy
balance that begins prior to calving and extends into early lactation (Knop and
Cernescu 2009, Butler 2012).
Negative energy balance (NEB) has been linked to impaired
polymorphonuclear neutrophil (PMN) function (Hammon et al. 2006). It has
been reported that severe negative energy balance leads to reduced
circulating white blood cells (WBCs) especially lymphocytes, and increased
gene expression for inflammatory mediators at 14DIM (Wathes et al. 2009).
It should be noted that other reports have shown that cytological endometritis
and purulent vagina discharge were not associated with milk yield (Dubuc et
al. 2011, Fourichon et al. 2000).
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When to remove a cow from the herd is regarded as one of the most complex
decisions dairy farmers make. The most likely reason for exiting the herd was
culling with both biological and managerial factors influencing the dairy
farmer’s decisions. There are different aspects considered in culling decisions
such as animal’s health, fertility (or lack of), milk yield, and stage of lactation
as well as the value of the replacement animal and it’s cost (Barkema et al.
1992, Beaudeau et al. 1994). The present study demonstrated that the
average exit rate was 21.7%. The rate of exited animals in this study was
unaffected by calving year. This was similar to the previous UK studies which
reported culling rates of 22.1% (Whitaker et al. 2000) and 23.8% (Esslemont
and Kossaibati 1997). This suggests that the standard culling rate in the UK
therefore, seems to be fairly steady about 22%. However, these are much
lower than that reported by Lee and Kim (2007) with a culling rate of 46.4%,
which was twofold higher compared to current study.
The observed exiting rate was significantly different between control cows and
those that experienced RTID during the lactation. Furthermore, cows with
RTID were 1.2 more as likely to exited in herds as cows without RTID.
Similarly, Opsomer and de Kruif (2009) reported cows with clinical
endometritis to be 1.2 times more likely to be culled for reproductive failure.
However, the difference was lower than expected and did not agree with
Beaudeau et al. (1994) who demonstrated that more than half of all culling
were related to health disorders. Furthermore, the effect of RTID on exit rate
was less compared to previous reports by Plöntzke et al. (2011) and LeBlanc
et al. (2002) who reported that cows with clinical endometritis were 1.6 and
1.7 times, respectively as likely to be removed from herd as cows without
clinical endometritis.
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2.5 Conclusion
Overall, this study quantified the reproductive performance in 80 commercial
dairy herds across the England and Wales. The incidence of RTID and its
impact in extensive dairy production system in England and Wales was similar
to previously published data from dairy farms with intense production
systems. In this study, postpartum RTID had a significant influence on the
subsequent reproductive performances in dairy cows. Cows which experienced
RTID were less likely to become pregnant, required more services per
conception and were more likely to be removed from the herd. This study has
quantified the negative associations between cows experiencing uterine
disease and subsequent reproductive performance. The biggest relationship
appearing to occur on the ability of cows to re-conceive. To our knowledge
this was the first study determine the association between RTID and
reproductive performance in multi-commercial dairy herds England and
Wales. Therefore, the next chapter will study on the effect of RTID on the
reproductive performance of dairy cows in the University of Nottingham dairy
centre.
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3 The association between uterine
disease and subsequent reproductive
performance at the University of
Nottingham and postpartum ovarian
cyclicity
3.1 General introduction
In dairy cows, one calving each year is generally accepted as the optimum
calving interval to maximise economic profit (Dijkhuizen et al. 1985). To
achieve this, cows should resume their ovarian cycles within 5 weeks post
calving and conceive within 85 days post-partum. The previous chapter
showed that in the immediate postpartum period approximately 12% of dairy
cows developed RTID and that this inhibited reproductive performance and
impaired fertility. Endometritis is regarded as the principle infectious disease
of the uterus and is caused by persistent bacterial infection after calving
(Runciman et al. 2008, Sheldon et al. 2006, Barlund et al. 2008, Sheldon et
al. 2009a, Gilbert et al. 2005). Chapter 2 indicated that RTID was associated
with an increase in days open (22 days), increase numbers of services per
conception (0.9 services) and an increased risk of culling (4%). Often, the
real impact of endometritis is only measured by subsequent statistical
analysis, while the economic impact of this disease remains to be quantified,
but it is speculated to exceed millions of pounds annually for the UK dairy
industry alone (McNaughton and Murray 2009).
The mechanism by which uterine infection with bacterial endotoxin during the
post-partum period adversely affects fertility is likely to be multi-factorial
influencing fertility both locally and systematically. For example, there is a
disruption in the production of PGF2 and PGE2 by the endometrium (Herath et
al. 2009). At the same time, there is an alteration to the immune system
mediators and production of cytokines, which can affect the function of
hypothalamus and pituitary gland (Sheldon et al. 2009a). An important
observation was that uterine infection affected follicular growth and function
(Sheldon et al. 2002b). Indeed, the bacterial endotoxin, LPS has been
detected in the follicular fluid. There has been an association between clinical
signs of uterine inflammation and post-partum ovarian cyclicity (Opsomer et
al. 2000, Mateus et al. 2003, Shrestha et al. 2004a, Taylor et al. 2003,
Williams et al. 2007, McCoy et al. 2006).
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Over the last few decades, milk progesterone monitoring has been used
widely for assessment of ovarian function, reproductive patterns and
abnormalities in dairy cows (Bulman and Lamming 1978, Bulman and
Lamming 1979, King et al. 1976). It has also investigated the impact of
environmental factors on reproductive fertility. Previous studies have revealed
that cows with an early onset of luteal activity (OLA) after calving had an
increased chance of an earlier 1st service, shorter interval to conception, and
higher conception rates (Darwash et al. 1997). However, early OLA has also
been regarded as a risk factor for irregular luteal cyclicity in a form of a
persistent corpus luteum (Opsomer et al. 2000, Petersson et al. 2006).
Cows with abnormal ovarian cycles have a significantly longer calving to first
service interval, lower conception rates to 1st service, longer calving to
conception interval and increased number of services per conception. Reduced
conception rates have been related to lower post-ovulatory progesterone
concentration or reduced number of cycles before insemination (Shrestha et
al. 2004a, McCoy et al. 2006). In the United Kingdom, the reduction in
pregnancy rate from 1975 to 1998 was related to an increased the incidence
of atypical progesterone profiles (Royal et al. 2000). Prolonged luteal phases
(high progesterone levels for >20 days in absence of pregnancy) were
considered to be the most common type of irregular ovarian cycles. The
incidence of prolonged luteal phase has increased from the 1970s to 1980 in
Belgium and Japan (Lamming and Darwash 1998, Opsomer et al. 1998,
Shrestha et al. 2004b).
It has been reported that prolonged luteal phases were associated with an
abnormal uterine environment which perturbed the production of
prostaglandins (Opsomer et al. 1998). The risk factors for prolonged luteal
phase in cows were metritis (odd ratio (OR) =11.0), abnormal vaginal
discharge (OR=4.4), retained fetal membrane (OR=3.5) and parity (increased
in multiparous) (Opsomer et al. 1998, 2000). This supported the concept that
prolonged luteal phases are primarily associated with uterine problems rather
than follicular dysfunctions. In this chapter, two experiments were performed
to investigate these associations further.
Hypothesis
RTID is associated with a negative impact on post-partum reproductive
performance and increased abnormal post-partum ovarian activity. This
hypothesis was tested by conducting detailed investigations (herd
performance, clinical data and endocrinological) on a high-yielding dairy herd
CHAPTER THREE
72
in the UK. The herd chosen was University of Nottingham dairy centre whose
256-cow herd averaged a 305d milk yield of 10306L
3.2 Experiment 1: The association between
RTID and reproductive performance at the
University of Nottingham dairy centre
3.2.1 Objectives
The detailed investigations were broken down into the following objectives:
1. To quantify the incidence of RTID in the herd form cows calving
between 2008 and 2014.
2. To assess the current status of fertility performance at the Nottingham
University dairy centre
3. To assess the impact of cows experiencing RTID on the following
fertility and production traits:
Day to first service (DFS)
Calving to conception interval (CCI)
Conception rate at first service
Number of services per conception (SPC)
Calving interval (CI)
Milk yield 305d
3.2.2 Materials and methods
3.2.2.1 Experimental animals
The present study involved 256 cows (n=708 lactations) British Holstein dairy
cows calving from 2008 to 2014, at the University of Nottingham dairy centre.
The parity of the cows ranged from 1-7. Animals were classified into two
groups according to their veterinarian reported uterine health status: (1)
control cows (n=603 lactations, these were not recorded RTID during
lactation) and (2) cows with RTID (n=105 lactations). The following
information was collected from Uniform Agriculture computer software
programme for each animal:
 Current animal number
 Ear tag number
 Calving date
 Inseminated date
 Reproductive diagnosis interventions
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Cows with RTID were treated by a veterinarian deemed appropriate for that
particular case no experimental interventional introduced. Treatments were
used included: Antibiotics such as (Naxcel® injection (S/C) and Metricure
syringe (intrauterine) and hormonal treatments such as PGF2α. Cows (n=58) 
left the herd due to multifactorial causes.
3.2.2.2 Feeding and management
All animals were managed under the herd’s standard procedures. The cows
were housed continuously indoors, calved all year round and were kept in a
loose house with individual rubber-matted cubicles. The cows were fed ad lib
on a total mixed ration based on maize and grass silage and a variety of
additional ingredients such as rolled wheat, sugar beet pulp nuts, molasses
and mineral supplements. Additional concentrates were fed in robotic milking
machines according to milk yield. Cows were milked by robot on average 3
times per day. Volume of milk yield at each milking was recorded and stored
in the database and then transferred each month. All breeding was performed
by artificial insemination at natural oestrus (n=1868) and all inseminations
were recorded by the herdsperson. Pregnancy diagnoses were based on
routine methods such as transrectal uterine ultrasound and rectal palpation by
a veterinarian according to normal herd practice. This was routinely done
from 30–60 days after the cows have been inseminated. Any post-partum
problems or abnormalities such as RTID were recorded by the veterinarian or
herdsmen. Once abnormalities were investigated, a therapeutic management
plan (including antibiotics or hormones) was initiated.
3.2.2.3 Definition of fertility parameters
Fertility traits for both primiparous and multiparous Holstein dairy cows used
for comparison of reproductive performance between control cows and cows
that experienced RTID from 2008-2014 are explained in Table 3.1.
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3.2.2.4 Data processing
All animal data included (calving date, any calving difficulties, insemination
dates, pregnancy diagnoses outcome, milk production, the occurrence of
diseases during post-partum period and date of treatments) were recorded by
the herdsmen into the Uniform Agriculture computer software programme.
Before statistical analysis was performed, these data were imported into
Microsoft Excel 2010 (Microsoft Corporation, 2010) individually. The
presence/absence of RTID and pregnancy diagnosis outcome were coded into
dichotomous values with “1” or “0” as appropriate. In order to compare
groups of cows with different fertility traits the following categories were
created based on: (1) Days to first service and (2) calving interval (Table
3.2).
Comparisons between “control” cows with different reproductive
performance
Within control group only, three sub-groups were created depending: 1) on
the cows’ day to first service interval (DFS) as follows: <42, 43-70 or >70
days; 2) calving interval as follows: <365, 365-400 and ≥401 DIM. For these 
sub-groups, reproductive parameters analysed were calving to conception
interval (CCI), conception rate at 1st service, number of services per
conception and milk yield 305d.
Fertility trait Definition
Day to first service
(DFS)
Number of days from parturition to the first
insemination after calving
Conception rate at first
insemination
The percentage of the number of cows that became
pregnant at the first insemination.
Conception rate at
second insemination
The percentage of the number of cows that became
pregnant at the second insemination.
Conception rate at third
insemination
The percentage of the number of cows that became
pregnant at the third insemination.
Calving to conception
interval (CCI) Number of days from calving to conception
Number of services per
conception (SPC)
Number of inseminations required for a cow needs to
become pregnant.
Calving interval (CI) Number of days between two subsequent calvings.
Table 3.1: The definition of fertility traits.
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RTID and its association with subsequent reproductive performance
Data from each lactation were entered and stored in Microsoft Excel 2010
(Microsoft Corporation, 2010). Dichotomous values were used for pregnancy
outcome at 1st insemination, RTID status where “1” indicated they were
pregnant/had RTID were coded into “0” when animals did not conceived at 1st
service and/or free from disease.
3.2.2.5 Statistical analysis
The normality of the data was checked using residual plots and appropriately
transformed where required.
The prevalence of RTID
The prevalence of RTID between calving years, and lactation number were
analysed using binomial logistic regression in GenStat 16th Edition (VSN
International Ltd, Hemel Hempstead, UK).
Table 3.2: The number of lactations in different reproductive performance categories.
Reproductive performance category Number of lactations
Number of services
1-10 services 708
Days to first service
19-160 708
Days open
20-353 664
No data 44
Calving interval
<365 days 257
365-400 days 144
≥401 days 250
No data 57*
Milk yield 305 d
5000-20000 268
No data 440**
*Includes cows that were removed and thus no calving interval
**Includes cows that were removed and thus no complete 305d milk yield, and data
that was not recorded into dairy record.
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Comparisons between control cows with different reproductive
performance
In order to assess the reproductive performance of cows with different DFS
values (<42 (early), 43-70 (normal), >70 (late) DIM), one-way ANOVA was
performed with the DFS categories as the factor. Similarly, one-way ANOVA
was conducted to compare reproductive performance of cows with different CI
values (<365, 365-400 and >401 DIM). One-way ANOVA was used to
compare SPC between the different DFS and CI categories. Binomial logistic
regression was performed to compare conception rate at 1st, 2nd and 3rd
service between DFS groups and CI groups.
The association between RTID and subsequent reproductive
performance
In addition, univariate, unbalanced ANOVA was performed to determine the
association between RTID status (included as the factor) and reproductive
performance (DFS, CCI, SPC and CI), as a response variable, blocked by the
cow identity. Kaplan-Meier survival analysis was performed to compare
calving to conception interval between cows that experienced RTID and those
that did not. The proportion of non-pregnant cows represented the survival
probability, which was plotted against the time (calving to conception
interval). Logistic regression was performed to compare conception rate at 1st,
2nd and 3rd service between control cows and cows experienced with RTID. All
candidate variables were kept in the model with significant attributes at
P<0.05.
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3.2.3 Results
3.2.3.1 Prevalence of RTID
The results demonstrated that the prevalence of RTID was significantly different
between calving years (P<0.01; Fig.3.1A). The mean prevalence of RTID across
the whole study was 14.8%. The highest incidence was observed in 2008 and
2009 at 25, 55.6%, respectively. Thereafter, the prevalence has been lower
between 6-18%. It should be noted that there were fewer cows in 2008, 2009
and 2010 database. However, this study did not find any difference in the
prevalence of RTID between the different lactation numbers (P>0.05; Fig. 3.1B).
Figure 3.1: The prevalence of RTID in lactations at Nottingham dairy centre. (A) Effect of
calving years on the prevalence of RTID. The highest percentage was seen in 2008 and
2009 (highlighted red column). (B) Incidence of RTID across different parities. There was
no difference in the RTID incidence between parity (P>0.05).
3.2.3.2 Reproductive performance of the herd at the
University of Nottingham dairy centre
This study performed descriptive statistics to measure reproductive performance
across the herd. The mean values, range and standard deviation for the different
endpoints are shown in Table 3.3.
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Lactations with the early DFS (<42 days) required nearly one more service in
order for them to conceive versus DFS >70 days (P<0.05; Table 3.4). Significant
differences in conception rate between the different DFS categories were
detected (P<0.05; Table 3.4). Lactations served after 70 days postpartum had
15% higher conception rate at 1st AI compared to cows served earlier (P<0.05,
Table 3.4). However, there was no difference in 305d milk yield between
lactations with different DFS range (P>0.05, Table 3.4).
A similar study was performed to compare the herds fertility performance by
categorising lactations according to their calving interval. Lactations with the
*= low number of data due to 58 lactations were removed before completed 305d, others
lactations had no data.
Table 3.3: Descriptive statistics for production variables for all 708 lactations at the
University of Nottingham dairy centre from 2008-2014.
Variable Minimum Maximum Mean SEM Number
Days to first service 19 160 58.4 0.87 708
Calving to conception
interval (days)
27 353 119.6 2.7 664
Service per conception (n) 1 10 2.98 0.08 708
Calving interval (days) 283 583 397.1 2.6 651
Milk yield 305 (L) 5000 20000 10214 157.0 271*
Conception rate at 1st AI 29.5%
Conception rate at 2nd AI 35.3%
Conception rate at 3rd AI 39.6%
Table 3.4: Mean±SEM for days to first service, services per conception, calving to
conception interval, calving interval, conception rate at 1st AI, and 305 day milk yield with
different days to first service: <42; 43-70 and >70days.
Reproductive
performance
Days to first service category
≤42 
days
43-70
days
>70
days
P value
Days to first service 36.1±1.1
n=165
54.3±0.6
n=384
92.3±1.0
n=159
<0.001
Number of services
per conception
3.2±0.1
n=165
2.9±0.1
n=384
2.5±0.1
n=159
0.028
Calving to conception
interval (days)
107.7±5.6
n=152
114.2±3.5
n=360
142.7±5.4
n=152
0.001
Conception rate at 1st
AI
24.3% 28.3% 39.6% 0.03
Calving interval
(days)
385.7±5.4
n=149
382.7±3.4
n=354
418.7±5.3
n=148
0.002
Milk yield 305 days
(L)
10240±418.8
n=142
10665±260.6
n=79
10178±384.6
n=114
n.s.
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shortest CI (<400 days) had an approximate 11 day shorter DFS compared to
lactations with the longest CI (P<0.001; Table 3.5). The striking observation was
that cows with the shortest CI had the least number of services to conceive
(P<0.001; 2-3.7 services less) and had a significantly higher conception rate at
first service (P<0.001) by over 40 percentage points. However, intriguingly,
there was no difference in 305d milk yield between lactations with different CI
(P>0.05; Table, 3.5).
3.2.3.3 Reproductive performance between control
cows and cows positive with RTID
Days to first service, calving to conception interval, number of
service per-conception and calving interval
Lactations that experienced RTID had a longer day to first service compared to
control lactations by about 11 days. The mean for the control lactations was
57.4±0.9 days to first service in comparison with lactations positive with RTID
where it was 68.3±2.1 days (P<0.01; Fig. 3.2A). However, no difference was
seen between control lactations and lactations in which RTID was experienced in
terms of CCI, SPC and CI (P>0.05; Fig. 3.2B-D).
Table 3.5: Mean±SEM days to first service,service per conception, calving to conception
interval, calving interval, conception rate at 1st AI, and milk yield 305d of lactations with
<365; 365-4200 and >401d CI.
Reproductive performance Calving interval (CI) category
<365
days
365-400
days
>401
days
P
value
Calving interval (days) 354.8±1.7
n=398
412.2±3.9
n=79
486.3±2.7
n=174
<0.001
Days to first service 55.3±1.1
n=398
64.8±2.6
n=79
66.3±1.8
n=174
<0.001
Number of services per
conception
1.7±0.1
n=398
3.1±0.2
n=79
5.1±0.1
n=174
<0.001
Calving to conception
interval (days)
76.4±1.8
n=398
132.1±4.1
n=79
210.3±2.8
n=174
<0.001
Conception rate at 1st AI 46.6% 10.8% 2.2% <0.001
305 day milk yield (L) 10203±263.9
n=143
9981±552.6
n=34
10852±362.5
n=79
n.s.
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Figure 3.2: Impact of lactations having RTID post-partum on reproductive indices.
(A) Days to first service (DFS) was greater in lactation that had RTID and those that
did not (P<0.001). (B) Kaplan-Meier survival analysis of days open between RTID
and control lactations. Median day for lactations with RTID (114.0 days), vs control
lactations (100.5 days) (P>0.05). (C) Number of services per conception (SPC) was
not different between lactations that had RTID (3.0±0.2) and those that did not
(2.9±0.1, P>0.05). (D) Calving interval was not different between control lactations
(396.1±2.6) vs lactations positive with RTID (407.9±67, P>0.05).
Conception rate at first service
There was an increase in the conception rate with increasing service number
(P<0.05). This study demonstrated that RTID had no significant effect on
conception rate at 1st, 2nd and even at 3rd service (P>0.05; Table 3.6).
Table 3.6: The conception rates at 1st, 2nd and 3rd service between cows that
experienced RTID and those that did not.
Conception
rate
Control cows RTID cows P value
At 1st service 28.9% 34.1% 0.525
At 2nd service 34.8% 31.9% 0.964
At 3rd service 41.1% 29.2% 0.321
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Milk yield 305d
The results showed that control lactations produced higher 305d milk yield
compared to the lactations experienced with RTID (P<0.01; Fig.3.3).
Figure 3.3: Effect of lactation having RTID on 305 d milk yield. The average of 305d milk
yield was higher in the lactations with RTID vs lactations experienced with RTID (P<0.01).
3.2.4 Discussion
The study examined the prevalence of RTID in the University of Nottingham dairy
centre from 2008-2014, and the effect of RTID on the post-partum reproductive
performance of dairy cows.
3.2.4.1 Prevalence of RTID
The prevalence of RTID in the present study was 14.7%, which was close to the
findings in the Chapter two. This was not too far from the findings of previous
other studies (Chunjie et al. 2013, De la Sota et al. 2008, LeBlanc et al. 2002),
they reported prevalence of endometritis were 17.4%, 20-21% and 17%,
respectively.
However, the result of this study was lower compared to study of Ribeiro et al.
(2013) who observed prevalence of clinical endometritis 37.5% and 59.0% of
subclinical endometritis in North-America (from 957 lactating multiparous dairy
cows). Furthermore, Plöntzke et al. (2011) reported higher prevalence of
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endometritis 35% than in the present study. The variation in the incidence of
endometritis between studies makes it challenging to define what the current
situation is. This is hindered by different management systems under which the
animals where kept and probably more importantly the different diagnostic
methods used that are used at different times postpartum period (Heuwieser et
al. 2000, Kaneene and Miller 1995, Lewis 1997).
There are equivocal reports about the effect of parity on the prevalence of RTID.
The present study reported that parity did not influence prevalence of RTID. This
is supported by several other studies that also demonstrated that parity had no
effect in prevalence of endometritis (Matiko et al. 2008, Noakes et al. 2001,
Nakao et al. 1997, Hare et al. 2006). In contrast, LeBlanc et al. (2002) observed
that parity had an effect on the prevalence of endometritis, and demonstrated
that a higher risk has been described for cows in the third or higher lactation in
intensive high-yielding dairy systems. Conversely, McDougall (2006) reported
that primiparous cows are more at risk than multiparous cows in more extensive
farming conditions. It can be speculated that while in some conditions, parity has
an impact on the prevalence of endometritis it is likely to be a relatively minor
player.
The present study found that the prevalence of RTID was greater in 2008 and
2009 compared to other years. Many previous studies have been published about
different risk factors for prevalence of endometritis such as calving difficulties
(normal vs abnormal); metabolic disorders; calving season; retained placenta;
negative energy balance and day in milk. There was no specific reason reported
which accounts for the higher levels, but it might be related to the different
environment conditions between years, or the quality of the feed.
Current fertility parameter in The University of Nottingham dairy centre
Prior to investigating the association between RTID and reproductive
performance in dairy cows, this study described the fertility parameters at the
herd level. The present study used a range of indices to describe reproductive
performance of cows within a herd. The mean interval from calving to first
service on herd level was about 58.4 days. This interval falls at the lower end of
the recommended range of 50 to 70 days after calving (Noakes et al. 2009) and
was lower than that reported in Chapter 2 across multiple herds in the UK. This
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could reflect the herd’s management strategy to serve earlier than most herds or
that the cows in this herd returned to cyclicity relatively early. Interestingly,
though cows with mean DFS >70 days had fewer services per conception and
higher conception rates at 1st service compared to cows with <42 days. This
agrees with Chapter 2 and is supported by previous reports (Williamson et al.
1980, Shannon et al. 1952, Dohoo 1983, Tenhagen et al. 2003, Řehák et al. 
2009, Buckley et al. 2003). This might be due to that uterine tract was fully
recovered from previous calving and conception results were normally high.
The mean calving to conception interval and calving interval in the present study
were 120 and 397 days, respectively. This was lower than 405.6 days in Chapter
2. Cows with <400 days had lower number of services, and higher conception
rate at first service compared to cows with longer CI >400. Similar to the
previous chapter which reported that cows with <400 days CI, had better
performance than cows with longer than >425 days CI. However, this parameter
had no effect on reproductive performance of dairy cows (Ratnayake et al. 1997).
The overall mean number of services per conception and conception rate at 1st
service was 2.98 services and 29.5%, respectively. These observations were
lower than findings in the Chapter 2 (36.3%). This study supports the previous
report by Royal et al. (2000) who demonstrate that pregnancy rate at first
service decreased from 56% in 1975–1982 to about 40% in 1995–1998 in the
UK, a decrease of about 1% per year. It has been reported that days to first
service has a significant effect on conception rate at first service in dairy cows
(Tenhagen et al. 2003, Řehák et al. 2009, Buckley et al. 2003). In the current 
study, this parameter did affect conception rate at first insemination, and it found
that cows inseminated after 70 days had significantly higher first service
conception rate than inseminated before 42 days. The reason is likely to be due
to that uterine tract in cows inseminated before 2 months was not fully restored
from previous calving. In the present study, mean 305d milk yield was 10306
litres, which was higher than the mean of 305d milk yield of 8425 liters shown in
Chapter 2. This indicated that this herd was a very high-yielding herd.
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3.2.4.2 Impact of RTID on reproductive
performance of dairy cows
It should be noted that this retrospective study did not check cows for subclinical
endometritis, thus the reference control cows may have included some animals
having subclinical endometritis which may have also affected reproductive
performance and, for that reason, this study could have underestimated the
effect of RTID on reproductive performance. Those cows that experienced RTID
had longer days to first service than control cows about 11 days. This is in strong
agreement with reports that cows with RTID had longer DFS compare to cows
without RTID (Lincke et al. 2006, Borsberry and Dobson 1989, LeBlanc et al.
2002). This was relatively longer than Gilbert et al. (2005) who reported that
cows with clinical endometritis had 5 days longer compared to cow that did not
have clinical endometritis. This was similar to that observed in Chapter 2. The
causes of extended days to first service in cows with RTID in this chapter is likely
to be due to cows having a shorter voluntary waiting period thus cows less likely
to have fully recovered before 1st service.
It is interesting to note that, this study did find any significant effect of RTID on
calving to conception interval; service per conception, conception rate at 1st
service and calving interval. All these were adversely affected numerically in
similar way to Chapter 2. In accordance to the previous studies by Kinsel and
Etherington (1998); Galvão et al. (2009) and (Marques et al. 2015) they did not
find an effect of endometritis on calving to conception interval. Moreover, in
agreement with Kasimanickam et al. (2006) who found that the presence of
endometritis has no effect conception rate at first insemination. The results of the
present study were contrast to the findings of LeBlanc et al. (2002); Gilbert et al.
(2005); Lincke et al. (2006) and the results of Chapter 2. Alternatively, the
reasons in the present study did not find an association between RTID on
reproductive performance might relate to: 1) good management factors, highly
efficient and early diagnosis of uterine disease, and efficient treatments; or 2)
due to limited numbers to fully determine significance.
The present study found that there was a significant difference in milk production
between cows which experienced RTID and control cows. This was similar to the
findings of Bell and Roberts (2007) who concluded that post-partum uterine
infection was associated with reduced feed intake, which would explain the
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decreased milk yield and lower milk protein composition. Dubuc et al. (2011) and
Mee et al. (2009) showed that metritis was associated with decreased milk yield
in multiparous cows, but not in primiparous cows. Another study by Ribeiro et al.
(2013) using daily milk data from 500 cows in one herd demonstrated a negative
impact of metritis on milk production in all cows, and found that cows with
metritis produced less milk. Control cows produced more 305d milk than cows
with endometritis. In contrast to chapter 2 which reported that cows with
endometritis produced more milk in 305d compared to control cows.
3.2.5 Conclusion
Prevalence of RTID at the University of Nottingham Dairy Centre was 14.8%. In
this herd, cows with RTID had extended days to first service by 11 days.
However, RTID had no adverse effect on the subsequent reproductive
performance in dairy cows such as calving to conception interval, service per
conception, conception rate at 1st service and calving interval. Additionally, cows
that had RTID had lower 305d milk yield. The next experiment focused on the
impact of endometritis on pattern of ovarian activity and cyclicity in the same UK
dairy herd.
3.3 Experiment 2: Effect of RTID on post-
partum ovarian cyclicity
3.3.1 Objectives
1. To quantify the incidence of typical and atypical progesterone profiles in a
high yielding dairy herd.
2. To determine the effect of endometritis and abnormal vaginal discharge
score on the postpartum ovarian cyclcity.
3. To quantify the postpartum reproductive performance between cows with
typical and atypical progesterone profiles.
3.3.2 Materials and methods
3.3.2.1 Animals and herd
Three sets of animals were used in this experiments: 1) The first group involved
46 multiparous Holstein dairy cows calving from August 1999 to February 2000
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selected from the Nottingham University commercial dairy herd (Manor Farm).
This group involve: 33 control cows and 13 cows with endometritis; 2) The
second group 38 animals from another local dairy herd (Rangemoor Farm), and
classified into 24 control and 14 endometritic cows; 3) The last group of animals
involved 86 cows from the University of Nottingham dairy centre, which calved
from July 2013 to April 2014: 61 control cows and 25 cows which experienced
endometritis. For analysis, this study combined all these cows together, and
classified into: 118 control cows and 52 cows that experienced endometritis. In
the later group, the lactating cows were kept indoors in groups of approximately
40. Housing consisted of a purpose-built shed with four pens, which was well
ventilated, with rubber matting, cubicles and shavings for comfort whilst lying. All
cows were fed the same silage based total mixed ration diet, with concentrated
feed at milking. Cows were milked by 4 robotic milkers (Lely Astronaut A3 AMS
units) voluntarily; visiting from 2 to 6 times per day. Milking was done on
average 3 times per days. In the other 2 groups, cows were milked in a
traditional parlour. In all three groups, cows were checked for uterine disease
through inspection of the vaginal discharges and categorised into two groups:
endometritis (n=52) and control group (n=118). Endometritis defined by the
presence of abnormal vaginal discharge within 3 weeks after calving. All cows in
all 3 groups were managed according to normal management practices.
Generally, control cows selected when there was no abnormal vaginal discharge
seen from 3 weeks after calving until cows getting pregnant.
3.3.2.2 Reproductive management
All cows with reproductive disorders were treated as appropriate by the
inspecting clinician.
3.3.2.3 Milk sampling
In the first two groups of animals, milk samples were collected manually, from
the milking jar and after milk had mixed thoroughly. A sample was taken twice
weekly (p.m., Monday and Friday) from each cow, starting two weeks after
calving and continued until 15 weeks post-partum. However, at the University of
Nottingham dairy centre, milk samples were collected via a Lely Shuttle
connected to the robotic milking machine for progesterone analysis. The milk
sampling procedure was started from 10-14 days postpartum period and
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continued until confirmation of a new pregnancy either by rectal palpation or
ultrasonography. Milk samples were collected thrice weekly (Monday,
Wednesday, and Friday). As cows entered the robot for milking, they were
identified to be sampled and approximate 20ml milk was collected. Samples were
collected in plastic tubes contain broad spectrum Microtabs®II (containing
Bronopol and Natamycin; D&F Control Systems, Inc., USA), which preserved and
prevented growth of bacteria, yeasts and molds. Milk samples were preserved
with one tablet per sample and refrigerated at 4°C until measurement. If the cow
was confirmed as pregnant, milk sampling of these cows was stopped.
Occasionally, milk samples were missed either due to the automated nature of
sampling or failure of robotic system due to power-cut communication which lead
to an error in robotic system. However, this had no impact on the ability to
interpret the progesterone profiles.
3.3.2.4 Assay for milk progesterone
The concentration of progesterone in milk was determined using a 96-well
microtiter plate-based enzyme-linked immunosorbent assay (ELISA) supplied as
a commercially available kit (Ridgeway Science Ltd., Alvingdon, UK). Microtiter
plates pre-coated with progesterone-antibody were stored at 4°C and were
warmed to room temperature prior to use. The foil seal was removed, wells
emptied and the plate blotted dry onto tissue paper. Prior to each assay the
following reagents: whole milk standards: 0, 1, 2, 5, 10, 20 and 50ng/ml; quality
controls: 2ng/ml and 8ng/ml in milk from ovariectomized cows and samples were
brought to room temperature and thoroughly vortexed to ensure homogeneity of
the samples and to ensure the fat was thoroughly mixed with milk. Standards,
quality controls and samples (10µl each) were added to the wells in duplicate.
Progesterone enzyme label (200µl) was added to each well and the plate
incubated at room temperature for 1 hour 30 minutes. After incubation, the wells
were emptied, washed with cold tap water and tapped dry on paper. This was
repeated a total of 3 times.  The supplied substrate solution (200μl) was then 
added to each well and incubated in the dark at 25°C for 20-30 minutes to allow
the colour to develop. The immunosorbance of each well was recorded at 570nm
using an automated plate reader (Labsystems Multiskan Ascent 354) and
processed using specific software to read the absorbance and transform into
progesterone concentration (Ascent Software Version 2.6, Thermo Labsystems).
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The software used a 4-parameter logistic regression line to fit the standards. The
ELISA’s reliable reading range was from 1.0 to 10ng/ml. All samples were
reading below or above this range were taken to be 1.0 to 10ng/ml, respectively.
All samples with a coefficient of variation >15% were repeated. The intra and
inter-assay coefficient of variation were 6.3 and 7.7%, respectively.
3.3.2.5 Onset of luteal activity (OLA)
The interval from calving to OLA was defined as the first day that milk
progesterone concentrations were ≥3 ng/ml for two successive measurements 
more than 10 days after calving (Mann et al. 2005, Garmo et al. 2009). The
average value was calculated for OLA and used to classify cows according to
early (on or before average day of OLA) or late OLA (greater than the average
OLA).
3.3.2.6 Ovarian cycle patterns analysis
This study described the nature of typical and atypical postpartum ovarian
patterns (as observed within the herd). The obtained ovarian activity profiles
were defined as previously reported. (Mann et al. 2005) Namely, the ovarian
activity profiles were split into five categories:
1. Normal profile (normal ovarian activity): Ovulation occurred ≤45 
days post-partum (detected rise in progesterone) with progesterone
concentration >3ng/ml for 14 days, followed by regular ovarian cycles
with about 2 weeks of luteal phase (high progesterone) and 1 week of the
follicular phase (low progesterone). A short luteal phase <10 days after
the first ovulation was considered as normal.
2. Anovulation or delayed first ovulation: The first detected ovulation
occurred more than 45 days after calving.
3. Cessation of cyclicity: Ovulation occurred within the normal period i.e
≤45 days after parturition, but it was followed by progesterone 
concentrations <3ng/ml for >12 days.
4. Prolonged luteal activity. It was characterised by progesterone
concentration >3ng/ml for >21 days without mating and thus not
pregnant.
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5. Short luteal phase. Progesterone concentration >3ng/ml for less than
10 days (excluding the first oestrus cycle).
3.3.2.7 Reproductive examination
Vaginal discharge scoring
The vaginal discharge scoring during post-partum was assessed by a
veterinarian, starting three weeks after calving. The cow’s vulva was wiped
thoroughly with a dry paper towel. Thereafter, a clean gloved hand lubricated
with gel was inserted through the vulva to the vagina. The dorsal, ventral and
lateral aspects of the vagina and the posterior part of the cervix of each cow
were palpated, and the vaginal contents withdrawn manually for inspection.
Intravaginal fluid was collected for examination prior to scoring it. Any discharge
during each vaginal examination was noted. According to Sheldon (2004), the
character of vaginal discharge was scored as follows:
(0) Clear or translucent mucus (healthy cows)
(1) Mucus containing flecks of white or off white pus
(2) Exudates containing ≥50% purulent material, usually white or yellow (Fig. 
3.4).
CHAPTER THREE
90
Figure 3.4: Typical samples of vaginal mucus character: score 0 = clear or translucent
mucus; score 1 = mucus containing flecks of white or off-white pus; and score 2 =
discharge containing >50% purulent material, usually white or yellow (Sheldon 2004).
Rectal palpation
Reproductive tracts of cows were examined by the vet and rectally palpated three
weeks after calving. Palpation of the uterus during the post-partum period was
carried out to assess the involution of the uterus and to detect any uterine
abnormalities. Both ovaries were palpated for identification of normal ovarian
structures, the examination of any possible abnormal pathological condition and
pregnancy diagnosed after 35 days post insemination. At the same time, ovaries
were checked for appropriate structures. By rectal palpation, ovarian cysts were
identified and distinguished mainly by size and consistency. A follicular cyst was
diagnosed as soft, thin walled large follicle. In contrast, a luteal cyst was
characterised as a firm, thick-walled structure.
Ultrasonography
A portable transrectal B-mode ultrasound scan was carried out with a 7.5-MHz
linear-array transducer used to monitor the ovarian activity, examine the
reproductive tract during post-partum period and for pregnancy diagnosis by an
experienced veterinarian. Cows with a negative pregnancy test and with
persistent corpus luteum or luteal cyst were treated with 2ml of Estrumate®
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(PGF2α). However, cows with a follicular cyst were treated with 5ml of receptal 
(GnRH agonist; buserelin).
3.3.2.8 Statistical analysis
All data were stored in Microsoft Excel 2010 (Microsoft Corporation). All statistical
analyses were performed in GenStat version 16th Edition. This study combined
three different sets of data for analysis. Various types of progesterone profiles
during the pre-service period were converted to a percentage of the total. One-
way ANOVA used to compare the OLA and vaginal discharge score between
normal and abnormal ovarian cycles. Kaplan-Meier survival curves were used to
compare days to first insemination between cows with typical and atypical
progesterone profiles. The 2 test was used to compare conception rates at first
insemination between progesterone profiles. One-way ANOVA was performed to
compare the onset of luteal activity between the endometritis and control groups,
and the same test was used to compare vaginal discharge score (VDS), DFS and
conception rate at 1st service between early and late OLA. Binominal logistic
regression was used to determine odds ratio and the effect of risk factors
(endometritis and vaginal discharge score 0, 1 and 2) on the incidence of typical
and a typical progesterone profiles. All candidate variables were kept in the
model with significant attributes at P<0.05.
3.3.3 Results
3.3.3.1 Types of typical and atypical progesterone
profile
The various types of ovarian cyclicity detected during the postpartum period
based on milk progesterone are shown in Fig.3.5.
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Figure 3.5: Schematic illustration of the types of reproductive cycles identified in Holstein
dairy cows by analysis of progesterone in milk: These represent: a) normal cyclicity, b)
prolonged luteal activity, c) cessation of cyclicity, d) short luteal activity, e) delayed
cyclicity. Red boxes represent the period during which specified problem occurred. The
blue dotted lines represent the limit of progesterone for luteal activity. AI: time of artificial
insemination; PGF2α: prostaglandin F2α. 
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3.3.3.2 The incidence of typical and a typical
progesterone profiles
A total of 82 animals had normal resumption of ovarian activity and typical
ovarian cycles. The other 88 cows experienced abnormal ovarian cycles (Table
3.7).
3.3.3.3 Onset of luteal activity (OLA)
Overall, the mean interval of OLA (1st milk progesterone rise >3ng/ml) was
28.4±0.8 days and ranged from (12-77 days). The onset of luteal activity was
significantly different between cows with normal or abnormal ovarian cycles
(P<0.05). Cows with normal ovarian cycle had a lower mean discharge score
compared to cows with abnormal ovarian cycle (P<0.05; Table 3.8).
Table 3.7: Incidence of typical and atypical ovarian patterns. Out of total of 170
animals (51.8%) had at least one atypical ovarian profile
Class Number
Normal ovarian cycle 82
Abnormal ovarian cycle 88
Abnormal ovarian category percentage
Prolonged luteal phase 41 46.6
Cessation of cyclicity 16 18.2
Short luteal phase 17 19.3
Delayed to first ovulation 14 15.9
Table 3.8: Mean±SEM time to onset of luteal activity, days to first insemination and
vaginal discharge score at first insemination at Nottingham dairy centre exhibiting
normal or abnormal ovarian cycles.
Characteristics Normal ovarian
cycles
Abnormal ovarian
cycles
P
value
Time to onset of luteal
activity (days) 26.0±1.1 (n=82) 30.4±1.1 (n=88) 0.009
Vaginal discharge score 0.2±0.1 (n=82) 0.7±0.1 (n=88) <0.001
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3.3.3.4 The association between atypical
progesterone profiles and the reproductive
performance in dairy cows
Days to first service
A total of 6 normal and 8 abnormal cows were not included analysis because they
were not inseminated. In addition, for the purpose of analysis, the delay to first
ovulation and cessation groups were merged together into one group to enable
full-satisfied analysis. Kaplan-Meier survival analysis revealed that days to first
service (DFS) was different between ovarian cyclicity groups in dairy cows (Fig.
3.6A). Survival analysis demonstrated that the rate at which the cows with
normal ovarian cycles were inseminated was higher than those cows with
abnormal progesterone profiles (P<0.05, Fig.3.6A).
Figure 3.6: The comparison of normal and abnormal progesterone profiles on days to first
insemination in cows that were served A) Kaplan-Meier survival curves for time to first
insemination in cows with normal resumption of luteal activity (blue line, median
survival=59.5) or abnormal ovarian activity (red, median survival=67.5) (P<0.05). B)
Kaplan-Meier survival curves for time to first insemination in cows with normal resumption
of ovarian cyclicity (n=76; blue line, median survival 59.5 days) or a prolonged luteal
phase (n=39; purple line, median survival 74 days, P<0.01), or a short luteal phase
(n=18; green line, median survival 63 days) or other abnormal cyclicities (n=24; red line,
median survival 59.5 days) (P=0.88).
Median DFS for cows with normal and abnormal ovarian cyclicity was 59.9 and
67.5 days, respectively. In addition, this test was used to determine this interval
between the different atypical progesterone profiles (short luteal phase and
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others) and normal ovarian cycles (P=0.88). The prolonged luteal phase (median
74 days) had longer days to first insemination compared to control cows (median
59.5 days, P<0.01; Fig 3.6B). However, days to first insemination was not
different between other abnormal cyclicity groups compared to control cows
(median 59.5 days, P=0.88; Fig 3.6B).
Conception rate at 1st service
Over all cows, conception rate at first service in this study was 38.0%. The
association between conception rate at 1st service and pattern of ovarian cyclicity
are shown in Table 3.9. Chi square test, showed that cows with normal ovarian
resumption of ovarian cycles had significantly higher conception rate at 1st
service compared to cows with abnormal ovarian cycles (P<0.05; Table 3.9).
Further analysis showed that among abnormal progesterone profiles, cows with
delay to first ovulation had the highest conception rate at first service (Table
3.9).
3.3.3.5 Comparison of progesterone profiles
between control cows and cows with endometritis
These results related reproductive data of cows which suffered from uterine
disease with occurrence of normal and abnormal ovarian cycles post-partum.
Table 3.9: Conception rate at first insemination of cows that were served at Nottingham
dairy centre exhibiting normal and abnormal ovarian activity.
Category Total number of
AI
Conceived at
1st AI
% Conception
rate
Normal luteal activity 76 38 50.0a
Abnormal progesterone
profiles
80 24 30.0b
Within abnormal progesterone profile
Prolonged luteal activity 39 10 25.6
Delay to first ovulation 12 5 41.0
Cessation of luteal activity 12 3 25.0
Short luteal phase 17 6 35.3
Values in the same column with superscripts,ab differed from normal resumption of
ovarian cyclicity: Chi-square (a,b=P<0.05).
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Onset of luteal activity (OLA)
The interval from calving to onset of luteal activity was affected by endometritis.
Control cows resumed cyclicity post-partum approximately 4 days earlier
compared to cows with endometritis (P<0.05; Fig. 3.7). The reproductive
performance of cows with early OLA (≤28 days) and those with late OLA (29
days) are shown in Table 3.10. Cows with early OLA had lower mean discharge
score compared to late OLA cows (P<0.05). However, there was no difference in
DFS and conception rate at 1st service between early and late OLA (P>0.05).
Figure 3.7: The comparison of onset of luteal activity between control cows and cows
that experienced endometritis. Cows that experienced endometritis had significantly
later onset of luteal activity compared to control cows about 4 days, (*; P<0.05).
Table 3.10: MeanSEM vaginal discharge score, day to first service, and conception
rate at 1st service in cows with early or late onse of luteal activity (OLA).
Class
Early OLA
(n=101)
Late OLA
(n=69)
P value
Vaginal discharge score 0.3±0.1 0.7±0.1 0.01
Days to first AI 66.5±2.9 69.9±3.5 0.37
Conception rate at 1st AI 44.5 32.8% 0.14
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The incidence of typical and atypical progesterone profiles
Cows that had endometritis had a greater incidence of atypical ovarian patterns
(P<0.001, Table 3.11). Cows that exhibited endometritis had significantly more
prolonged luteal phases compared to control cows (P<0.05). However, incidence
of cessation of cyclicity, short luteal phase, and delay to 1st ovulation were not
different between cows with endometritis and control cows. While cessation of
cyclicity was significantly higher in control cows than in cows experienced
endometritis (Table 3.11).
Values in the same row with superscripts,ab differed from normal luteal phase (ab P<0.001;
aaP >0.05).
Risk factors associated with normal and abnormal ovarian
progesterone profiles
Logistic regression revealed that cows with endometritis had a reduced chance of
having a normal ovarian cycle (P<0.01, Fig.3.8). Similarly, abnormal vaginal
discharge also reduced the chance of a normal ovarian cycle (P<0.01) and this
was further reduced in cows with the highest vaginal discharge score of 2.
Endometritis significantly increased the proportion of prolonged luteal phase as
discharge score increased, there was further increase proportion of prolonged
luteal phase (p<0.05). However, endometritis had no effect on the risk of having
delayed ovulation, cessation of luteal phase and short luteal phase as well
(P>0.05, Fig.3.8).
Table 3.11: Incidence of typical and different types of atypical progesterone profiles in
control and endometritic cows.
Class
Control Endometritis
P-valuen % n %
Normal ovarian cycle 68 57.6a 14 27.0b <0.001
Abnormal ovarian cycle 50 42.4a 38 73.0b <0.001
Prolonged luteal phase 16 32.0a 25 65.8b 0.034
Cessation of cyclicity 13 26.0a 3 7.9b 0.02
Short luteal phase 12 24.0a 5 13.1a 0.20
Delayed 1st ovulation 9 18.0a 5 13.1a 0.54
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Figure 3.8: Odds ratio for the association between vaginal discharge and endometritis on
the chance of having normal or abnormal progesterone profiles. A) Cows with endometritis
had signifcantly reduced risk of having normal ovarian cycles (**P<0.01) and increased
prolonged luteal phase (***P<0.001), however, endometritis had no effect on the risk
having another abnormal progetertone profiles (P>0.05). B) Odds ratios of vaginal
discharge score 1 vs control; cows with VDS1 had significantly increased prolonged luteal
phase (** P<0.01). C) cows with VDS2 had signifcantly reduced proportion of normal
ovarian cycles (*P<0.05) and increased prolonged luteal phase (***P<0.001). Note:
Other types of progesterone profiles are not shown in A) or B) due to low numbers.
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Conception rate at first insemination
Conception rate at first service between cows with or without endometritis having
normal and abnormal progesterone profiles are shown in Table 3.12. While the
control cows with normal and abnormal ovarian cycles had numerically higher
conception rate at 1st AI but this was not significantly different. This might be due
to the small of animals in the endometritis group.
3.3.3 Discussion
The objectives of this study were to determine the effect of post-partum bacterial
uterine infection (endometritis) on the post-partum ovarian cyclicity and their
effect on post-partum reproductive performance in Holstein dairy cows at Manor,
Rangemoor and Nottingham University dairy centre. The results of the study
supported the hypothesis that endometritis has a detrimental effect on
postpartum ovarian cyclicity in Holstein dairy cows
The combined results of Manor, Rangemoor farms and the University of
Nottingham dairy Centre showed that there was no association between the
interval from calving to onset of luteal activity and subfertility in dairy cows
during the postpartum period. The findings of the present study did not find any
differences in day to first service between an early and late onset of luteal
activity. In contrast to Darwash et al. (1997) who found early postpartum onset
of luteal activity was positively linked with fertility. They recorded that cows with
early onset of luteal activity had a reduced calving to first insemination interval
Table 3.12: Conception rate at 1st service of control and RTID cows at Nottingham
dairy centre exhibiting normal and abnormal ovarian activity.
Classes Control cows Uterine disease P value
Normal ovarian cycles 50.8 (n=32/63) 46.2 (n= 6/13) 0.59
Abnormal progesterone
profiles
32.6 (n=15/46) 26.5 (n= 9/34) 0.55
Prolonged luteal phase 35.7 (n= 5/14) 20 (n= 5/25) 0.28
Others 31.3 (n=10/32) 44.4 (n= 4/9) 0.46
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compared to cows with late onset of luteal activity. They observed that for each
extra day of onset of luteal activity lengthened the period of calving to 1st service
and calving to conception interval by 0.24 and 0.41 days, respectively. Other
studies reported that calving to 1st service was longer in cows with abnormal
ovarian cycles compared to cows with normal ovarian cycles (Petersson et al.
2006, Hommeida et al. 2005). Furthermore, this study did not find a relationship
between onset of luteal activity interval and conception rate at 1st service. This is
consistent with Royal et al. (2000) who failed to observe a relationship between
conception rates and early onset of ovulation in Holstein Frisian cows.
The combined results of Manor, Rangemoor farms and the University of
Nottingham dairy showed that postpartum reproductive cycle abnormalities were
present in 51.8% of animals. These abnormal progesterone profiles were
associated with reduced conception rate at 1st service, increased time to OLA and
abnormal vaginal discharge. After reproductive cycles have re-commenced, many
cows continue to cycle at regular intervals until they are successfully served.
These results corresponded to the results of a previous Belgium study which
reported 49.0% incidence of abnormal ovarian cyclicity (Opsomer et al. 2000).
However, the results of the present study were relatively higher compared to
previous study carried out at the University of Nottingham where about 32% of
an abnormal pattern of the total (n=2503) cows (Lamming and Darwash 1998).
Previous studies in 1980 carried out at the University of Nottingham found 22.5%
of cows had an abnormal ovarian cycle (n=533) in the late 1970s (Claire and
Wood 1980). Another study in the late 1990s reported 32-42% of cows had an
abnormal cycle which was associated with reduced pregnancy rate at first
insemination from 56 to 40%. (Royal et al. 2000).
Compared with earlier studies, this study demonstrated that modern high
producing dairy cows are more susceptible to ovarian abnormal cycles in the
immediate postpartum period, especially prolonged luteal phase type (positive
progesterone level for >20 days without insemination). It should be noted that it
is difficult to completely compare the results of this study with previous studies,
because the definition of abnormal progesterone proﬁles used in current study 
are slightly different from other studies. The particular variation is due to the
different number of days used in the definition. This study classified postpartum
ovarian dysfunction into four types: Of the cows with different types of
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progesterone profiles (14%, 16%, 17% and 41%) showed delayed to first
ovulation, cessation of ovarian cyclcity, short luteal phase and prolonged luteal
phase, respectively.
Findings of the present study showed that endometritis significantly impaired
postpartum ovarian cyclicity in Holstein dairy cows. Cows exhibiting endometritis
had the highest rate of atypical progesterone profiles particularly prolonged luteal
phase, (65.8%) compared to control cows (32.0%). In agreement with Taylor et
al. (2003) who found that cows with abnormal vaginal discharge had a 47.6%
incidence of prolonged luteal phase. The results of the current study were higher
than recently published by Ghanem et al. (2015) who observed that cows which
experienced endometritis had 60% prolonged luteal phase. In addition,
Ranasinghe et al. (2011) recorded 32% of prolonged luteal phase in cows with
postpartum complications (retained fetal membrane, endometritis, metritis and
pyometra), which was lower compared to current study.
The precise mechanism through which postpartum endometritis increases the
incidence of prolonged luteal phase in dairy cows is unknown. It is feasible that it
is through the disturbance of the luteolytic process that results in the extended
CL lifespan (Williams et al. 2008a, Sheldon et al. 2008, Lamming and Darwash
1998). In addition, endometritis caused an increase in PGE2 concentration in
uterine fluid of cows (Mateus et al. 2003), with epithelial cell of endometrium
exposed to bacterial endotoxin undergo an endocrine switch from luteolytic PGF2α
to luteotrophic PGE2 production (Herath et al. 2009). Increased PGE2
concentrations in uterine fluid were shown to cause luteal persistence in cows
(Thibodeaux et al. 1992). This suggests that in cows with endometritis this
prostaglandin plays a local role in the pathogenesis of prolonged luteal function.
It is interesting to note that, there was no relationship between endometritis and
delayed first ovulation, cessation of ovarian activity or short luteal phase. This
study showed that the incidence of delay to first ovulation was 13.0% in cows
with endometritis. This is consistent with study of Ghanem et al. (2015) which
observed there was no difference between cows with uterine bacterial infection
and cows without uterine infection in terms of delay to 1st ovulation. Here they
reported that cows positive with uterine infection are less likely to ovulate
because they have a lower growth rate of the dominant follicle and lower plasma
oestrogen concentrations. However, the incidence of delay to ovulation was
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comparatively lower compared to other studies where they observed a delay to
first ovulation in about 20–25% (Sheldon et al. 2008, Nakao et al. 1992)
The present study observed that abnormal vaginal discharge had a significant
effect on subsequent progesterone profiles which was consistent with the
hypothesis that clinical endometritis adversely affects post-partum resumption of
ovarian cyclicity. As the abnormal vaginal discharge score increased, the
frequency of atypical ovarian cycles was increased as well. This is consistent with
the previous study which used a regression analysis for confirmation and
quantification of the relation between vaginal discharge index and progesterone
profiles which was significant (Gorzecka et al. 2011). However, others found that
there was no signiﬁcant relationship between vaginal discharge and abnormal 
progesterone proﬁles (McCoy et al. 2006).  
The present study found that endometritis and abnormal purulent vaginal
discharge were important risk factors for the development of abnormal ovarian
cycles, particularly prolonged luteal phase. This study found that cows with
endometritis and vaginal discharge score >1 were 4 times more likely to show a
prolonged luteal phase than other abnormal progesterone profiles. In agreement
to the findings of the previous study which observed that cows with postpartum
complications (endometritis, metritis and pyometra) were 5 time more likely to
show prolonged luteal phase (Ranasinghe et al. 2011). Four major risk factors for
prolonged luteal phase have been previously identified; metritis, abnormal
vaginal discharge, retained placenta and parity (Opsomer et al. 2000). The same
study observed that metritis is the most important factor and cows with metritis
were 11 times more at risk of developing prolonged luteal phase. In agreement
with these data support the concept that prolonged luteal phases were associated
with endometritis.
The present study attempted to quantify the severity of inflammation symptoms
by examination of vaginal discharge based on visual inspection of vaginal
discharge (Williams et al. 2005, Gorzecka et al. 2011), which have been shown to
accurately reflect uterine bacterial infection and immune system. In addition to
metritis, abnormal vaginal discharge and difficult calving have a negative impact
on the postpartum ovarian cyclicity by day 50 PP (Opsomer et al. 2000) and on
time to resume ovarian cyclicity (El-Din Zain et al. 1995). The impact of metritis
on cyclicity may be partly explained by the relation between metritis and
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negative energy balance (Galvão et al. 2010b, Huzzey et al. 2007, Hammon et
al. 2006) and by the release of bacterial endotoxin (LPS) into the uterine lumen,
and then enters into the blood stream (Mateus et al. 2003, Herath et al. 2009).
As reported previously LPS can affect GnRH and LH release, follicle development,
oestradiol production and ovulation.
In this study, reproductive cycle abnormalities were associated with reduced
conception rate at 1st AI, increased OLA time and abnormal vaginal discharge.
Once reproductive cycles have re-commenced, after a time of post-partum
anoestrus, many cows continue to cycle at regular intervals until they are
successfully inseminated. It should be noted that cows with endometritis had
longer interval of onset of luteal activity compared to control cows. In agreement
with (Borsberry and Dobson 1989, Holt et al. 1989) reported that cows with
endometritis delayed onset of ovarian activity compared to healthy cows.
3.3.5 Conclusion
This study demonstrated that endometritis has a negative impact on the post-
partum ovarian cyclicity in Holstein dairy cows in the University Nottingham dairy
centre and elsewhere. Cows which experienced endometritis had longer onset of
luteal activity, higher rate of abnormal ovarian cycles, particularly prolonged
luteal phase. However, the occurrence of other types of abnormal ovarian cycles
including delayed to first ovulation, short luteal phase and cessation of luteal
activity was not influenced by endometritis. As vaginal discharge score increased,
the occurrence of prolonged luteal phase significantly increased. Furthermore,
this study found that abnormal ovarian cycle had negatively associated with
fertility of cows during post-partum period. Cows with abnormal ovarian cycles
had longer onset of luteal activity, longer calving to 1st AI interval, lower
conception rate at 1st service versus cows with normal ovarian cycles.
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4 The association between endometritis
and vascularisation, progesterone
production and steroidogenic enzyme
expression in the bovine corpus luteum ex
vivo.
4.1 Introduction
In post-partum dairy cows, infections in the bovine uterus with Gram-
negative bacteria commonly cause endometritis (Sheldon et al. 2009a).
Endometritis subsequently influences ovarian function through various
mechanisms including delayed follicular growth, reduced circulating oestradiol
concentrations, altered luteal phase duration, and disruption of ovarian cyclic
activity (Sheldon et al. 2002b, Herath et al. 2007, Williams et al. 2008a;
Chapter 3).
Uterine infection with Gram-negative bacteria leads to release of endotoxin
such as LPS into the circulation that can cause ovarian dysfunction, in part,
through its accumulation in follicular fluid (Herath et al. 2007). The extremely
rapid growth and development of the CL that is associated with a period of
intense angiogenesis might also be sensitive to bacterial endotoxin exposure.
Inadequate angiogenesis is likely to result in reduction of progesterone
production (Robinson et al. 2008).
Often angiogenesis and inflammation are co-dependent processes (Voronov et
al. 2007), but their precise mechanisms and cross-talk in the regulation of
luteal growth, differentiation, and regression are poorly understood.
Endothelial cells are considered major targets of cytokine actions during the
immune process, particularly in inflammation (Sprague and Khalil 2009).
Because endothelial cells/pericytes are the most abundant cells in the
developing CL, microvascular endothelial cells (O'Shea et al. 1989, Gaytan et
al. 1999) and their responsiveness to cytokines are likely to influence luteal
function (Cherry et al. 2008). The role of cytokines in regulation of luteal
function has been investigated in humans (Yan et al. 1993), and cattle
(Sakumoto et al. 2000, Nishimura et al. 2004, Skarzynski et al. 2005). For
example, tumour necrosis factor alpha (TNFA) and interferon gamma (IFNG),
have been shown to regulate bovine luteal endothelial cell function (Okuda et
al. 1999, Fenyves et al. 1993, Pru et al. 2003). The innate immune system
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depends on pattern recognition receptors on host mammalian cells to detect
microbe- or pathogen-associated molecular patterns, such as LPS (Hoshino et
al. 1999). LPS is recognised by Toll-like receptor 4 (TLR4) by binding with
other co-receptors including CD14 and MD-2. This, in turn, stimulates cellular
responses characterised by the production of inflammatory mediators,
including interleukin-1β (IL-1β), IL6, and IL8 (Moresco et al. 2011). Indeed, 
LPS induced a TLR4-dependent inflammatory response in bovine granulosa
cells collected from antral follicles and perturbed oocyte development
(Bromfield and Sheldon 2011). It is less clear, however whether LPS affects
ovarian endothelial cells and/or pericytes directly.
An in vivo study demonstrated that infusion of LPS (0.5mg/kg body weight)
decreased luteal blood flow, and luteal size using power-flow Doppler
ultrasound (Herzog et al. 2012). The level of caspase-3 mRNA expression was
increased and at the same time luteal expression of STAR mRNA was
decreased. These were all associated with decreased plasma progesterone
concentrations (Herzog et al. 2012).
Pericytes, myofibroblast and vascular smooth muscle cells are present in the
CL, and have the same lineage but they differ in their location relative to
endothelium. Pericytes are in close contact blood capillaries, pre-capillaries
arterioles and are embedded within the endothelial cell basement membrane
(Gerhardt and Betsholtz 2003, Armulik et al. 2005). Vascular smooth cells are
principally involved in the regulation of blood vessel contraction and tone
(Armulik et al. 2005). However, there is increasing evidence that pericytes are
active players in the initiation of angiogenesis (Verbeek et al. 1994, Nehls and
Drenckhahn 1993).
Hypothesis
Endometritis will reduce luteal vascularisation, size, and progesterone content
and steroidogenic enzyme expression in dairy cows.
Aims
1. To determine the association between uterine infection and
vascularisation of the bovine CL and the degree of pericyte coverage.
2. To evaluate the association between uterine infection, luteal progesterone
content and expression of progesterone synthesis proteins.
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3. To detect the expression of TLR4 and its co-receptors (CD-14 and MD-2)
in bovine CLs at different stages of the oestrus cycle.
4.2 Materials and methods
4.2.1 Animals
In all experiments, bovine ovaries with corpora lutea were obtained from a
local abattoir (Horton wood 60, Telford, Shropshire, TF1 7FA, UK) and
transported back to the laboratory in 1x phosphate buffered saline (PBS) at
room temperature. However, samples for mRNA analysis were transferred and
placed into RNA Later within 20 min of slaughter. The same CL samples were
used for the different components of this experiment.
4.2.2 Tissue collection and section preparation
Corpora lutea from the mid-luteal phase (day 8-12) were isolated from bovine
ovaries of uterine disease-free cows (n=3) and cows with reproductive tract
inflammatory disease (n=3). Beyond this, we had no further information
about how long this disease had been on going or what treatments if any had
been administered. The CL were classified according to the criteria that has
been previously reported (Fig. 4.1, Ireland et al. (1980)), and their weights
recorded. CLs were cut into three segments: (1) fixed in Bouins’ solution for
6h for IHC analysis, and (2) snap frozen and stored at -80C for Western blot
and mRNA purposes (2 separate segments).
The uterus was collected from the same animals, to confirm the health status
of the uterus. At the slaughterhouse, uterine horn cross-sections (ipsilateral
to CL) were collected 5 cm from the oviduct-uterus junction these were fixed
with Bouins’ solution for 6 h, followed by a 1x PBS wash for 5 min to remove
excess Bouins’ solution. The remainder of the reproductive tract was checked
for the presence of endometritis by examination of vaginal discharge and an
incision made from the uterine tip to the cervix.
The fixed luteal and uterine tissues were dehydrated in a series of alcohols:
30% (v/v) ethanol for 5 min, 70% (v/v) ethanol 3 x 5 min. Sections were put
into cassettes and dehydrated and then embedded as follows: 70% (v/v)
ethanol for 2h; 80% (v/v) ethanol for 2h; 95% (v/v) ethanol for 2h; and
100% ethanol 2 x 2h, 95% (v/v) ethanol plus histoclear 1 x 2h, histoclear for
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2 x 4h each time and molten paraffin-wax for 2x 2h in an automatic tissue
processor (TP1020, Leica, Milton Keynes, UK).
Figure 4.1: Image of a mid-luteal phase (day 5-12) bovine corpus luteum (CL). (A)
Shows the CL within the ovary, while (B) shows it dissected out of the ovary. Scale
bar: 10mm.
Embedded tissues were sectioned at 5µm using a microtome (HM355, Micron,
Walldrof, Germany) and sections were floated onto water (40°C) and placed
onto Superfrost Plus, positively charged slides. Sections then were heat fixed
to slides to dry overnight at 50°C. Uterine sections were stained with
haematoxylin and eosin to check histological appearance. This was done by
placing slides in: Histoclear for 3x 5 min to remove excess wax followed by
rehydration using decreasing concentration of alcohol, 100% (v/v) ethanol for
2 min, 95% (v/v) ethanol for 2 min, 70% (v/v) ethanol for 2 min. Rehydrated
sections were stained with Harris’s haematoxylin for 5 min and then washed
with running tap water for 5 min to remove excess stain. The sections were
differentiated with 1% (v/v) acid/ethanol for 2-4 second and washed with
running tap water. Sections were dipped 8 times in 1% (v/v) ammoniated
water to turn the stain blue in colour, and then slides were transferred to 1%
(w/v) eosin for 5 min. Sections were washed with running tap water to
remove excess eosin stain and were dehydrated with increasing concentration
of alcohol: 70% (v/v) ethanol for 2 min, 95% (v/v) ethanol for 2 min, 100%
ethanol for 2 min, histoclear 2 x 5 min. Sections were finally mounted using
DPX (Raymond A Lamb, East Sussex, UK) mounting media.
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4.2.3 Luteal content analysis
4.2.3.1 Luteal progesterone extraction and ELISA
The analysis of progesterone content in luteal tissue was performed as
previously described (Tsang et al. 1990). Luteal tissue was thawed on ice and
200 mg was transferred to a 10 ml glass extraction tube to which 5 volume of
ice-cold PBS was added and then vortexed for 1 min. Luteal tissue was
homogenised using a tissue homogeniser (Polyton tissue grinder) for 3x 30
sec each time, with samples were kept on ice in between homogenisation.
Then, in duplicate, 100 µl aliquot of homogenised samples was added to a
fresh 10 ml glass extraction tube (previously cleaned with petroleum ether).
Petroleum ether (2 ml; Acros, New Jersey, USA), was added and vortexed
vigorously for 5 min. The homogenised tissue was then rapidly frozen by
placing on methanol in dry ice. The ether liquid was transferred to a new glass
tube (Borosilicate test tube, 12x75mm) and dried in a fume hood around 36
hours. The residue was reconstituted by adding 500µl progesterone media
buffer (0.1% (w/v) bovine serum albumin (BSA) in 1X PBS) and vortexed for
further 5 min. Immediately prior to analysis, the reconstituted solution was
further diluted 1:800 in progesterone media buffer for cows with metritis
and1:1000 for control cows. The progesterone concentration was then
determined by a competitive progesterone ELISA (Ridgeway Science) as used
for plasma samples and described in Chapter 3.2.3. This assay was designed
for plasma/buffer progesterone samples and standards were; 0, 0.5, 1, 2, 5,
10 and 20 ng/ml in buffer. The lower limit of sensitivity was 0.2ng/ml and the
intra-assay coefficient of variation was 5.6%. All samples were analysed in a
single assay.
4.2.3.2 Protein extraction from luteal tissue
Corpus luteum tissue (100 mg) from both healthy cows (n=3) and
endometritic cows (n=3) were transferred into 2 ml of ice-cold lysis buffer
[0.1 M Tris pH7.4, 0.1% (w/v) dithiothreitol (DTT), 0.1% (w/v) sodium
dodecyl sulphate (SDS), 0.18 mg/ml sodium orthovanadate and protease
inhibitors [Complex protease inhibitor cocktail; Roche Diagnostic Ltd, East
Sussex, UK]. The tissue was homogenised as described for progesterone
extraction. The homogenised tissue was additionally sonicated for 3 × 20 sec
on ice with >1 min on ice in between sonications. The luteal samples were
then centrifuged at 13000g for 15 min. The supernatant was collected and
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transferred to a new labelled tube on ice. The supernatant volume was
recorded for the purposes of calculating total protein. Samples were aliquoted
and stored at -80 ºC until use.
4.2.3.3 Quantification of protein concentration
The protein concentration of the supernatant was quantified against a protein
standard curve (0-0.6mg/ml bovine serum albumin (BSA); Sigma) by the
method of Bradford assay using Bio-Rad dye reagent. Samples were diluted
1:100 with PBS buffer prior to analysis. Standards or samples (10µl) were
added to the appropriate wells in triplicate. To this, 250μl of Bio-Rad reagent 
(Bradford Reagent, Sigma) was added to each well, mixed thoroughly using
plate shaker and incubated at room temperature for 15 min. Absorbance was
read using a microplate reader (Bio-Rad model 680) at 595 nm wavelength
and protein concentration determined from the standard curve by linear
regression (Microsoft Excel).
4.2.3.4 SDS-polyacrylamide gel electrophoresis
All reagents for Western blotting were purchased from Bio-Rad unless stated.
Plates (1mm thick) were cleaned with water and ethanol. The gel apparatus
was assembled with 1mm spacers and tested with distilled water for leaks.
Then, 15ml of 12% (w/v) polyacrylamide solution required for 2 gels was
carefully added. The polyacrylamide solution was prepared for four gels as
follows:
 4.9ml of dH2O
 3.8ml 1.5 M Tris HCl, pH8.8
 150µl 10% (w/v) SDS
 6.0ml 30% (v/v) acrylamide/bis-acrylamide solution
 8µl 0.1% (v/v) N,N,N',N'-tetramethylethane-1,2-diamine (TEMED)
 150µl of ammonium persulphate (APS) (10% v/v) was added to start
the cross-linking reaction.
The polyacrylamide was overlaid with water to avoid air interfering with the
crosslinking reaction. Once set after approximately 40 min, water was
removed by using blotting paper. The stacking gel (4% (w/v) polyacrylamide)
5.8ml was prepared for two gels and composed of:
 4.0ml dH2O
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 750µl 0.5M Tris HCl, pH6.8
 60µl 10% (w/v) SDS
 1.0ml 30% (v/v) acrylamide solution
 5µl TEMED
 60µl 10% APS.
This was immediately laid over the separating gel and the gel comb inserted
making sure no bubbles were present. The staking gel was allowed to
polymerise for 40 min and then the comb was removed. Luteal protein
samples (20µg) were prepared by adding 10µl protein sample buffer (5%
(v/v) β-mercaptoethanol in Laemmli buffer) and then were boiled at 100C for
10 min.
The gel was removed from casting rig and placed into the electrophoresis
chamber (gel tank). Running buffer (1X TGS [2.5 mM Tris HCl, 19.2 mM
Glycine, 0.01 % SDS, pH 8.3]) was poured into the centre of the chamber
until full. The first well of the gel was loaded with 10µl molecular weight
marker (Bio-Rad Kaleidoscope). Samples were added to subsequent wells,
wells between samples were loaded with loading buffer only. The tank was
filled with 1x running buffer and gels were electrophoresed at 150V for 45-60
min until the proteins had through across the gels.
4.2.3.5 Protein transfer
Immediately prior to transfer, PVDF membrane was prepared by briefly
soaking in methanol and then in transfer buffer (250 mM Tris HCl, 19.2 mM
glycine, pH8.3 in 20% methanol) for 2 min. Sponges and blotting paper were
soaked in cold transfer buffer. Gels were removed from the electrophoresis
tank and gently removed from the glass plates and rinsed in dH2O. Gels were
equilibrated with transfer buffer and made in a blotting sandwich.
The sandwich was rolled with a glass pipette to remove air bubbles and wiped
away excess buffer. Semi-dry electroblotting (Owl Panther Semi-dry
Electroblotter) was used for protein transfer. Transfer was carried out at 150V
for 40 min. Once transfer was complete, the membrane was carefully
removed and protein transfer was checked with Ponceau S stain for less than
1 min. Subsequently, the membrane was de-stained in dH2O and then 0.1%
(v/v) Tween20 (Sigma) in PBS (PBST) until the solution became clear.
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4.2.3.6 Western blotting
After protein transfer, membranes were blocked with 5% (w/v) skimmed
dried milk (Marvel) in PBST for 1 h at room temperature. Following blocking,
membranes were washed briefly with PBST, and then membranes were
further incubated with primary antibody overnight at 4C (Table 4.1).
On the following day, membranes were washed 5 times in PBST for 10 min
each. Subsequently, the membranes were further incubated with secondary
antibody (Table 4.2) for 90 min diluted with blocking solution (5% (w/v)
skimmed dried milk in PBST). The membranes were again washed 5 times in
PBST for 10 min each and then rinsed in distilled water twice.
4.2.3.7 ECL detection
Enhanced chemiluminescent (ECL) Plus detection kit (GE Healthcare,
RPN2132) was used to detect the HRP conjugate. Membranes were covered
with mixed ECL reagent (2 ml per gel) for 5 min. The blot was covered away
Table 4.1: Primary antibodies used for Western blotting.
Antibody SourceCat no
Size
(kD) Dilution
2nd
Ab
Histone (H3) Abcam,ab1791 15 1/1000 Rabbit
Smooth muscle actin (ACTA2) Sigma, A2547 42 1/1000 Mouse
3beta-hydroxysteroid
dehydrogenase (HSD3B)
Dr Richard
Parker,
University of
Alabama
42 1/200 Rabbit
Steroidogenic acute regulatory
enzyme (STAR)
Abcam,
ab96637
32 1/3000 Rabbit
Cholesterol side-chain cleavage
enzyme (P450scc/CYP11A)
Abcam,
ab75497
61 1/1000 Rabbit
Table 4.2: Secondary antibodies used for Western blotting.
Antibody name Company Cat.No. Dilution Time
Goat anti-Rabbit IgG,
HRP conjugate
Sigma A9169 1/8000 1 h
Sheep anti-mouse IgG,
HRP conjugate
GE
Healthcare
NXA931 1/50000 1 h
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from direct sunlight at all times. The ECL was poured off the membranes
which were transferred to a piece of cling film and wrapped.
4.2.3.8 Development of film
Under a safe light, one piece of film (Fuji Medical X-ray film, Fujifilm UK) was
placed on the top of the membrane and the cassette was closed. The film was
exposed to the membrane for 30 sec prior to being placed in developer
(Sigma) for 30 sec and then washed with water. Subsequently, films were
placed in fixer for 1 min, washed in water and hung to dry. The films were
scanned to obtain a digital image and the quantification of protein in samples
was assessed by using image analysis (Image J 1.47).
4.2.4 Immunolocalisation of endothelial cells,
pericytes and steroidogenic cells in bovine CL
4.2.4.1 Dewaxing and rehydration
Slides were placed in histoclear (3 x 5 min) to remove paraffin wax then
rehydrated through a graded series of decreasing concentration of ethanol
(100%, 95% (v/v), 70% (v/v)), then slides were washed twice in PBS for 5
min each, prior to immunohistochemical analysis.
4.2.4.2 Antigen retrieval
This step was performed to expose epitopes and permit antibodies to bind.
There are two different antigen retrieval methods which were performed in
this study (1) trypsin digestion (2) boiling in 10mM citrate buffer pH6.0. This
was dependent on the primary antibody, which is described in Table 4.3.
Trypsin retrieval
Antigen retrieval was performed by incubating sections in 0.4 mg/ml trypsin
and 0.25 mg/ml CaCl2 in PBS for 15 min at room temperature (RT). The
sections were then washed twice in PBS for 5 min each.
Citrate retrieval
Antigen retrieval was performed by boiling sections in 10 mM citrate buffer,
pH6.0 in an 800 W microwave for 10 min. Following this, sections were
allowed to cool for 30 min at RT, and then the sections were washed twice in
PBS for 5 min each.
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4.2.4.3 Blocking
An endogenous peroxidase block step was performed by incubating sections in
3% (v/v) H2O2 in methanol for 10 min at RT, and then sections were washed
with PBS buffer for 10 min. After this, sections were blocked with an
appropriate normal serum for 30 min at RT (Table 4.3) to minimise non-
specific primary antibody binding.
4.2.4.4 Primary antibody/isolectin-B4 step
von Willebrand factor, smooth muscle actin and HSD3B
For VWF, the primary antibody and control rabbit IgG was diluted in 2% (v/v)
normal goat serum. While, PBS was used to dilute ACTA2 and HSD3B primary
antibodies and their respective IgG controls. For control slides, the primary
antibody was replaced with rabbit or mouse IgG at equivalent concentration.
Then slides were incubated in a humidified chamber overnight at 4C.
Table 4.3: Primary antibodies used to detect endothelial cells, pericytes and large
luteal cells in the bovine corpus luteum.
Primary
antibody
Target
cell
Supplier Retrieval Blocking
serum
Conc/
dilution
Species
VWF
Endothelial
cell
Dako;
A0082
Trypsin
20%
NGS
20µg/ml Rabbit
Isolectin
B4
Endothelial
cell
Vector;
B1205
Citrate 4% NGS 10µg/ml n/a
ACTA2 Pericyte
Sigma;
A2547clone
1A4
Citrate 4% NHS 5µg/ml Mouse
HSD3B
Steroidogenic
luteal cells
Gift1 Citrate 4% NGS 1:400 Rabbit
1Gift from Richard Parker, University of Birmingham, Alabama; NGS= normal goat
serum; NHS= normal horse serum
Biotinylated Griffonia (Bandeiraea) simplicifolia isolectin B4
Biotinylated isolectin was diluted with PBS buffer, and for control slides to this
500mM galactose was added. Then slides were incubated in a humidified
chamber overnight at 4C.
4.2.4.5 Secondary antibody
On the following day, the primary antibody was removed, and slides were
washed twice with PBS for 5 min except for VWF IHC where slides were
washed with 0.1% (v/v) Triton-x-100 in PBS as the first wash to decrease the
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background staining. Then, the primary antibodies were detected using the
Vector ABC Elite method, that used biotinylated goat anti-rabbit IgG or
biotinylated horse anti-mouse IgG as secondary antibodies.
The biotinylated secondary antibodies were diluted 1:250 in 2% (v/v) normal
goat or horse serum, added onto the slides and incubated for 30 min at RT.
Then slides were washed with PBS twice for 5 min each time. However, for
isolectin-B4, sections, the biotinylated step was omitted and went straight to
the ABC step. The ABC solution (prepared by adding 2 drops of solution A and
2 drops of solution B to 5 ml of PBS buffer 30 min prior to adding to sections.
ABC solution was then added onto each slide and incubated for 30 min at RT.
This step was followed by two washes with PBS for 5 min.
4.2.4.6 Detection of antigen
3,3’-diaminobenzidine tetrahydrochloride (DAB) was used for visualisation of
antigen-antibody binding. The DAB solution (prepared as per instructions) was
added to slides and incubated for 1-5 min, and then the reaction of
development was stopped by rinsing slides into tap water for 10 min.
4.2.4.7 Counterstaining and mounting
Sections were counterstained with haematoxylin for 20 sec then washed with
running tap water for 5 min, before being dipped (8 dips) in 1% (v/v)
ammoniated water. Slides were washed once with tap water before being
dehydrated in a series of increasing ethanol concentrations (70%, 95%) and
100% (v/v) for 2 min each time then placed in histoclear for 2 x 5 min. Slides
were then mounted with DPX mounting medium. Pictures across each whole
section were taken under brightfield with a Leica DM 4000 B microscope
(Leica Microsystem (UK) Ltd, Milton Keynes, UK), fitted with a Qlmaging
Micropublisher 5.0 RTV colour camera (Qlmaging (UK) Ltd, St. Helen,
Merseyside, UK).
4.2.5 Quantification of immunohistochemistry
staining
The quantification of VWF, ACTA2 or isolectin B4 was based on that previously
described by Robinson et al, (2006). Slides were allocated a random code to
ensure unbiased analysis. For each slide, 10 fields of view were randomly
selected across the whole section under 20x objective and analysed to
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determine % area of staining. For each section, the mean was then taken
from these values. The brown colour was selected using Image Pro-Plus 6.0
(Media Cybernetics, Wokingham, UK), which converted this staining into a %
area of staining. The estimated total endothelial cell (VWF or isolectin) or
pericyte (ACTA2) weight was calculated by multiplying the CL weight by the
mean percentage per-area of staining for each CL.
4.2.6 Expression of TLR4, CD14 and MD2 in
bovine CLs at different stage of oestrus cycle.
4.2.6.1 Tissue collection
Ovaries were collected within 20 min of slaughter at a local abattoir (Telford
abattoir). Corpus luteum were removed from bovine ovaries of disease-free
uteri (n=9) and categorised by stages into: early, mid, regressed CL (n=3 per
time point) as previously described (Ireland et al. 1980). Three CL from
uterus with reproductive tract inflammatory disease explained in Section 4.3.1
and for confirmation see Fig.4.2. The CL segments were placed in RNALater
until RNA extraction.
Figure 4.2: Images of bovine corpus luteum (CLs) from different stage of the oestrus
cycle.
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4.2.6.2 RNA extraction
Luteal tissue (15mg) was transferred into tube containing 350µl of TRK lysis
buffer (MicroEluteTM Total RNA Kit, OMEGA Bio-Tek) and 7µl β-
mercaptoethanol added, and then luteal tissue was homogenised using a
tissue homogenizer. The homogenised lysate has transferred into 1.5ml
Eppendorf tubes and centrifuged at 13000g for 2 min. The clear supernatant
was then transferred into a new 1.5ml Eppendorf tube. An equal volume of
ethanol (70%) was added and vortexed thoroughly, and the entire lysate was
transferred to a MicroEluteTM RNA column. The lysate was then centrifuged at
13000g for 15 sec. The flow through was discarded and the column
transferred to a new 2ml collection tube, then 500µl of RWF wash buffer I
added to column, and then centrifuged at 13000g for 30 sec. Flow-through
was discarded and then 500µl of RNA wash buffer II added to column and
then centrifuged at 13000g for 30 sec, the last step was repeated once.
The micro-column was centrifuged at 13000g for up to 2 min to completely
dry it. The column was to a new cooled 1.5 ml Eppendorf tube, and then 10µl
of DEPC water was added to the column. Lastly, columns were centrifuged at
13000g for 1min and eluted RNA was stored at -70ºC. RNA yield was,
measured using ultraviolet spectrophotometer (Eppendorf UK Ltd,
Cambridgeshire, UK) at absorbance of 260nm. Purity of RNA was assessed
using the A260nm:A280nm ratio and only samples with a ratio between 1.8
and 2.0, were used for further analysis.
4.2.6.3 Primer design
Primers were designed using the DNA sequence obtained from the NCBI
Genbank for Bos taurus TLR4, CD14, and MD-2 and SUZ12 (Table 4.4). This
study used SUZ12 as a housekeeping gene as it showed a good stability
across bovine luteal samples (Rekawiecki et al. 2012). Primers were
positioned in different exons to avoid the amplification of genomic DNA.
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4.2.6.4 Multiplex PCR
Multiplex forward primers were prepared adding 5µl each primers (TLR4,
CD14, MD2, and SUZ12; 0.5µM) into 25µl of nuclease free water. Multiplex
reverse primers were prepared by adding 5µl each primer (CD14, MD-2,
SUZ12; 0.5 µM) or 10µl of TLR4 into 1.5ml Eppendorf tube containing 25µl of
nuclease free water. Multiplex PCR reactions were assembled as described in
Table 4.5 and performed using the Eppendorf Master cycler (Eppendorf,
Stevenage, UK). The reactions were started at 48C for 30 min and for other
30 min at 42C, this cycle generate single strand cDNA. Then followed with
thermal cycles (denaturation) 95C for 15 min, 95C for 30 sec, 68C for 30
sec, 72C for 30 sec, 95C for 30 sec, 55C for 30 sec (annealing), 72C for 30
sec. The last 72C (extension) used to seal the production ends of newly
synthesised PCR products (Table 4.6).
Table 4.5: The PCR reaction reagents.
Table 4.4: Primer sequences for multiplex PCR in bovine CL samples.
Gene Sequences (5´-3´) Size
(bp)
Anne
. temp
Accession
No.
MD-2
5’GAATCGTTGGGTCTGCAACT’3
125 60 AB072456.1
5’AGAGTATTCCACGGCTTCC’3
TLR4
5’TCCCCGACAACATCCCCATA’3
224 60 NM_174198.6
5’AAAGGCTCCCCAGGCTAAAC’3
CD14
5’GAAGCCTGACTGGTCTAGCG'3
230 60 D84509.1
5’CCTTGAGACGAGAGTACCCG’3
SUZ12
5’AACGAAATCGTGAAGATGGG’3
286 60 XM_58260
5'CTAGTGGCAAGAGGTTTGGC’3
Reagent Volume (µl)
Multiplex TEMPase 2x master mix 5
Multiplex forward primer 0.5
Multiplex reverse primer 0.5
RNA 1 (1µg)
RNAase inhibitor (40U/µl) 0.3
Reverse transcriptase enzyme (200U/µl) 0.3
dH2O 2.4
Total volume 10
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4.2.6.5 Agarose gel electrophoresis
Aliquots (10µl) of the PCR reaction were mixed with loading dye and
electrophoresed on a 1.8% (w/v) agarose gel in Tris-acetate-EDTA (TAE)
buffer with 50 ng/ml ethidium bromide at 82V until sufficient separation was
directly visualised on an ultraviolet trans-illuminator (UVP Ltd, Cambridge,
UK) and photographed using Polarised film. To estimate the size of the
products a 100bp DNA molecular weight marker was used.
4.2.6.6 DNA Sequencing
In order to confirm the identity of the multiplex PCR product, DNA sequencing
was performed, following gel electrophoresis. The DNA band was excised from
the agarose gel using scalpel under UV light machine (Fig 4.3) and purified as
per the ZymocleanTM Gel DNA Recovery kit protocol (Omega Bio-Tek). Briefly,
the DNA band was dissolved at 50C on a heat block (Techne DRI-BLOCK
DB.3A) in a 3 volumes of agarose dissolving buffer to release the DNA for 5-
10 min. When the gel had dissolved fully the samples were vortexed
thoroughly. Then, samples were transferred to a Zymo-Spin Column with a
2ml collection tube and samples centrifuged (Mini Spin, Eppendorf,
Stevenage, UK) at 10,000g for 1 min. Wash buffer (200µl) was added to
Zymo-Spin Colum, centrifuged at 10,000g for 1 min, and the process
repeated to wash the DNA. The empty column and collecting tube were then
centrifuged at 10,000g for 1 min to remove the residual wash buffer
(alcohol). The columns were transferred to a clean 1.5ml Eppendorf tube.
Table 4.6: PCR amplification protocol.
Cycles Steps Temp.°C Time (min) Purpose
1 (1x) 1 48 0.30
2 42 0.30
2 (1x) 1 95 15.00 Initial
denaturation
3 (12x) 1 95 0.30
2 68 0.30
3 72 0.30
4 (40x) 1 95 0.30
2 55 0.30 Annealing
3 72 0.30 Extension
5(1x) 1 72 3.00 Elongation
6 (1x) 1 15 0.00
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DNA Elution buffer (10µl; 10 mM Tris-HCl, pH 8.5, 0.1 mM EDTA) was added
directly to the Column matrix to elute the DNA, and centrifuged for 1 min to
collect the purified PCR product. Samples were sent for sequencing (Beckman
CEQ8000 Sequencer).
4.2.7 Statistical analysis
All data were checked for normality and homogeneity of variance by using
residual plots and Bartlett's test, respectively. Data were log transformed
where appropriate. The effect of endometritis on the percentage area of von
Willebrand factor or ACTA2 staining as well as the expression of progesterone
synthesis proteins were analysed using general analysis of variance ANOVA in
GenStat 16th Edition. Disease (endometritis) was added as the factor to the
fixed model to account it effect on the responses variance (area stained of
endothelial cell, estimated total ECs weight, estimated total of pericytes
weight, CL weight and luteal progesterone content). For all experiments
P<0.05 was considered as significant and all data are presented as
mean±SEM.
Figure 4.3: Agarose gel showing DNA bands for MD2, CD14, SUZ12 and TLR4
examined under UV light (A) before and (B) after excision for sequencing.
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4.3 Results
4.3.1 Gross morphology of the uterus
Macroscopically, both uterine horns from diseased-free uteri cows were
similarly sized and had completely involuted. However, in diseased cows the
uteri were characterised by thickened walls, congested, and contained
exudates (Fig.4.4). They were similar in overall size to the diseased-free uteri
cows and looked like they were completely involuted as judged by gross
examination and palpation of both uterine horns.
4.3.2 Histology of the uterus
Histologically, all uterine layers in the control cows appeared normal, with a
complete luminal epithelium, and more extensive formation of defined glands
compared to endometritis cows (Fig 4.5). However, in endometritis cows,
there was a sloughing of epithelial surface and severe infiltration of
inflammatory cells (especially neutrophils and macrophages under light
microscope) in the sub-epithelial layer as determined by H&E staining (Fig.
4.6). In addition, uteri with endometritis were characterised by a dilatation of
blood vessels; scattered of inflammatory cells in the basal layer of
endometritis, around uterine glands, and even in the myometrium (Fig. 4.6C-
F).
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Figure 4.4: Reproductive tract of cows used in this Chapter: (A) diseased-free
uterus, (B) Cow 1 with endometritis, purulent discharge presented within uterine
horn. (C & D) Cows 2 and 3 with severe metritis and bad odour bloody watery
discharge inside the uterus.
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Figure 4.5: Histological analysis of the uterus from (A-C) disease-free uteri and (D-F)
endometritic cows; (A&D) show the functional layer of endometrium with luminal
epithelium (black arrows), uterine glands (yellow arrows). (B&E) show the deep layer
of endometrium. (C&F) show myometrium and perimetrium with blood vessels (blue
arrows); scale bar = 100µm.
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Figure 4.6: Photomicrograph showing epithelial and sub-epithelial layers of the
endometrium in (A) disease-free uteri and (B-F) endometritic cows (A) Shows that both
epithelial (red arrow) and sub-epithelial layers were normal. (B) Shows infiltration of
polymorphonuclear cells (PMC) in sub-epithelial layer of endometrium (yellow arrows).
Scale bar = 20 µm. (C) Aggregation of inflammatory cells around uterine glands in the
sub-epithelial layer (black arrows), Scale bar = 50 µm, (D) Dilatation of blood vessels
(black arrows) and scattered inflammatory cells in the basal layer of endometrium (red
arrows), scale bar =50 µm. (E&F) High magnification micrographs showing infiltration
of inflammatory cells in the myometrium (black arrows), which indicated that this cow
had severe metritis. Scale bar =20 µm.
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4.3.3 Corpus luteum weight, luteal progesterone
content and expression of progesterone synthesis
proteins in cows with endometritis
The results showed that endometritis affected CL weight and luteal P4 content.
Cows with endometritis had a 1.2-fold smaller CL (P<0.05) and a 1.2-fold
lower luteal progesterone content per unit mass (P<0.05) compared to control
cows (Fig. 4.7). This resulted in the total progesterone content being nearly
1.5-fold less in the CL from endometritis cows.
Figure 4.7: (A) CL weight and (B) luteal progesterone (P4) content in cows with
endometritis. Cows with endometritis had decreased CL weight vs. control cows (*;
P<0.05 vs. control); (B) shows that cows with endometritis had lower luteal
progesterone content compared to control cows compared to control cows (*; P<0.05
vs. control).
Western blot showed that there was a single prominent band for STAR (25kD),
HSD3B (42kD), CYP11A (61kD) and histone H3 (15 kD) at expected molecular
weights (Fig. 4.8-4.10). Quantification clearly showed that the expression of
these key proteins associated with progesterone synthesis were lower in the
CL from cows that had endometritis. Namely, STAR (2-fold), HSD3B (8-fold)
and CYP11A (3-fold) protein levels were lower in cows with endometritis
versus control cows, (P<0.01; Fig. 4.8-4.10). Histone (H3) is housekeeping
gene was being stable across the control samples.
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Figure 4.8: The expression of steroidogenic enzyme acute regulatory (STAR) protein in
the CL of cows with and without endometritis. (A) Western blot of STAR and histone H3
showed single bands at 25 and 15kD respectively. The housekeeping protein histone
H3 (H3) expression was consistent across the different samples. (B) The expression of
STAR protein (normalised to histone H3) was different between control and
endometritis cows (P<0.01; ** vs. control). Data are mean±SEM.
Figure 4.9: The expression of 3β-hydroxysteroid dehydrogenase (HSD3B) in the CL of 
cows with and without endometritis. (A) Western blot image of HSD3B protein showing
a single band for HSD3B at 42kD and the housekeeping protein (Histone H3) was
unchanged across the two groups. (B) The expression of HSD3B (normalised to
histone H3) was different between control and endometritic cows P<0.001; ** vs.
control). Data are mean±SEM.
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Figure 4.10: The expression of cholesterol side-chain cleavage enzyme (CYP11A)
protein in the CL of cows with and without endometritis. (A) Western blot image of
CYP11A protein revealed a single band for CYP11A at 61kD and the housekeeping
protein (Histone H3) was unchanged across the two groups. (B) The expression of
CYP11A (normalised to histone H3) was different between control and endometritis
cows P<0.01; ** vs control). Data are mean±SEM.
4.3.4 Immunolocalisation of endothelial cells in ex
vivo CL
There was a different pattern of endothelial cell staining in the luteal tissue
between the control and endometritic cows (Fig. 4.11). There was an
extensive microvasculature across the whole CL section in control cows with
steroidogenic cells very close or adjacent to endothelial cells (Fig. 4.11A&B)
this appeared much greater compared to CL of endometritis cows where there
was limited staining of endothelial cells (Fig. 4.11C&D). The negative IgG
controls were blank (Fig. 4.11E&F).
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Figure 4.11: Immunohistochemical localisation of von Willebrand factor in the corpus
luteum from (A&B) control cows, (C&D) cows with endometritis and (E&F) with the
control rabbit IgG (primary antibody absent). In control cows, there was widespread
staining (brown) for endothelial cells compared to corpus luteum of cows experienced
with endometritis. Arrows indicates area positive with staining VWF. A, C & E; 10X; B,
D & F; 40X magnification.
The area of VWF staining in the CL was affected by endometritis (Fig. 4.12;
P<0.001) with a 3-fold greater percentage area of endothelial cells in control
cows compared with cows that had endometritis. The estimated total
endothelial cell weight was also affected by endometritis (P<0.05), and
showed that this was also about 4-fold greater in control compared to cows
with endometritis (Fig.4.12B).
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Figure 4.12: The quantification of (A) % area of VWF staining and (B) total estimated
weight of endothelial cells in bovine corpus luteum of control cows and those with
endometritis. There was a significant effect of endometritis on % area of VWF staining
(***; P<0.001 vs. control) and estimated total endothelial cells weight (***; P<0.001
vs. control). The values are mean±SEM.
In the control cows, the pattern of isolectin B4 staining in the CL was similar to
that for VWF immunohistochemistry (Fig 4.11). Additionally, the proportion of
luteal EC positively stained with isolectin-B4 in the CL of diseased cows was
lower than in control cows (Fig. 4.13A-D). The addition of galactose to the
isolectin B4 revealed no positive staining thus confirming specificity of isolectin
staining (Fig. 4.13 E&F).
Quantification of isolectin-B4 staining revealed that the percentage area of
isolectin-positive endothelial cells was greater (4-fold) in control cows than
cows that were experiencing endometritis (P<0.001). The estimated total
weight occupied by isolectin B4 positive-endothelial cells in the CL was also 5-
fold lower in cows with endometritis (P<0.001; Fig. 4.14B).
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Figure 4.13: Immunohistochemical localisation of endothelial cells using isolectin B4
as a marker. (A, B) shows corpus luteum from a control cow. (C,D) shows corpus
luteum from a cow with endometritis cows. (E,F) Represent the control section showing
no positive staining. In control cows, there was widespread staining of endothelial cells
compared to corpus luteum of cows with endometritis. Arrows indicates positive
staining.
Figure 4.14: The quantification of (A) % area of isolectin B4 staining and (B)
estimated total of endothelial cell weight in bovine corpus luteum of control cows and
those with endometritis. The % area of isolectin staining (***;P<0.001 vs. control) and
estimated total luteal endothelial cell weight (***;P<0.001 vs. control) were reduced in
cows that had endometritis. The values are mean±SEM.
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4.3.5 Immunolocalisation of ɑ-smooth muscle
actin (ACTA2) in ex vivo CL
Pericytes/vascular smooth muscle cells were stained with ACTA2 in the CL.
Staining of pericytes with ACTA2 in the CL from cows with endometritis was
visibly less extensive compared to control cows (Fig. 4.15). Furthermore, the
staining that was present had a lower intensity appearance. The possible
exception was in the larger blood vessels where staining was similar to that for
control cows. The negative IgG control revealed no staining (Fig. 4.15E&F).
Quantification of ACTA2 showed that the area of ACTA2 was greater in control
cows by about 4-fold than cows with endometritis (P<0.001; Fig. 4.16A). In
addition, estimated total weight of pericytes 4-fold greater in control cows
compared with cows that had endometritis (P<0.001, Fig.4.16B).
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Figure 4.15: Immunohistochemical localisation of ɑ-smooth muscle-actin (ACTA2) in
bovine CL. (A,B) shows CL from control cows while (C,D) shows CL from cows with
endometritis. (E,F) shows negative mouse IgG controls where no staining was evident.
The ACTA2 staining was more extensive and covered a greater area in control cows
compared to those from cows with endometritis. Arrows indicates positive staining of
pericytes (yellow) and vascular smooth muscle cells (red).
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Figure 4.16: The quantification of (A) % area of ACTA2 staining and (B) total
occupancy of pericytes in the bovine CL. There was a significant decrease in % area of
ACTA2 staining (***;P<0.001 vs control) and total amount of pericytes (***;P<0.001
vs control) in cows With endometritis. The values are mean+SEM.
The Western blot for ACTA2 revealed a single band at the expected molecular
weight of 42kD. Quantification of this band showed that ACTA2 protein
expression was markedly lower (6-fold) in endometritic cows compared to
control cows (P<0.001; Fig.4.17 A&B).
Figure 4.17: The expression of α-smooth muscle actin (ACTA2) protein  in the 
bovine CL in cows with and without endometritis. (A) Shows a representative
Western blot analysis for ACTA2 with a single band at 42kD and a single band for
histone H3 at 15kD which was constant across the two groups. (B) The expression of
ACTA2 (normalised to histone H3) was greater in the control cows than those that
had endometritis (P<0.001). The values are mean±SEM
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4.3.6 Expression of TLR4, CD14, MD-2 and SUZ12
mRNA in the bovine CL at different stages of
oestrus cycle
Using TLR4, CD14, MD-2 and SUZ12 primers (Fig. 4.18), the DNA bands from
the PCR were at the expected sizes of 224, 230, 125, and 286 bp,
respectively. The appropriately-sized bands were observed in all disease-free
CLs and diseased CLs, indicating the presence of mRNA encoding the LPS
receptor and its co-receptors mRNA throughout the oestrus cycle. Multiplex
PCR products were sent for sequence analysis, which confirmed that fragment
sequences generated were 100% homologous in both directions to the bovine
sequence already published (Genbank accession numbers, Table 4.4). No
quantification or qPCR was performed, thus it was not possible to compare the
expression levels between samples. Negative control samples were blank.
4.4 Discussion
The present study determined the association between endometritis and luteal
vascularisation and steroidogenic capacity in dairy cows. Endometritis was
defined as an inflammation of the superficial layers of the uterus which was
Figure 4.18: Representative multiplex PCR reactions showing the
expression of TLR4 mRNA (LPS receptor) and its co-receptors in bovine CL at
different stages of oestrus cycle. Far left lane shows the DNA molecular
weight marker. A)1=Marker, 2= mid stage CL (endometritic cow), 3= mid
stage CL (endometritic cow), 4= negative control [no reverse transcriptase
enzyme], 5= mid stage CL (endometritic cow). B) 1=Marker, 2=early stage
CL (control), 3= mid stage CL (control), 4= regressed CL (control). bp= base
pairs.
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further diagnosed by microscopic examination of pathological lesion of uterine
sections with the presence of purulent discharge inside the uterine horns.
Metritis is distinguished from endometritis by inflammation of all layers of the
uterus, and presence of fetid blood, bad odour and discharge from the vagina
and inside the uterus. Animals with endometritis, are microscopically
characterised by infiltration of polymorphonuclear cells in the sub-epithelia
layer and among the uterine glands, but this does not extend to the deeper
layer of the uterus (Sheldon et al. 2006). However, cows with metritis are
characterised by an erosion of the superficial layer with severe infiltration of
leukocytes in the submucosal layer and among uterine glands. Furthermore,
blood vessels appear dilated and blood cells scattered in the myometrium
(myometrium degeneration) (Moss et al. 2002, Chapwanya et al. 2012,
Sheldon et al. 2006, McEntee 2012).
It has been reported that uterine infection not only affects endometrial
function, but also affects ovarian function. Cows with uterine infection
particularly those infected with E.coli infection have decreased ovarian follicle
growth and functions and are less likely to ovulate (Williams et al. 2007,
Peters et al. 1989, Sheldon et al. 2002b). In this Chapter, cows with
endometritis/metritis had smaller CLs and lower luteal progesterone content
versus oestrus cycle-matched control cows. The logical extension of this would
be that these endometritic/metritic cows, where ovulation had clearly
occurred, would have lower circulatory progesterone concentrations, although
this was not tested. This agrees with previous reports that demonstrated that
cows with metritis that had small CL and produced less progesterone in vivo
(Williams et al. 2007, Strüve et al. 2013). Furthermore, treatment of cows
with an intra-uterine infusion of LPS reduced CL size and plasma progesterone
transiently (Sheldon et al. 2009b, Herzog et al. 2012).
In addition, uterine disease directly perturbed steroidogenesis by ovarian
granulosa cells (i.e. reduced aromatase expression and oestradiol production)
(Sheldon et al. 2002b, Herath et al. 2007). It is likely that this could reduce
the ability of the follicle to ovulate and/or form a fully functional CL. However,
it is important to note in this study, the CL were collected had the appearance
of those from the mid-luteal phase, thus any compromised follicular function in
these cows was not sufficient to prevent ovulation.
The reduced luteal progesterone content was strongly supported by markedly
reduced luteal protein expression of key proteins involved in progesterone
synthesis in cows with endometritis. Namely, the expression of steroidogenic
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acute regulatory protein (STAR) protein (Miller 2007) which transports
cholesterol from the outer to the inner mitochondrial layer was decreased;
cholesterol side-chain cleavage P-450 complex (CYP11A) protein, which
converts cholesterol to pregnenolone (Tuckey and Stevenson 1984) was
decreased, and expression of 3β-hydroxysteroid dehydrogenase (HSD3B) 
protein, which converts pregnenolone to progesterone (Rekawiecki et al.
2005) was reduced in cows with endometritis compared to control cows.
Similarly, it has been reported that intra-uterine LPS infusion down-regulated
luteal STAR mRNA expression which concurred with reduced plasma P4
concentrations (Herzog et al. 2012, Magata et al. 2014). The mechanism
through which LPS inhibits steroidogenic enzyme expression in bovine luteal
cells is unclear. But this could be as a result of bacterial endotoxins decreasing
luteal blood flow which coincided with decreased plasma progesterone as well
as reduced steroidogenic enzyme activity (Herzog et al. 2010).
There are some discrepancies about the effect of LPS on plasma P4
concentrations. Some studies have shown that LPS treatment actually
increased P4 concentration at some earlier time points after administration
(Herzog et al. 2012, Gilbert et al. 1990). However, several studies support the
concept that LPS decreases plasma progesterone concentrations. It was
reported that CL size decreased after treating animals with E.coli LPS
(0.5µg/kg body weight) on day 10 of the oestrus cycle (Herzog et al. 2012)
and between day 29 and 39 of pregnancy (Debertolis 2015). Also, they found
reduced expression of STAR mRNA at 12h after infusion. The same
observations were reported by Williams et al. (2008b) where systemic
progesterone concentrations were decreased over several days in cows after
intrauterine infusion of LPS. However, previously it has been reported that
reduced plasma P4 concentrations occurred concurrent with decreased luteal
blood flow (Herzog et al. 2012). In that regard, plasma progesterone
concentrations decreased to minimal values between 9 and 24h after LPS
treatment, consistent with the close correlation between luteal blood flow and
P4 (Herzog et al. 2012).
The results of the current study demonstrated that CL from cows with
endometritis had a significantly reduced degree of vascularisation and
estimated total luteal vasculature. Additionally, there was reduced pericyte
coverage in the CL. A particularly interesting aspect to this novel finding was
the high amount (4-fold) by which these vasculature parameters were
affected. The logical extension of this observation would be markedly reduced
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luteal blood flow, reduced biochemical/metabolite exchange and decreased
supply to steroidogenic cells of cholesterol/LDL for progesterone production.
It is important to understand the mechanisms through which uterine
inflammation could affect luteal angiogenesis. This could be via altered
cytokine production such as tumour necrosis factor alpha (TNFA). When
leukocytes and macrophages infiltrate the endometrium TNFA expression is
up-regulated (Haddad et al. 1995, Bondurant 1999, Janowski et al. 2013).
TNFA could then act directly via the circulation on luteal cells and endothelial
cells (Williams et al. 2008b, Crespo et al. 2010). Circulating TNFA is increased
in cows with endometritis (Brodzki et al. 2015, Kasimanickam et al. 2013). It
known that TNFA exerts actions on the CL though multiple signalling pathways
involving two receptors: TNFR1 (responsible for induction of the cell death)
and TNFRII (implicated in cell proliferation) (Korzekwa et al. 2008). Both luteal
cells and endothelial cells possess TNF receptors (Okuda et al. 1999, Friedman
et al. 2000). It has been reported that TNFA is cytotoxic for endothelial cells
derived from the corpus luteum (Friedman et al. 2000). This was mediated
through TNFRI and preceeded structural luteolysis, which is a prerequisite for
the initiation of apoptosis in endothelial cells (Pru et al. 2003, Friedman et al.
2000). TNFA enhanced apoptosis which associated with both morphological
and biochemical features of apoptosis, including caspase-3 activation,
shrunken nuclei, and DNA fragmentation (Petroff et al. 2001, Jo et al. 1995).
Thus, altered systemic TNFA as a consequence of an extensive uterine
infection could have a role in the regression of the luteal microvasculature.
Several studies demonstrated that LPS affects cytoskeletal filaments in
endothelial cells and in so doing makes gaps between adjacent cells, and
disrupts intercellular gap formation that led to endothelial barrier dysfunction,
(Chakravortty et al. 2000, Goldblum et al. 1993, Stasek et al. 1992). Vascular
endothelial cadherin (VE-cadherin) is located exclusively at the endothelial
intercellular junction, and plays an important role in the maintenance and
regulation of the endothelial barrier via cell-cell adhesion (Dejana et al. 1999,
Lampugnani et al. 1992). In vitro LPS (20µg/ml) reduced VE-cadherin
expression in human umbilical vein endothelial cells (Hama et al. 2008).
Furthermore, Bogatcheva et al. (2009) observed that lower doses of LPS
(100ng/ml) caused disturbance in the endothelial cytoskeletal organisation.
They speculated that this gap was due to decreased expression of VE-cadherin
in human lung microvascular endothelial cells.
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It has been reported that transforming growth factor B1 (TGFB1) has been
implicated in the positive and negative regulation of angiogenesis in vivo by
inhibiting the proliferation of endothelial cells in vitro (Iruela-Arispe and Sage
1993, Ferrari et al. 2009). Previously, it was reported that LPS induced
upregulation of TGFB1 (Chen et al. 2008) and this could be a mechanism by
which LPS could reduce the degree of vascularisation in the CL that requires
intense angiogenesis for its formation.
The sharp decrease in luteal blood flow after LPS infusion could be associated
with, significant systemic problems such as septicaemia, and blood flow is
diverted from the periphery to the core (Richardson et al. 1996). This might
have accounted for the precipitous decline after LPS perfusion. Furthermore,
luteal size decreased from 5.2 to 3.8 cm within 24 h after treatment with LPS
and remained smaller throughout the remainder of the cycle (Herzog et al.
2012). It has been shown that LPS can contribute to the initial damage of
various types of endothelium (Frey and Finlay 1998, Choi et al. 1998, Koide et
al. 1996). Microvascular injury happens during sepsis, such as in liver, gut and
lung. Generally, this event has been considered important in the pathogenesis
of the septic shock syndrome (Morrison and Ryan 1987). It has been reported
that critical role of endothelial cell apoptosis in the pathogenesis of endotoxin
shock. However, prolonged exposure to lower LPS (0.01-100µg/mL) can lead
to stimulation of angiogenesis. For example, Kim et al. (2008) reported that
LPS increased VEGFA mRNA expression pericytes from rat lungs.
The results of this study established that TLR4 and its LPS co-receptors are
expressed in bovine CLs at different stages of the oestrus cycle, using
multiplex PCR. The results showed that TLR4, CD14 and MD2 mRNA were all
present in the bovine CL throughout the oestrus cycle from both control cows
and cows with endometritis. While no quantification of this expression was
performed, the next step would be to perform quantitative PCR in order to
precisely quantify their expression. It has recently been shown that TLR2 and
TLR4 mRNA is expressed in mid-cycle CL of isolated perfused bovine ovaries in
vivo (Lüttgenau et al. 2016). The identification of receptors in the bovine CL
that recognise LPS indicate that LPS could potentially directly influence the
function and development of CL. It has been reported that TLRs are important
mediators of the immune system and the TLR-mediated production of
inflammatory cytokines could affect the other luteal cells populations (e.g.
steroidogenic cell, endothelial cells, fibroblasts and pericytes). Previously,
there was no differences in mRNA expression of TLR4 between healthy and
diseased CL (Lüttgenau et al. 2016).
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LPS receptors including TLR4, MD2 and CD14 were expressed in bovine
granulosa cells, which have an important role in initiating the innate immune
response to Gram-negative pathogens. It has been demonstrated that
granulosa cells exhibited functional TLR1, TLR2 and TLR4 responsiveness to
PAMPs with increased accumulation of inflammatory cytokines and chemokines
leading to activation of MAPK pathway (Price et al. 2013). The high level of
TLR2, TLR3, and TLR4 expression in luteolytic CL tissue could indicate a role in
the initiation of luteolysis (Tyson 2014). Previously, reported that the
degradation of luteal tissue may serve as a source of endogenous ligands for
LPS receptors and would potentially activate inflammatory mediators like
TNFA, IFNG, IL6, IL12, and TGFB (Tyson 2014).
4.5 Conclusion
There is no doubt that luteal angiogenesis is essential for the proper function
of the CL and thus pregnancy. The % area of both endothelial cells and
pericytes were markedly reduced in cows with endometritis. Furthermore,
luteal progesterone content and expression of progesterone synthesis proteins
were significantly reduced in cows with endometritis. The present findings
suggest a novel mechanism by which endometritis could affect ovarian and in
particular CL function in vivo. LPS receptor and its co-receptors TLR4, MD-2
and CD-14 were expressed in luteal tissue throughout the oestrus cycle of
control cows and cows with endometritis. It seems possible that luteal and
endothelial cell TLR4, MD-2 and CD14 are involved in the immune response of
luteal tissue to LPS in vivo, which could be related to the production of pro-
inflammatory cytokines and decreased ovarian steroidogenesis in cows. Future
studies are required to measure the production of pro-angiogenic (e.g. FGF2,
VEGFA, fibronectin), anti-angiogenic factors (e.g. TGFB, TNFA) as well as pro-
inflammatory cytokines (e.g. IL-1, IL-6 and IL-8), in the CL and endometrium
at different time points in cows with endometritis. To gain a deeper
understanding of how endometritis could affect luteal angiogenesis, the next
chapter focussed on dose-dependent effects of LPS on luteal endothelial cells
and progesterone production in culture.
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5 The effect of E.coli LPS on bovine
luteal endothelial cell network
formation and steroidogenesis in vitro
5.1 Introduction
In dairy cows, post-partum uterine inflammation caused by Gram-negative
bacteria (e.g. E.coli) suppresses follicular function and reduces fertility. LPS is
an endotoxin that is present on the outer membrane of Gram-negative
bacteria. Furthermore, LPS is detected in follicular fluid (0.004-0.88µg/ml) of
cows with endometritis. The mechanism by which LPS enters the follicular
fluid is controversial. However, it has been suggested that LPS is absorbed by
the uterus and then into the blood stream (Mateus et al. 2003, Dohmen et al.
2000). The corpus luteum (CL) is a site of high vascular formation,
characterised by the formation of a dense capillary network. This plays a key
role in suppling hormone-producing cells with oxygen, nutrients and hormone
precursor required to synthesise and release of large amount of progesterone,
that is necessary for establishment and maintenance of early pregnancy
(Redmer and Reynolds 1996, Reynolds and Redmer 1998, Acosta et al. 2003).
Angiogenesis in the CL involves a complex series of cellular processes and
molecular changes. An establishment of vascular system in the CL depends on
different cell types including: The inner lining endothelial cells, related to
mural cells such as pericytes and vascular smooth muscle cells (vSMC). Such
vessels remain quiescent until there is an angiogenic stimulus such as
hypoxia, injury, or ovulation.
The degree of vascularisation can be determined by immunostaining for von
Willebrand Factor (VWF) as a marker for endothelial cells (Ratcliffe et al.
1999, Antczak and Van Blerkom 2000). Angiogenesis in the CL is principally
controlled by several factors, including vascular endothelial growth factor A
(VEGFA) (Ferrara et al. 2003, Gerhardt and Betsholtz 2003, Woad et al.
2009), and fibroblast growth factor 2 (FGF2) (Woad et al. 2009). For
example, immunoneutralisation of VEGFA in the early luteal phase decreased
endothelial cell number and reduced progesterone production in marmoset
monkeys (Fraser et al. 2000) and cows (Yamashita et al. 2008). Many
previous reports have demonstrated the angiogenic potential of LPS (Mattsby-
Baltzer et al. 1994, Harmey et al. 2002). However, there is controversy as to
whether lipopolysaccharide (LPS) directly stimulates endothelial sprouting and
angiogenesis, or whether it is mediated through cytokine production (Koolwijk
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et al. 1996, Pidgeon et al. 1999). In addition, it has been suggested that the
angiogenic effect of LPS may be secondary to the release of angiogenic
factors from adjacent non-endothelial cells (Pidgeon et al. 1999, Leibovich et
al. 2002). Conversely, LPS has induced apoptosis in various endothelial cell
subtypes such as human umbilical vein endothelial cells and lung-derived
normal human microvascular endothelial cells (Koide et al. 1996, Bannerman
et al. 1998, Munshi et al. 2002). The present study determined whether LPS
would adversely affect the proliferation of luteal endothelial cells and their
ability to form networks. In vitro effects of LPS on luteal function and
endothelial cells are poorly understood. In this chapter, two experiments were
preformed, to investigate this further.
Hypothesis
E.coli LPS will reduce luteal endothelial network formation, through increased
apoptosis and decreased proliferation of luteal endothelial cell. At the same
time, LPS will reduce luteal progesterone production and steroidogenic
enzyme expression in vitro.
Aims
In order to address this hypothesis, this chapter had two aims: (1) to
determine the effect of LPS on luteal endothelial cell (EC) network formation
and progesterone production and (2) to elucidate the effect of LPS on luteal
endothelial cell proliferation and apoptosis as well as the expression of ACTA2
(smooth muscle actin).
5.2 Experiment 1: Effect of LPS on
luteal endothelial cell networks and
progesterone production in culture
5.2.1 Materials and methods
5.2.1.1 Luteal angiogenesis culture system
Coating of coverslips
Coverslips (circular, 19 mm diameter, 0.25 mm thick, SLS, Nottingham, UK)
were placed in 70% (v/v) IMS for at least 1 hour. These coverslips were taken
out individually and briefly dipped in 70% (v/v) IMS, then placed on a petri
dish to dry at least 1 hour before being transferred to 12-well plates.
Fibronectin (500µl; 10µg/ml) was added to each well, and then incubated in a
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humidified chamber at 39°C. After 4 hours, the fibronectin was removed and
the wells allowed to dry at 39°C overnight. On the next day, coverslips were
washed once with 1ml of sterile distilled water, and then 1ml endothelial cell
media (EBM-2, Lonza, Wokingham, UK) was added to each well. Plates were
incubated at 39°C until cell plating, as required.
Preparation of specialised endothelial cell media
The endothelial cell media (ECM) is a proprietary specialised endothelial cell
medium (EBM-2; Lonza, Wokingham, UK), which was supplemented as per
manufacturer’s instructions (Table 5.1). In addition, the media was
supplemented with 5ng/ml LH (AFP11743B, biopotency 1.06, LH NIDDK-I-2;
NIDDK,CA, USA), 100 units/ml penicillin, 10 µg/ml streptomycin and 5 ml of
100x of ITS (1.0mg/ml recombinant human insulin, 0.55mg/ml human
transferrin (substantially iron-free), and 0.5μg/ml sodium selenite). 
# As appropriate
Tissue collection and luteal angiogenesis culture system
Bovine ovaries were collected from a local abattoir and transported to the
laboratory in warmed 1×PBS (PBS). Corpora lutea chosen were from an early
stage (day 1-4) and mid stage (day 5-7) of the oestrus cycle. These were
selected according to the standard classification system (Ireland et al. 1980,
Fig. 5.1).
Table 5.1: Composition of endothelial cell media-2, Lonza [500ml bottle].
Supplement Volume
Human epidermal growth factor 0.5 ml
Ascorbic acid 0.5 ml
LongTM R3 insulin like growth factor-1 0.5 ml
Fetal bovine serum 10 ml
Heparin 0.5 ml
Hydrocortisone 0.2 ml
VEGFA 1ng/ml#
FGF2 1ng/ml#
Gentamycin sulphate, amphotericin (GA
1000)
0.5 ml
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Figure 5.1: Bovine ovaries at different stages of oestrus cycle: (A) Ovary from very
early luteal phase (day 1-4). (B) Ovary from mid-luteal phase (day 5-7).
The ovaries were rinsed with 70% (v/v) IMS and then rinsed with sterile PBS
and handled in an aseptic manner henceforth. CLs were dissected from
connective tissue into a petri dish and then sliced up using scissors and
chopped with surgical blades. Chopped luteal tissue was dissociated in 10ml
DMEM/Hams medium containing 2 mg/ml collagenase I type 1A (Sigma,
C2674) and 25 µg/ml DNase I (Sigma; D0525) which was put into a conical
flask and incubated in a shaking water bath for 30-45 minutes at 37˚C. 
Following incubation, the solution was poured into 50 ml falcon tubes and
allowed to settle before the solution was pipetted off and filtered through a
70µm cell strainer (BO Biosciences, Oxford, UK) into a new falcon tube which
was then centrifuged at 150g for 5 min. The supernatant was removed and
the cell pellet resuspended in ECM media. Meanwhile, fresh dissociation
solution was added to the remaining tissue from the first digestion and
incubated in a shaking water bath at 37C for a further 30-45 minutes. The
cells were prepared as for the first digestion and then combined together
before being centrifuged at 150g for 5 minutes.
The supernatant was removed and the pellet washed with 10 ml of ECM three
times to remove any visible RBC and clean-up the cell pellet. After the final
centrifugation, the pellet was re-suspended with 5 ml of ECM. The number of
viable cells were counted using Trypan Blue exclusion and hemocytometer
after diluting the cell suspension 1 in 20.
Experimental design
The cells were diluted to 1×105 cells per ml and 2ml of this dilution was added
to each well (12 well plates; Fig.5.2). The cells were treated with E.coli
O111:B4.lipopolysaccharide (Alpha diagnostic international, LPS11-1, is highly
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purified with <3% impurities) (0, 0.01, 0.1, 1, 10µg/ml) in the presence and
absence of FGF2 and VEGFA (both 1ng/ml) (Fig. 5.2A and B). The plate was
then incubated at 39C in humidified incubator in 5% CO2; 95% air. The
culture media changed every other day and media was collected and stored at
-20˚C for progesterone measurement.  Total number of cultures performed at 
early stage (n=5) and at mid stage CLs (n=5).
Figure 5.2: Cell plate layout for Exp 1. (A) Cells were treated with 0-0.1µg/ml LPS
under basal and angiogenic stimulated conditions (VEGFA and FGF2; both 1ng/ml). (B)
Cells treated with 1-10µg/ml LPS under basal and angiogenic stimulated conditions for
9 days.
5.2.1.2 Immunohistochemical analysis for VWF
Fixation and blocking
On day 9 of culture, cells were fixed and permeabillised in acetone: methanol
(1:1) at 4˚C for 5 minutes, then washed twice with PBS. An endogenous 
peroxidase block (3% (v/v) hydrogen peroxide in methanol) was applied to
the wells for 10 minutes at RT to prevent endogenous peroxidase from being
visualised. Then wells were washed with PBS (2 × 5 minutes each). The cells
were blocked with 20% (v/v) normal goat serum (NGS) for 30 minutes to
prevent any binding to non-target sites.
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VWF antibody
Rabbit anti-human VWF IgG (Dako) was diluted in 2% (v/v) NGS (in PBS) to
5µg/ml and 300µl was added to each well and incubated for 2 hours at RT.
Secondary antibody
After two hours incubation with primary antibody, the coverslips were washed
with PBS (2 × 5 minutes each). The secondary antibody was used according
to the Vector ABC Elite method as follows: biotinylated goat anti-rabbit IgG
was diluted 1/250 with 2% (v/v) normal goat serum in PBS and incubated for
30 minutes at room temperature. Then coverslips were washed with PBS (2 ×
5 minutes each). This was followed by preparing the avidin-biotin complex as
per manufacturer’s instruction, which was incubated for 30 minutes at RT.
Then coverslips were washed with PBS (2 x 5 minutes each).
Visualisation of the antibody complex, counterstaining and
mounting
Visualisation of the bound antibodies was determined by incubating with 3.3’-
diaminobenzidine tetrahydrochloride (DAB) for 4 minutes (Section 4.2.4.6).
The cells were then counterstained with haematoxylin (Section 4.2.4.7).
5.2.1.3 Image analysis of von Willebrand factor
The method of quantification was developed according to an established
protocol, (Robinson et al. 2008). For each treatment in each culture, both
wells were selected for analysis. Images acquired from a total of 20 fields of
view per coverslip visualised randomly under 5x magnification using Leica
DM4000B microscope (Leica Microsystems Ltd., Milton Keynes, UK) and
Qlmaging Micropublisher 5.0 RTV colour camera (Qlmaging (UK) Ltd., St
Helens, UK). All image analysis was performed using Image Pro-Plus 6.0
(Media Cybernetics, Wokingham, UK). Captured images were tiled to create a
composite image for processing. The brown of area (VWF) staining was
highlighted. The highlighted brown areas were smoothed and any holes in the
staining were removed and any VWF staining area <150mm2 excluded (to
eliminate very small cluster of isolated EC of <3 cells). Only brown areas
positively stained with VWF were included in the analysis. Then, the total area
of VWF staining, total number of EC islands, the number of EC networks, and
the area and length of each individual network was recorded. The number of
branch points present in the EC islands undergoing sprouting was determined
using an automated measure of branching points (Branch/End feature; Image
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Pro-Plus 6.3;(Masri et al. 2007, Woad et al. 2012). Branch points per cluster
was calculated by dividing total number of branch points by total number of
EC clusters.
5.2.1.4 Progesterone ELISA
Progesterone ELISA (Ridgeway Science; St Briavels, Gloucestershire) was
performed according to manufacturer’s instructions. Samples were thawed
and diluted with PBS. As follows: Day 5 (1:50) and Day 9 (1:150). ELISAs
were performed as detailed in Section 3.3.2.4. The lower limit of sensitivity
was 0.2ng/ml and the intra- and inter-assay coefficient of variation were
7.2% and 8.8%, respectively.
5.2.1.5 Statistical analysis
Data were checked for normality and homogeneity of variance by using
residual plots and Bartlett's test, respectively. Data were log transformed
where appropriate. To investigate the effect of CL stages on total EC area and
EC branch points, randomised block one-way ANOVA in GenStat 16th Edition
was used. In order to minimise the effect of culture, the data were blocked by
culture. Additional analysis included investigating the effect of VEGFA/FGF2 on
progesterone production and EC network formation. This was compared using
randomised block ANOVA. Similarly, the effect of day on progesterone
production was analysed by a randomised block ANOVA. For each culture, the
EC network variables were converted into % control. The effects of LPS were
analysed using randomised block one-way ANOVA in GenStat 16th Edition.
Again, in order to minimise the effect of culture, the data were blocked by
culture. LPS was added as a factor to the fixed model on the response
variable (total area endothelial cell networks, area of individual EC networks,
branch points, and progesterone production). Separate analysis was
performed to look at the effects of LPS (1) on EC networks from early and mid
CLs and (2) under basal and angiogenic stimulated conditions. If there was a
significant effect of LPS, then Tukey’s multiple comparisons were performed to
determine where the difference lay. For all experiments P<0.05 was
considered as significant and all data are presented as mean ±SEM
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5.2.2 Results of experiment 1
5.2.2.1 Characterisation of the luteal
angiogenesis culture system
On day 9 of culture, the cells had formed a confluent monolayer. Numerous
endothelial cells EC were stained using VWF as a marker showing that a
number of networks had formed in each culture. Each EC network had a
central body of endothelial cells, from which a number of branches had
developed. These EC networks were different in size and degree of branching
depending on the stage of luteal development (Fig.5.3A&B). In addition, other
cell types had proliferated with their nuclei abundant across the whole
coverslip (Fig. 5.3A&B). The results showed that early CL produced a slightly
more extensive EC networks compared to those from mid CL under both basal
condition (without VEGFA and FGF-2) (Fig. 5.3A&B) and under angiogenic
stimulated conditions (Fig. 5.4A&B). Early CL produced a significantly higher
area of branched endothelial cells (Fig. 5.3C and Fig. 5.4C, P<0.05), and
increased number of branch points (Fig. 5.3D, P<0.01) and (Fig.5.4D,
P<0.05). Progesterone production was significantly increased under
angiogenic stimulus (VEGFA and FGF-2) compared to basal conditions
(Fig.5.5A, P<0.001). Furthermore, progesterone production was higher on
day 9 than day 5 of culture by about 2-fold (Fig.5.5B, P<0.001).
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Figure 5.3: Representative images of bovine luteal cells treated with control ECM
medium (without FGF2/VEGFA). (A) From early stage CL (days 1-4), (B) from mid
stage CL (days 5-7). Endothelial cells were immunostained for von Willebrand factor
(brown) after 9 days of culture. Endothelial cells formed organised tubule-like
networks when derived from both early stage and mid stage CL. Black arrows indicate
EC branch endpoints. (C) There was significant effect of CL stage on area of branched
EC. (D) There was significant effect of CL stage on EC branch points (*; P<0.05). All
treatments within culture were performed in duplicate and the values are mean (n=5
cultures) ± SEM.
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Figure 5.4: Representative images of bovine luteal cells under angiogenic stimulated
conditions without LPS treatment. (A) from early stage CL (days 1-4), (B) from mid
stage CL (days 5-7). Endothelial cells were immunostained for von Willebrand factor
(brown) on 9 days of culture. Endothelial cells formed organised tubule-like networks
when derived from early stage CL and mid stage CL. Black arrows indicate EC branch
endpoints. (C) There was a significant effect of CL stage on the area of branched EC.
(D) There was a significant effect of CL stage on EC branch points (*; P<0.05). All
treatments within culture were performed in duplicate and the values are mean (n=5
cultures) ± SEM.
Figure 5.5: Progesterone production by luteal cells in culture. (A) shows that
angiogenic stimulation (FGF2 and VEGFA; both 1ng/ml) increased P4 production (***;
P<0.001). (B) shows that progesterone production across all treatments increased
between day 5 and 9 of culture (***; P<0.001). The values are mean (n=5 cultures)
± SEM.
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5.2.2.2 The effect of LPS on in vitro luteal
angiogenesis [early CL]
The patterns of endothelial cells networks that formed under basal angiogenic
conditions were greater in control compared to LPS-treated wells (Fig.5.6).
LPS had adverse effects on EC network formation under both basal and
angiogenic-stimulated conditions. In non-LPS treated wells, EC formed highly
Figure 5.6: Effect of LPS on development of endothelial cell (EC) networks on day 9 of
luteal culture from early stage CL under basal angiogenic conditions. (A) In the
absence of E.coli LPS, endothelial cells formed highly organised tubule-like networks,
without angiogenic stimulation. (B) 0.01µg/ml, (C) 0.1µg/ml, (D) 1µg/ml, (E) 10µg/ml
LPS. EC were immunolocalised stained with VWF. Black arrows indicate EC branch
endpoints.
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organised tubule-like networks, which were dramatically increased under
angiogenic-stimulated conditions (Fig.5.7). Reduced numbers of EC networks
were observed in LPS-treated wells and at 10μg/ml LPS virtually no EC 
networks were detected (Fig.5.7).
Figure 5.7: Effect of LPS on development of endothelial cells networks on day 9 of
luteal culture from an early stage CL under angiogenic stimulated conditions. (A) In
the absence of E.coli LPS, endothelial cells formed extensive highly organised tubule-
like networks, (B) 0.01µg/ml, (C) 0.1µg/ml. (D) 1µg/ml, (E) 10µg/ml LPS. EC
networks and cluster were immunolocalised stained with VWF. Black arrows indicate
EC branch points.
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LPS significantly dose-dependently decreased the area of EC networks, the
number of EC clusters and branch points as well as the degree of branching
per EC cluster (Fig. 5.8-5.9; P<0.001). Significant differences were detected
at the different LPS doses (P<0.001).
Figure 5.8: Effect of LPS on endothelial cell networks on day 9 of luteal culture under
angiogenic-stimulated conditions from an early CL. (A) In the absence of E.coli LPS,
endothelial cells branching points were highly extensive under angiogenic stimulated
conditions (1ng/ml VEGFA & FGF2). (B) 0.01µg/ml LPS. (C) 0.1µg/ml LPS. (D) 1µg/ml
LPS. (E) 10µg/ml LPS. EC networks were lower at all the different LPS doses.
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Figure 5.9: Quantification of the effect of LPS on endothelial cell (EC) network
formation from early CL after 9 days in culture under angiogenic stimulus (VEGFA and
FGF-2). (A) Total EC area. LPS reduced the branched EC area in a dose-dependent
manner (P<0.001); (B) area of clustered EC; (C) branch points; and (D) branch point
per EC cluster. There was significant effect of LPS on branch points and branch points
per cluster in different doses of LPS under angiogenic stimulus (VEGFA and FGF2)
(P<0.001). Significances between treatment groups are indicated by different letters
a<b<c. Values are mean (n=5 cultures) ± SEM expressed as % control (no LPS) with
all treatments within each culture performed in duplicate.
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5.2.2.3 The effect of LPS on luteal angiogenesis in
vitro [mid CL]
There were visibly fewer endothelial cell networks in mid CL developed under
basal condition (without VEGFA/FGF2, Fig. 5.10) compared to those under
angiogenic stimulus (Fig. 5.11). As for the early stage CL, these EC networks
were composed of numerous endothelial cells that formed complex inter-
connecting structures.
Figure 5.10: Effect of LPS on development of endothelial cell networks in vitro on day
9 under basal conditions [mid stage CL]. (A) In non-LPS treated wells, endothelial cells
formed interconnecting networks but these were limited. (B) 0.01µg/ml, (C)
0.1µg/ml, (D) 1µg/ml, (E) 10µg/ml LPS-treated wells. EC were stained with VWF, and
the EC network formation appeared less with different doses of LPS. Black arrows
indicate EC branch points.
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Figure 5.11: Effect of LPS on development of endothelial cell networks on day 9 of
luteal culture under angiogenic stimulated conditions [mid-stage CL]. (A) In the
absence of E.coli LPS, endothelial cells formed highly organised networks. LPS
treatments at (B) 0.01µg/ml LPS; (C) 0.1µg/ml LPS; (D) 1µg/ml LPS and (E) 10µg/ml
LPS are shown. Area of EC networks were observed in the LPS treated wells but
appeared to be lower, particularly at 10µg/ml LPS. Dashed yellow line indicates EC
cluster, black arrow indicate EC sprouts and white arrows indicate branch points.
In control wells, EC formed highly organised tubule-like networks, which were
dramatically increased under angiogenic-stimulated conditions. In addition,
LPS significantly decreased EC network formation, under both basal and
angiogenic-stimulated conditions. A reduced number of EC clusters with a
smaller number of branches was observed in LPS-treated wells and at the
highest dose (10μg/ml LPS) virtually no EC networks (14% of control) were 
detected (Fig 5.12). LPS significantly decreased the area of EC network, the
number of EC clusters and branch points as well as the degree of branch
points/cluster (Fig. 5.13A-D, P<0.001).
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Figure 5.12: Effect of LPS on endothelial cell (EC) network formation from mid stage
CL under angiogenic stimulated conditions. (A) in the absence of E.coli LPS, EC
branching points and branching within each cluster was extensive LPS at all doses
appeared to reduce the number of EC clusters and the number of branches per cluster:
(B) 0.01µg/ml, (C) 0.1µg/ml, (D) 1µg/ml, (E) 10µg/ml LPS.
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Figure 5.13: Effect of LPS on: (A) total EC area (B) number of EC clusters, (C) total
branch points and (D) branch points per culture. Bovine luteal cells (from mid CL) were
cultured for 9 days under angiogenic stimulus (mid-stage CL). There was significant
dose dependent effect of LPS on all four parameters (P<0.001). Significances between
treatment groups are indicated by different letters a<b<c. Values are mean (n=5
cultures) ± SEM expressed as % control (no LPS). All treatments within a culture were
performed in duplicate.
5.2.2.4 Effect of LPS on luteal progesterone
production in vitro [early CL]
LPS had no effect on progesterone production on day 5 (Fig. 5.14A, P>0.05)
or day 9 of culture (Fig. 5.14B, P>0.05). Furthermore, these results showed
that progesterone was not affected by LPS under basal on day 5 of culture
(Fig. 5.15A, P>0.05) or angiogenic conditions on day 9 of culture (Fig.5.15B,
P>0.05).
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Figure 5.15 Progesterone production by luteal cells cultured from early CL under
angiogenic stimulus (VEGFA/FGF-2). (A) Effect of LPS on P4 production in day 5 of
culture. There was no difference in progesterone production between treatment
(P>0.05). (B) Effect of LPS on P4 production in day 9 of culture. There was no
difference in progestogen production between treatment (P>0.05). The values are
mean (n=3 cultures) ± SEM.
5.3 Experiment 2: Effect of LPS on
luteal EC apoptosis, EC proliferation,
progesterone production and
expression of steroidogenic enzymes
in vitro
5.3.1 Materials and methods
The coating of the coverslips, collection of samples, culture media and
identification of luteal endothelial cells were described in Section 5.2.1.1. In
this experiment, only luteal cells dispersed from early (day 1-4) CL were
used.
Figure 5.14: Progesterone production by luteal cells cultured from under basal
conditions [early CL]. (A) Effect of LPS on P4 production on day 5 of culture. There was
no difference in progesterone production between treatments (P>0.05). (B) Effect of
LPS on P4 production on day 9 of culture. There was no difference in progesterone
production between treatments (P>0.05). The values are mean (n=5 cultures) ± SEM
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5.3.1.1. Experimental design
Cells were plated and treated with LPS (0, 0.01 and 1 µg/ml) as described in
Fig.5.16. The cells from one plate (A) were subjected to VWF
immunohistochemistry; activated caspase-3 (apoptotic marker)
immunohistochemistry; Ki67 (proliferation marker) and isolectin (endothelial
cell marker) immunofluorescence and dual immunofluorescence for activated
caspase-3 with isolectin (Fig. 5.16A). On day 5 of culture, cells were fixed
with acetone: methanol for 10 min (Section 5.2.1.1). Then, cells from the
other plate (B) collected for protein preparation and Western blot (Fig 5.16B).
Additionally, media was collected on days 3 and 5 for progesterone
measurement.
Figure 5.16: The plate layout for Experiment 2. Luteal cell collected from early CL
were cultured (A) Cells treated with 0, 0.01 and 1µg/ml LPS under angiogenic
stimulation (VEGFA and FGF2) and then fixed on day 5 for immunohistochemistry of
VWF [column 1], activated caspase 3 [column 2], dual `immunofluorescence for Ki67
and isolectin [column 3]; dual immunofluorescence of caspase-3 and isolectin [column
4]. (B) Cells treated with 0, 0.01 or 1µg/ml LPS from day 1 to 5 of culture. Samples
were used for Western blot.
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5.3.1.2 VWF Immunohistochemistry
On day 5 of culture, coverslips were prepared for immunolocalisation for VWF
as described in Section 5.2.1.2.
5.3.1.3 Immunohistochemical analysis of
caspase-3 in luteal endothelial cells
Caspase-3 is a widely used apoptosis marker (Jeruc et al. 2006, Bressenot et
al. 2009). On day 5 of culture, coverslips were fixed with acetone:methanol
and blocked with hydrogen peroxide (Section 5.2.1.2). The non-specific
binding was blocked using 4% (v/v) NGS diluted with PBS and incubated for
30 minutes at RT. The primary antibody was polyclonal rabbit antihuman
cleaved caspase-3 IgG, (diluted 1:300; Cell Signaling, Danvew, USA). An
equivalent concentration of rabbit IgG was used for negative control well. The
cells were incubated with the primary antibody in a humidifed chamber at 4°C
overnight. For the detection of the primary antibody, Vector ABC Complex
Elite (Vector Labs, Peterborough, UK) kit was used. This used a biotinylated
goat anti-rabbit IgG (diluted 1:250 in 2% (v/v) NGS) and incubated for 30
min at RT. This step was followed by washes in PBS (2 x 5 minutes). The ABC
complex was added as per manufacturer’s instructions for 30 min at RT
followed by PBS washes. Visualisation of this complex was performed using
diaminobenzidine (DAB) for 4 min at RT. The coverslips were counterstained
with haematoxylin for 20 secs, then dehydrated in ethanol and xylene before
being mounted on a microscope slide using DPX mountant. Images of the
whole coverslip were taken under brightfield with a Leica DM 4000B under
40x objective lens.
5.3.1.4 Dual immunofluorescence staining of Ki67
with isolectin
To determine the proliferation index of endothelial cells, a dual
immunostaining was performed with Ki67 (proliferation maker) and isolectin-
B4 (marker for endothelial cells). The coverslips were fixed and blocked
(Section 5.2.1.2). The primary antibody was mouse anti-human Ki67 (Clone
MM1, Vector KP452, diluted 1:80 in 1xPBS) and biotinylated Griffonia
(Bandeiraea) simplicifolia isolectin B4 (20µg/ml, diluted 1:25 in PBS, Vector,
cat no B1205). The primary antibody and isolectin were incubated in a
humidifed chamber at 4°C overnight. On the next day, the cells were washed
with PBS (2 x 5 minutes each). Next, Texas-Red labelled anti-mouse IgG
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(20µg/ml) and Avidin-labelled with Flourescence DCS (20 µg/ml) were applied
to the wells and incubated for 1h at RT. The coverslips were washed with PBS
(2 x 5 minutes each). The coverslips were mounted by adding 3 drops of
Vectashield with DAPI, then sealed with nail varnish and stored 2-3h at -20C.
Five pictures under the 40X objective lens were taken using a Leica DM 5000
B florescence microscope, equiped with a Leica DFC 350fx camera (Leica
Microsystem (UK), Ltd, Milton Keynes, UK) for each coverslip.
5.3.1.5 Dual immunoflurescence staining of
caspase-3 with isolectin
To determine the number of endothelial cells that were apoptotic, caspase-3
was co-localised with isolectin B4. The coverslips were fixed with acetone:
methanol for 5 min at 4°C, then followed by two washes with PBS for 5
minutes each. The non-specific binding was blocked using 4% (v/v) normal
goat serum (NGS) and incubated for 30 min at RT. The primary antibody was
rabbit anti-human caspase-3 (diluted 1:300) and biotinylated Griffonia
(Bandeiraea) simplicifolia isolectin B4 (20µg/ml, Vector, diluted 1:25 in
1xPBS). These were incubated in a humidifed chamber at 4°C overnight. On
the next day, cells were washed with PBS (2 x 5 minutes each). Then, Texas-
Red avidin IgG (25µg/ml; Vector) and FITC-labelled anti-rabbit IgG conjugate
(20µg/ml; Vector) mixed together were applied to the cells and incubated for
1 hour at RT. The coverslips were mounted by adding 3 drops of Vectashield
with DAPI, then sealed with nail varnish and stored 2-3h at -20C. Five
pictures under the 40X objective lens were taken using a Leica DM 5000 B
florescence microscope, equiped with a Leica DFC 350fx camera (Leica
Microsystem (UK), Ltd, Milton Keynes, UK) for each coverslip.
5.3.1.6. Protein extraction from cell culture
On day 5, culture media was collected and 500µl of 1xPBS was added to each
well. Cells were scraped off using the end of the pipette, and then pipetted up
and down to help dispersion. Samples were centrifuged at 13000g for 5
minutes, and supernatant was removed. Then 50 µl of lysis buffer was added
and samples stored at -70C until analysis. Lysis buffer composed of [0.1 M
Tris pH7.4, 0.1% (w/v) dithiothreitol (DTT), 0.1% (w/v) sodium dodecyl
sulphate (SDS), 0.18 mg/ml sodium orthovanadate plus protease inhibitors
(25 x (v/v), Complex protease inhibitor cocktail; Roche Diagnostic Ltd, East
Sussex, UK). Samples were taken out and thawed on ice, then centrifuged at
13000g for 2 minutes and supernatant collected and added a further 100µl of
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cell lysis buffer (0.18mg/ml sodium orthrovandate, 0.01% SDS) and stored
on ice. Samples were rapidly frozen in methanol in dry ice for 2 minutes and
then rapidly thawed for 1 minute using a hot block at 50C. This step was
repeated 5 times. Samples were sonicated in water bath for (4× 20 seconds
in ice) then with 1 minute on ice in between sonications. This was followed by
centrifugation at 13000g for 5 min. The supernatants were collected and 30µl
from each sample was used for protein measurement, and the remaining
aliquots 70µl were stored at -70C until Western blot was performed.
5.3.1.7 Protein determination and Western
blotting
Protein concentrations were determined using a Bradford assay (Section
4.2.3.3) and then Western blot was performed using 10µg protein for HSD3B,
STAR, ACTA2 and 20µg protein CYP11A (Sections 4.2.3.3-8). Protein was only
used from cells under angiogenic stimulation (VEGFA/FGF2) because
insufficient protein was collected from cells cultured under basal conditions.
5.3.1.8 Progesterone analysis
Progesterone ELISA (Ridgeway Science) was performed according to
manufacturer’s instructions (Section 5.2.1.4). Samples collected on day 3
were diluted 250 fold; whereas, samples collected on day 5 of culture were
diluted 500 fold. The lower limit of sensitivity was 0.2ng/ml and the intra and
inter assay coefficient of variation were 6.3% and 12.1%, respectively.
5.3.1.9 Image analysis for caspase-3 and Ki67
All image analysis was performed using Image Pro-Plus 6.0 (Media
Cybernetics, Wokingham, UK). A total of 5 images were captured for each
coverslip under 20x objective lens and the EC area highlighted. Cells with
nucleus immunostaining were visually counted using Image Pro-Plus 6.0
software. Brown stained nucleus with caspase-3 IHC were visually assessed;
green stained with capase-3 and red stained nucleus with Ki67 with
immunofluorescence were visually assessed. The total number of counted
cells was recorded automatically. The proliferation and apoptotic index were
calculated as follows:
 Proliferative rate =100 x (Number of nuclei stained positive with
Ki67/Total number of nuclei present).
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 Apoptotic rate= 100 x (Number of nuclei stained positive with caspase-
3 /Total number of nuclei present).
5.3.1.10 Statistical analysis
Data were checked for normality and homogeneity of variance by using
residual plots and Bartlett's test, respectively. Data were log transformed
where appropriate. The association between LPS treatment and percentage of
area of von Willebrand factor, area of clustered EC, branch points and branch
points per cluster were analysed by randomised block one-way ANOVA. If
there was a significant effect of LPS, the multiple comparisons (Tukey) were
used to determine where the differences lay. Furthermore, the effect of day
on progesterone production was analysed by randomised block ANOVA. For all
experiments P<0.05 was considered as significant and all data are presented
as mean±SEM.
5.3.2 Experiment 2, Results
5.3.2.1 Immunolocalisation of endothelial cells
In this experiment, luteal cells were cultured under angiogenic stimulation for
5 days. The patterns of endothelial cells networks was different on day 5 of
culture to that observed for day 9 in the Experiment 1. In the control wells,
some of EC islands had begun to branch away from the island (Fig 5.17A,
5.18A). However, the majority of the endothelial cells remained in large
clusters. Additionally, the number and size of these EC islands were visibly
reduced in those wells treated with LPS at both doses (Fig. 5.17, 5.18).
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Figure 5.17: Effect of LPS on development of luteal endothelial cell networks on
culture day 5 under angiogenic stimulation. (A) In the absence of E.coli LPS,
endothelial cells formed large islands of ‘poorly developed’ endothelial cells. These had
partly begun to sprout from the EC island and form network-like structures. Cells
treated with (B) 0.01µg/ml LPS or (C) 1µg/ml LPS had reduced number and size of EC
islands and networks were noted. Black arrow indicates branching in the EC islands.
Figure 5.18: Effect of LPS on number of endothelial cell networks and their degree
of branching on day 5. (A) In the control wells, moderate level of EC networks with
branching was observed. This appeared to be reduced when cells were treated with
(B) 0.01µg/ml LPS and particularly (C) 1µg/ml LPS.
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Furthermore, quantification showed that even in the presence of FGF2/VEGFA,
the total area of these EC islands was significantly reduced by LPS treatment
at both doses (Fig.5.19A, P<0.001). The total area of clustered EC (Fig.
5.19B; P<0.01) and the total branched points/cluster were significantly
reduced by LPS treatment at both doses. However, total number of branch
points was only significant different at 1µg/ml (Fig.5.19 C; P<0.05).
Figure 5.19: Effect of LPS on: (A) total area of VWF staining; (B) total area of
clustered EC networks; (C) total number of branch points and (D) total number of
branch points per cluster in luteal EC after 5 days in culture. There was a significant
effect of LPS on each parameter (P<0.01). Significances between treatment groups are
indicated by different letters a<b<c Values are mean (n=3 cultures) ± SEM.
5.3.2.2 Effect of LPS on endothelial cell
proliferation
Ki67 was present in the cell nucleus across the well of all treatments (Fig
5.20). Islands of endothelial cells were also identified with isolectin staining
and had a similar appearance to that observed with VWF. These were
particularly evident in the control wells. In the control well, endothelial cells
were positive for Ki67 (proliferation index = 30%) throughout the islands
(Fig.5.20). Non-endothelial cells were also positive for Ki67. In the LPS-
treated cells, the EC islands were smaller but a few endothelial cells were
Ki67-positive (Fig.5.20B&C). The quantification of EC Ki67-positive cells
showed that LPS had significantly decreased proliferation index of endothelial
cells by 2-fold (Fig. 5.20D, P<0.01).
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Figure 5.20: Effect of LPS on luteal endothelial cell proliferation on culture day 5; (A-
C) Immunofluorescence showed that expression of Ki67 (red nucleus) in endothelial
cells (isolectin staining; green) was higher in control well compared to wells treated
with LPS. The white circles indicate Ki67 positive cells within the EC islands; the cells
were counterstained with DAPI (blue); (D) The quantification of proliferation index
within EC island showed that it was significantly inhibited (a<b; P<0.05) by treatment
with LPS. Values are mean (n=3 cultures) ± SEM.
5.3.2.3 Effect of LPS on apoptosis of endothelial
cells
Immunostaining for activated caspase-3 was observed in the cell nucleus. In
the control wells, few endothelial cells and non-endothelial cells were positive
for caspase-3 (Fig 5.21A). The caspase 3 staining was more evident in the
cells treated with 0.01µg/ml or 1µg/ml LPS (Fig.5.21B&C). The quantification
showed that LPS significantly increased the apoptotic index in luteal
endothelial cells in a dose depended manner (Fig. 5.21D; P<0.001).
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Figure 5.21: Effect of LPS on apoptosis in luteal endothelial cells on culture day 5. (A-
C) Immunohistochemistry showed expression of caspase-3 (brown staining) in
presumptive endothelial cell islands (indicated by dashed yellow line). The white circles
highlight caspase 3 positive cells in these EC islands. The smaller EC islands in the
LPS-treated wells had visibly higher expression of caspase 3 staining. (D) The
quantification of caspase 3 staining showed that it was significantly inhibited (a<b<c;
P<0.05) in cells treated with LPS. Values are mean (n=3 cultures) ± SEM.
These observations were confirmed with immunofluorescent dual staining of
endothelial cells (with isolectin) and apoptosis (activated caspase-3). Again
the number of endothelial cells that were caspase-3 positive was lower in
control cells compared to those exposed to LPS (Fig. 5.22A-C). Quantification
revealed that LPS had increased luteal endothelial cell apoptosis by 2-fold,
(Fig. 5.22D, P <0.01).
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Figure 5.22: Effect of LPS on luteal endothelial cell apoptosis on culture day 5; (A-C)
Immunofluorescence showed expression of caspase-3 (green) in endothelial cells
(isolectin; red). These cells are highlighted with white circles. This was more evident in
cells treated with LPS. The cells were counterstained with DAPI (blue); (D) The
expression of caspase-3 was significantly increased (a<b<c; P<0.05) in cells treated
with LPS. Values are mean (n=3 cultures) ± SEM.
5.3.2.4 Effect of LPS on progesterone production
Progesterone production was affected by culture day with P4 concentration
being higher on day 5 versus day 3 of culture (Fig. 5.23, P<0.05). LPS had no
effect on P4 production on days 3 and 5 of culture (Fig. 5.24, P>0.05).
Figure 5.23: The effect of culture day on P4 production. There was a significant
difference in progesterone production between days of culture (*; P<0.05). The values
are mean (n=3 cultures) ± SEM.
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5.3.2.5 Western blot quantification of
progesterone production proteins
Western blot showed that there were two bands present for STAR (Fig 5.25).
A dominant band was detected at 25kD and lower abundance band at 32 kD.
Single bands at the expected molecular weight were detected for HSD3B
(42kD; Fig 5.26) and CYP11A (61KD; Fig 5.27). Quantification demonstrated
the expression of all three proteins was unaffected by LPS treatment (P>0.05;
Fig.5.25-5.28).
Western blot for ACTA2 showed a single band at the expected molecular
weight of 42kD. Quantification showed that expression of ACTA2 protein was
significantly reduced in cells treated with 0.01µg/ml LPS by about 2-fold and
4-fold for those treated with 1µg/ml LPS compared to control cells (P<0.01;
Fig.5.28).
Figure 5.24: Effect of LPS on P4 production by bovine luteal cells on day (A) 3 and
(B) 5 of culture. There was no treatment effect of LPS on progesterone production on
either day 3 (P>0.05) or day 5 (P>0.05) of culture. The values are mean (n=3
cultures) ± SEM.
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Figure 5.25: The expression of steroidogenic acute regulatory (STAR) protein in the
bovine luteal cells in vitro. (A) Western blot of STAR revealed two bands at (A) 25kD
and (B) 32kD. There was a single band for histone H3 at 15 KD. The housekeeping
protein, histone 3 (H3) was stable across groups. The expression of STAR (normalised
to histone H3) band at (C) 25kD and (D) 32 kD was not different between control and
LPS treated well (P>0.05). The values are mean (n=5 cultures) ± SEM.
Figure 5.26: The expression of 3β-hydroxysteroid dehydrogenase (HSD3B) 
protein in the bovine luteal cells in vitro. (A) Western blot analysis of HSD3B
protein showed a single band for HSD3B at 42kD (B) The expression of HSD3B
(normalised to histone H3) was not different between control and LPS treated
wells, (P>0.05). The values are mean (n=4 cultures) ± SEM.
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Figure 5.27: The protein expression of cholesterol side-chain cleavage enzyme
(CYP11A) in the bovine luteal cells in vitro. (A) Western blot analysis of CYP11A
protein expression showed a single band for CYP11A at 61kD (B) The expression of
CYP11A (normalised to histone H3) was not different between control and treatments
wells (P=0.12). The values are mean (n=3 cultures) ± SEM.
Figure 5.28: The effect of LPS on expression of α-smooth muscle actin protein 
(ACTA2) in the bovine luteal cell culture after 5 days in vitro under angiogenic-
stimulated conditions. (A) Western blot analysis showed a single band for ACTA2 at
42kD. (B) The expression of ACTA2 (normalised to histone H3) was reduced by LPS at
both doses (P<0.01). Significances between treatment groups are indicated by
different letters a<b. Values are mean (n=5 cultures) ± SEM.
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5.4 Discussion
This chapter aimed to determine the effect of E.coli lipopolysaccharide (LPS):
a) on luteal endothelial cell (EC) network formation, progesterone production
and expression of steroidogenic proteins (STAR, 3BHSD, CYP11A); b) on
luteal endothelial cells proliferation and apoptosis and on expression of ACTA2
(smooth muscle actin). To the best of our knowledge, this is the first study on
the direct effect of LPS on the ability of luteal endothelial cells to form
networks, proliferate and undergo apoptosis in vitro. LPS dose-dependently
suppressed luteal endothelial network formation, by suppressing proliferation
and increasing apoptosis.
The present study reported that LPS adversely effected luteal EC network
formation in vitro even at low dosage of LPS (0.01µg/ml). Conversely, LPS
has been shown to stimulate endothelial cells to promote angiogenesis in
other systems. It has been demonstrated that LPS increased angiogenesis in
different tissues (e.g. human pulmonary microvascular endothelial cells
(Menden et al. 2015); human dermal microvascular endothelial cells in vitro
(Pollet et al. 2003) and outgrowth endothelial cells (Ma et al. 2015). The
mechanism by the LPS increased angiogenesis in these studies might be
associated with the use of different endothelial cell phenotypes compared to
the present study.
The present study demonstrated that LPS exerted an effect on luteal
endothelial cells in the presence of pro-angiogenic factors. This inhibition
could be due to LPS adversely affecting (1) endothelial cell survival (2)
interfering with the stimulatory effects of VEGFA or FGF2. These factors are
potent stimulators of both endothelial cell proliferation and migration (Ferrara
et al. 2003, Carmeliet 2003). Indeed, in this exact model system, the
development of endothelial cell networks was dependent on FGF2 and VEGFA
(Robinson et al. 2008, Woad et al. 2009). 3) LPS could induce the production
of factors (e.g. member of the TGFB superfamily) that could inhibit EC
function and proliferation. TGFB plays a key role in the process of the
angiogenesis (Lebrin et al. 2005, ten Dijke and Arthur 2007, Goumans et al.
2009). TGFB1 promotes endothelial cell apoptosis in bovine aortic endothelial
cells (Pollman et al. 1999) and human umbilical vein endothelial cells (Ferrari
et al. 2009). Furthermore, TGFB1 reduced luteal endothelial cell growth and
network formation (Maroni and Davis 2011). There is very limited evidence to
support LPS increasing expression of TGFB in luteal tissue. Previous studies
reported that LPS stimulated the expression of TGFB1 by human and rat bile
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duct epithelial cells in vitro (Kassel et al. 2012), they reported a potential
mechanism through which LPS could enhance TGFB1-promoted PDGFB
expression by increasing activation of SMAD transcription factors.
Furthermore, Seki et al. (2007) demonstrated that TLR4 stimulated by LPS
induced expression of TGFB1 in vitro culture of mice hepatic cells.
LPS reduced luteal EC proliferation during the earlier stages of EC network
formation (decreased number of Ki67-positive cells) as well as increasing EC
apoptosis (caspase3 positive cells). This occurred across the range of
concentrations even at the lower concentration of 0.01µg/ml. This is not
dissimilar to the concentration (0.04-0.8 µg/ml) of LPS measured in follicular
fluid (Herath et al. 2007) but was greater than LPS concentrations of <10
ng/ml measured in plasma of cows with uterine infection postpartum (Mateus
et al. 2003). It has been shown that LPS contributed to vascular damage in
various types of endothelium (Frey and Finlay 1998, Fujita et al. 1998, Choi et
al. 1998). However, other types of cells (e.g. steroidogenic (large and small
luteal cells), LPS did not have a toxic effect.
It has been shown that LPS contributes to the damage observed in various
types of endothelium in mice (Fujita et al. 1998), humans (Hotchkiss et al.
1999, Wort and Evans 1999, Koide et al. 1996, Frey and Finlay 1998), and in
the bovine (Frey and Finlay 1998). LPS induced EC apoptosis in vitro and in
vivo, in the development of diseases including septic shock and its syndromes
(Hotchkiss et al. 1999, Wort and Evans 1999, Koide et al. 1996). Frey and
Finlay (1998) stated that LPS at 10µg/ml induced apoptosis in bovine
pulmonary artery the endothelial cells through fragmentation of DNA. The
same study has shown that VEGFA protects the endothelium against LPS-
induced apoptosis. However, the present study demonstrated that LPS
induces luteal endothelial cells apoptosis through increased expression of
caspase-3 in a dose dependent manner, even in presence of VEGFA.
It is feasible that LPS stimulated apoptosis by inducing oxidative stress and,
inhibiting cellular antioxidant systems. Indeed LPS caused apoptosis through
the mitochondrial apoptotic pathway in buffalo luteal cells (Mishra and Dhali
2007). Similarly, in vivo infusion of LPS increased caspase-3 mRNA and
protein expression in the CL within 12 hours of administration (Herzog et al.
2013). However, they also found that LPS only caused a temporary
suppression of CL function and morphology, without complete luteolysis.
It has been demonstrated that VEGFA can inhibit LPS-induced endothelial cell
apoptosis in human umbilical vein endothelial cells (HUVEC) (Munshi et al.
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2002). It is not surprising since VEGFA acts as a survival factor for
endothelium. This is in contrast to the present study, where LPS increased
apoptosis when cells were treated with exogenous VEGFA and FGF2. This
study demonstrated that in bovine luteal endothelial cells that VEGFA/FGF2
co-treatment did not protect endothelium against LPS-induced apoptosis.
LPS had a large effect on the expression of α-smooth muscle actin (ACTA2), 
which is present in vascular mural cells including pericytes. This is in
agreement with Sandbo et al. (2007) who observed that expression of ACTA2
in aortic smooth muscle cells was inhibited after 24 hours treatment with
higher doses of LPS (10µg/ml) in vitro. Furthermore, LPS (10µg/ml) caused
pericyte loss and microvascular dysfunction by disrupting angiopoietin
expression in lung microvascular endothelial cells co-cultured with human
coronary artery smooth muscle cells (Zeng et al. 2016). The primary role of
perivascular cells is to regulate endothelial cell function and angiogenesis
during tissue growth and development (Folkman and D'Amore 1996, Hirschi
and D'Amore 1996). Furthermore, vascular smooth muscle cells and pericytes
produce VEGFA which is increased under hypoxic conditions (Shifren et al.
1994, Nomura et al. 1995, Stavri et al. 1995). Thus pericytes, like endothelial
cells, could sense and react to low tissue oxygen and initiate angiogenesis.
Reproductive tract infections in dairy cows lead to endocrine dysfunction and
ultimately infertility (Herath et al. 2007, Williams et al. 2008a, Dohmen et al.
2000). Gram negative E.coli is regarded as the most prevalent pathogenic
bacteria isolated from the uterus during the post-partum period (Herath et al.
2007, Sheldon et al. 2010). Furthermore, uterine diseases negatively affect
the production of androstenedione by bovine theca cells (Herath et al. 2007,
Shimizu et al. 2012, Magata et al. 2014). In vivo, LPS inhibited progesterone
and androstenedione production by suppressing mRNA expression of StAR
and CYP17 from bovine theca cell (Magata et al. 2014). However, in this
study in two separate experiments E.coli LPS had no effect on progesterone
production by bovine luteal cells in vitro even at high doses (10µg/ml). This
was supported by the Western blot, which showed that LPS did not affect the
expression of STAR, HSD3B or CYP11A. Similarly, it was reported that LPS
had no effect on P4 production by bovine granulosa cells, with STAR and
HSD3B expression not being affected by LPS, even at high concentration of
LPS (10µg/ml) (Shimizu et al. 2015). Similar observations were made in rat
granulosa cells (Taylor and Terranova 1996). In contrast, Grant et al. (2007)
reported that LPS increased progesterone production from bovine luteal cells
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in culture in response to LPS during the first 48h, however, progesterone
production was not increased after 48h, even at 3µg/ml.
It is interesting to note that, this study demonstrated that luteal cells were
not affected by LPS across the range of concentrations tested, even though
the higher concentrations (10µg/ml), were much greater than the LPS
concentrations <10 ng/ml (Mateus et al. 2003) and <1µg/ml in follicular fluid
(Herath et al. 2007) measured in postpartum cows with uterine disease.
Unlike endothelial cells, steroidogenic cells still proliferated, even at the high
concentrations of LPS (10µg/ml). This is in contrast to, Grant et al. (2007)
who demonstrated that 1 μg/ml of LPS induced cell death after 48h,  which is 
lower than present study in which 10 μg/ml used at high concentration but did 
not affect luteal cells.
The present study found that progesterone was increased by addition of
VEGFA/FGF-2. This is in agreement with previous reports (Kobayashi et al.
2001, Miyamoto et al. 2009, Robinson et al. 2008) which reported that VEGFA
promotes progesterone production in vitro. Similar results have found by
Woad et al. (2009) using the same bovine luteal angiogenesis system, where
progesterone production was decreased when VEGFA signaling was inhibited.
Moreover,Yamashita et al. (2008) have shown that local immunoneutralisation
of VEGFA reduced luteal development and progesterone production. In
contrast, Laird (2010) reported that VEGFA had no additive effect on
progesterone production in a bovine follicular angiogenesis culture system.
The present study found that progesterone production was increased
throughout the culture period even in the presence of the high LPS dose. This
suggests that the steroidogenic cells underwent further luteinisation and/or
proliferation in the presence of LPS. Thus, the doses of LPS were not generally
cytotoxic and that the EC appear to be particularly sensitive to LPS challenge.
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5.5 Conclusion
We have shown repeatedly that LPS inhibited in vitro luteal angiogenesis from
CL from both the early and mid-luteal phase. LPS exerted its action by
significantly increasing apoptosis in luteal endothelial cells and suppressing
their proliferation. In addition, LPS significantly decreased ACTA2 expression,
which is likely to reflect decreased number of vascular mural cells or altered
phenotype. This might be a mechanism by which LPS elicited its inhibitory
effect on luteal endothelial cells. Surprisingly, LPS had no effect on
progesterone production and expression of progesterone production proteins.
Thus, it can be speculated that in vivo negative effects of LPS on progesterone
level is as a consequence of attenuated vasculature rather than direct effects
on luteal steroidogenic cells.
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6 General discussion
Declining fertility in dairy cows is a global problem that is related to the
genetic selection for high milk production recovery little selection for other
traits (Royal et al. 2000, Butler 2003, Pryce et al. 2004). The central theme of
this thesis to improve our understanding of the mechanisms behind
subfertility and in particular the way in which uterine infections affect fertility
in high yielding dairy herds. This was achieved by; firstly comparing
reproductive performance in cows that experienced uterine disease with
others that did not in a large scale multi-herd study. Secondly, determining
the association between uterine infection and post-partum ovarian cyclicity in
high yielding dairy cows at the Nottingham dairy centre. Thirdly, assessing the
impact of uterine infection on bovine CL vascularisation and steroidogenesis
ex vivo. Finally, determining the effect of E.coli lipopolysaccharide (LPS) on
bovine luteal endothelial cell network formation and steroidogenesis in vitro,
and the underlying mechanism by which LPS exerts its action.
The primary production goal in postpartum dairy cow management is to
establish a pregnancy in an efficient manner and at a profitable interval after
calving. However, while fertilization rates in cows may be as high as 90%,
conception rates much are lower (Pomar et al. 2005). The common reasons
for reproductive failure in high yielding dairy cows are poor detection of
oestrus (Van Eerdenburg et al. 2002) and early embryonic losses (Humblot
2001, Wathes et al. 1998, Mann and Lamming 1999). Opsomer et al. (2006)
stated that good oestrus detection, high semen quality, good insemination
technique and a healthy uterine environment are essential for high
reproductive performance in dairy cows. Uterine disease such as endometritis
can have dramatic effects on reproductive performance of high milk-yielding
cows due to persistent bacterial infection causing uterine inflammation and
damage to the endometrium thereby, prolonging uterine involution and
impairing fertility (Fourichon et al. 2000, Gilbert et al. 2005, Kasimanickam et
al. 2004).
Sizeable and significant associations between the occurrence of reproductive
tract inflammatory disease (RTID) and reproductive outcomes were
established at the level of a unit of time within lactation (Chapter 2 and 3).
Chapter 3 further demonstrated that RTID had negative effect on post-partum
reproductive performance in dairy cows particularly day to first service and
increased incidence of prolonged luteal phase.
CHAPTER SIX
177
The present study showed that reproductive tract inflammatory disease
(RTID) is present in 12% of dairy cows. This was extracted from a large-scale
multi-commercial dairy herds across England and Wales. Similarly, in dairy
herds in the UK, 15% annual incidences of vulval discharge/endometritis have
been reported (Esslemont and Peeler 1993, Esslemont and Kossaibati 1996).
It is worthy while noting that these studies were carried out in 90 herds and
involved >14,000 cows, (average 150 cows per herd), which is fewer than in
the present study. Various factors, such as efficiency and method of
examination of disease, size of herd, level of production, incidence of other
diseases, genetics, housing, and management could increase the prevalence
of reproductive disorders, which might have contributed to the observed
variations among the different studies.
Although many diagnostic methods are applied in the diagnosis of RTID within
3 weeks and onwards, all of them vary and are applicable for RTID in practice.
These depends on the sensitivity and specificity on the methods. For example,
trans-rectal palpation has been used extensively but is not considered an
accurate method because the assessment of uterine size and palpable content
might be varied between people. Vaginoscopy is a routine diagnostic method
used by a veterinarian, particularly when rectal palpation is the only other
diagnostic modality being used (LeBlanc et al. 2002). However, vaginoscopy
is not as effective as endometrial cytobrush cytology for both clinical and
subclinical endometritis (Barlund et al. 2008, Kasimanickam et al. 2004).
However, vaginoscopy did support for diagnosis >4 week post-partum period
(Barlund et al. 2008). It would be beneficial to use all methods (ultrasound,
endometrial cytological and uterine biopsy), but this is time consuming and
uterine biopsy is invasive and expensive (Sheldon 2004, Bonnett et al. 1993).
Current state of dairy cow fertility across England and Wales
The current state of dairy cow fertility in England and Wales was assessed.
The present study found that the observed overall mean estimates of three
intervals namely days to first service, calving to conception interval and
calving interval fall within the ranges reported previously (Mayne et al. 2003).
Although the present mean intervals were within the range of previous
studies, they are considered unfavourable and extended compared with the
optimum CCI (80–85 days) recommended achieving the commonly accepted
360-365 days calving interval (Ball and Peters 2004, Arbel et al. 2001). The
results of this thesis (Chapter 2) with previous similar reports from UK
CHAPTER SIX
178
suggest that the efficiency of reproduction in dairy herds is still unsatisfactory
and hence deserves attention.
Effect of RTID on reproductive performance
The results of Chapter 2 and 3 have shown that the three intervals (DFS, CCI
and CI) were significantly longer in those cows that experienced RTID than in
those that did not. Cows with RTID had 5 days longer DFS. Causes of
extended DFS in cows with RTID might be due to: 1) ovarian pathologies such
as prolonged anovulatory anoestrus (Sheldon et al. 2009b), ovarian cysts
(Tsousis et al. 2009, Vacek et al. 2007) or persistent CL (Sheldon et al.
2009b). 2) cows failed to respond to the fertility treatments; 3) cows have
lower peripheral plasma oestradiol concentration due to slower growth of the
first postpartum dominant follicles which has been associated with lower
peripheral plasma progesterone concentration after ovulation (Sheldon et al.
2002b, Williams et al. 2007); 4) bacterial LPS and/or various mediator
cytokines (e.g. TNFA and IL-1) entering the circulation and blocking the
secretion of GnRH from the hypothalamus (Rivest et al. 1995, Battaglia et al.
2000, Williams et al. 2007). Importantly management factors such voluntary
waiting period, silent heat, and poor oestrus detection, herd size, and farmer’s
decision, could further contribute to such extended intervals.
Similarly, the results of survival analysis (Chapter 2) indicated that cows with
RTID had a reduced chance of becoming pregnant in the 85-day period after
calving compared to their respective control counterparts. The presence of
RTID can not only influence the resumption of normal ovarian cyclicity, but
also could have influence on sperm transport, sperm death and finally reduce
conception rate (Rahman et al. 1996). In another way, the presence of pus in
the uterus alters immune responses which are crucial at the interface between
the endometrium and the embryo and finally leads to repeat breeding.
Another reason for extend CCI in cows with RTID might be due to poor CL
formation after the first ovulation during the post-partum period resulting in
inadequate P4 production to establish pregnancy.
Cows with RTID had an increased number of services per conception and had
lower conception rate at first service compared to cows without RTID. This
reduction in the reproductive efficiency of cows could be associated with
uterine tissue damage, delayed uterine involution (Shrestha et al. 2004b,
Sheldon et al. 2003), disruption of endometrial function, reduction of steroid
concentrations of ovarian follicles (Green et al. 2011), and disruption of
ovarian cycles (Opsomer et al. 2000, Herath et al. 2009). Furthermore, this
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study has shown that cows with RTID (Chapter 2) had a 22 day longer CI
compared to cows without RTID. This might be because that cows with RTID
had a longer CCI and took longer to get pregnant since CCI is regarded as a
major component of CI. It should not be neglected that others factors could
contribute to extended CI include management expertise, environmental
constraints, herd size, and labour availability.
At the herd level, RTID was associated with subfertility in dairy cows, and this
was characterised by longer DFS, CCI or conception for cows experienced with
RTID, and more cows exited for failure to conceive in a timely manner. These
effects on fertility and the costs of treatment mean that RTID is one of the
most expensive conditions challenging the dairy industry (Sheldon et al.
2008). Thus, substantial effort is required to further understand the risk
factors for RTID. Fertility can account for one of the major costs of
production. Inadequate dairy herd fertility is known to have many
consequences, both direct and indirect (DairyCo 2014b). The loss of mature
dairy cows due to early culling has a significant adverse financial impact
(DairyCo 2014b). Currently, the costs of replacement is around £14,400 per
annum per 160 cows herd, this equates to £90 per cow (DairyCo 2014a). It
has been reported that the direct cost associated with treatment for RTID was
approximately £72 per cow (Arnott et al. 2015). This, however, does not
include the indirect costs associated with poor subsequent reproductive
performance.
Diagnosis and treatment of RTID are crucial components of fertility programs.
It is assumed that cows with reported RTID in this study were treated,
however, the type of treatments and doses were unknown. In addition, the
efficiency of any treatment used was unknown, but still adverse effects of
RTID were observed. Indeed, type of treatments, dose of treatment and time
of administration, can influence the efficiency of control systems (Dolezel et
al. 2008).
In the 170 cows, whose milk was analysed for progesterone (Chapter 3), the
mean onset of luteal activity (OLA) after calving was 28 days. Moreover, 16%
exhibited a delay to 1st ovulation (>45 days); 19% had short ovarian cycles;
18% cessation of cyclicity and 47% had prolonged luteal phase. The presence
of endometritis significantly impaired post-partum ovarian cyclicity in Holstein
dairy cows. Cows exhibiting endometritis had a higher incidence of atypical
ovarian cycles, particularly prolonged luteal phase (65.8%). The most
prevalent pathology was a persistent CL and is likely to indicate altered
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endometrial prostaglandin production. The endometrium expresses specific
receptor complexes for the detection of LPS, and LPS switches prostaglandin
secretion from PGF2α to PGE2 (Herath et al. 2009). This would lead to 
disrupted luteolysis (Herath et al. 2009, Sheldon and Dobson 2004). Cows
with normal ovarian cycle had shorter DFS and were 1.8 times more likely to
become pregnant at first service.
Reproductive tract inflammatory diseases (RTID) might have had an affect
either locally or systemically. Bacterial endotoxin such as LPS infused into the
uterus or peripheral circulation disrupted LH secretion from the pituitary
(Battaglia et al. 1999, Peters et al. 1989). The mechanism by which LPS
enters into the peripheral circulation from the uterus is poorly understood;
however, it has been suggested that following escape through the oviduct into
the peritoneal cavity, LPS might then enter the bloodstream by transmural
movement in the peritoneal cavity (Peters et al. 1989). On the other hand,
LPS can be absorbed from the uterine lumen into the peripheral circulation
(Peters et al. 1990, Mateus et al. 2003). Moreover, LPS may signal indirectly
from the uterus to the ovary via altered prostaglandin production (Herath et
al. 2006a).
Lipopolysaccharide accumulation in the follicular fluid has been demonstrated
and one candidate molecule that could contribute to this accumulation is LPS
binding protein (LBP). LBP is an acute protein produced by liver, which enters
into circulation where it detects and forms a high affinity complex with LPS
(Schumann et al. 1990). During the acute phase of inflammation, LBP has
been detected in serum and in such situation is increased by about 50 fold in
human (Zweigner et al. 2001). Therefore, it is probable that LBP is produced
in response to acute uterine inflammation and binds with LPS, then would
accumulate in the follicular fluid.
In Chapter 4, it was demonstrated that endometritis/metritis significantly
reduced CL size. This reduction might be due to a reduction in the degree of
vascularisation and estimated total luteal vasculature. Furthermore, there was
reduced expression of ɑ-smooth muscle-actin (ACTA2) reflecting
pericyte/smooth muscle cell coverage in the CL, which plays an important role
in the function of CL vasculature. The logical extension of this observation
would be markedly reduced luteal blood flow, and the ability to exchange
nutrients and supply steroidogenic cells with cholesterol/LDL for progesterone
production. Indeed, decreased blood flow after LPS treatment has been
observed in cows (Herzog et al. 2012).
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It is important to know the mechanism by which endometritis and/or LPS
affect on the uterine angiogenesis, however, according to our best knowledge
there are not studies have been reported in this situation. Uterine blood flow
was affected by uterine disease, this was demonstrated by an increased blood
flow volume and a decreased pulsatile index in the uterine arteries of cows
with uterine disease, 8 days post-partum, as assessed by Doppler sonography
(Heppelmann et al. 2013). The same study established that blood flow volume
in the contralateral artery of affected cows was greater than in healthy cows
during the entire examination period. This might also be a key to decreasing
blood flow to the follicle and CL vasculature in cows with RTID. LPS increased
mRNA expression encoding Caspase-3 in CL, which cause suppression of
luteal function and morphology (Herzog et al. 2012, Debertolis 2015). This
could contribute to reduction of P4 production in cows with endometritis.
Cows with endometritis/metritis had reduced luteal P4 content, as measured
from homogenised CL. This was confirmed by markedly reduced protein
expression of key proteins involved in progesterone synthesis (STAR, CYP11A
and HSD3B) in vivo. However, surprisingly neither progesterone production
nor expression of progesterone synthesis enzymes were affected by LPS
treatment of luteal cells even at high doses of LPS (10µg/ml) in vitro.
Surprisingly LPS had minimal effect on P4 production even at 10 µg/ml of LPS
on day 3, 5 and 9 of culture and protein expression of steroidogenic enzymes
on day 5. The explanation for this could be due to that 1) all cells were
supplemented with 5ng/ml LH, and fetal bovine serum; 2) P4 concentrations
increased in control wells and LPS treated wells, due to increased luteinisation
of steroidogenic cells proliferation and; 3) cells being provided with all the
required nutrients for progesterone production.
The mechanism through which LPS inhibits steroidogenic enzyme activity in
bovine luteal cells in vivo might be due to: 1) endometritis suppressing
hypothalamic release of GnRH, and hence pituitary secretion of luteinising
hormone (LH) (Peters et al. 1989, Battaglia et al. 2000). Any suppression of
GnRH-induced LH surge by LPS could play an important role in diminished
stimulation of angiogenesis during the follicular luteal transition (Robinson et
al. 2009). LH has been shown to stimulate luteal hyperaemia and increases
blood flow to the CL (Niswender et al. 1976), 2) suppression of CL vasculature
through which the CL is supplied with oxygen and nutrients as discussed
above; 3) increased endothelial cell apoptosis and decreased proliferation, as
confirmed in the in vitro study.
CHAPTER SIX
182
A focus of this thesis was to elucidate the mechanism by which endometritis
could affect the function of the CL. In this regard, the effect of the bacterial
endotoxin, LPS, on luteal angiogenesis and steroidogenesis in vitro was
investigated. Firstly, it was important to verify that the LPS receptors TLR4,
CD14 and MD-2 were present in the bovine CL. Indeed, all three mRNAs were
identified in the CL at all stages of oestrus cycle using multiplex PCR.
Additionally, the mRNA encoding the LPS receptors (TLR4, CD14 and MD2)
was present in the CL from cows with endometritis. Further investigation
using qPCR is required in order to precisely quantify their expression.
Additionally, the cellular localisation of these receptors would confirm whether
LPS could have a direct effect on luteal development via endothelial and/or
steroidogenic ells).
On both day 5 and 9 of culture, LPS significantly inhibited luteal endothelial
cell network formation, even at the lowest dosage of LPS (0.01µg/ml). To our
knowledge, this is the first study investigating the effect of LPS inhibits on
luteal endothelial cells network formation in vitro. Even at low dose of LPS
0.01 µg/ml luteal endothelial cell network formation was decreased by about
50%. This study has shown that LPS decreased luteal vasculature thorough
increased luteal endothelial cell apoptosis and decreased proliferation in a
dose dependant manner. The pattern of caspase3 and Ki67 staining was more
abundant in the EC islands compared with the other regions on the coverslip.
The inhibition of luteal endothelial cells angiogenesis is confirmed by
immunolocalisation of caspase-3 to presumptive EC islands and dual
immunofluorescence of Caspase-3 and Ki67 to luteal endothelial cells on day
5 of culture. This study has shown that LPS in vitro reduced expression of
ACTA2, and this could be another important factor by which LPS inhibits luteal
endothelial cells angiogenesis. Reduced levels of ACTA2 expression and
associated with diminish cellular contraction (Wylam et al. 2001).
6.1 Conclusion
This thesis has improved the understanding of how uterine infection can affect
high yielding dairy cow fertility by: 1) RTID had negative effects on
reproductive performance in high yielding dairy herds, through extension of
DFS, CCI, CI, higher SPC, lower conception rate at 1st AI and increased exit
rate; 2) Endometritis has potential effects on post-partum ovarian activity,
and is associated with an increased rate of abnormal progesterone profiles;
particularly prolonged luteal phase; 3) Endometritis decreased luteal P4
content and protein expression of steroidogenic enzymes including STAR,
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HSD3B and CYP11A in vivo. However, neither P4 concentration nor protein
expression of steroidogenic was affected by LPS treatment of luteal cells in
vitro; 4) LPS significantly inhibited luteal endothelial cells network formation,
and decreased protein expression of ɑ-smooth muscle-actin (ACTA2); 5) LPS
increased endothelial cell apoptosis and reduced EC proliferation.
Future work
There is no doubt that it is the interaction of several systems which ultimately
determines luteal function and subfertility in dairy cows. Uterine infection is
regarded as the primary factor affecting reproduction in dairy cows and could
exert effects on ovarian function. The studies in this thesis have established
that endometritis decreased CL angiogenesis and luteal function in vivo.
Further work is required to measure the effect of endometritis on both uterine
and CL blood flow using colour Doppler ultrasound. In order to determine
whether LPS directly affects luteal endothelial cells in vitro. Future work
requires isolation of endothelial cells (devoid from contamination with other
cells) from an early stage CL and treatment with LPS. The following
procedures required to perform such as:
1) Quantification of LPS complex receptors (TLR4, CD14 and MD-2) from
isolated endothelial cells using Multiplex qPCR.
2) Immunohistochemistry for caspase-3 and Ki67 from isolated
endothelial cells and treatment with LPS at 0-10µg/ml on day 3, 5 and
9 of culture, to identify the pathway by which LPS causes EC apoptosis.
3) Expression of mRNA encoding TGFB from CL of cows positive with
endometritis in vivo and in vitro by using co-culture of luteal
endothelial cells.
TGFB has also been related to the interaction between pericytes and
endothelial cells. TGFB localise in CL and ovarian vasculature of most species
(Gangrade et al. 1993, Zheng et al. 2008, Maroni and Davis 2011). TGFB
reduce bovine luteal endothelial cells migration and supress endothelial
network formation (Maroni and Davis 2011). Furthermore, TGFB increase
apoptosis in bovine aortic endothelial cells (Pollman et al. 1999) and in human
umbilical vein endothelial cells (Ferrari et al. 2009). It has been reported that
endotoxins are capable of inducing the expression and secretion of TGF-B1
and TGFB as amechanisms to stimulate endotoxin-induced endothelial fibrosis
(Echeverría et al. 2014). Therefore, TGFB will be a prime target for future
work into effect of role of TGFB on luteal endothelial cells angiogenesis after
treated with LPS.
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4) The measurement of TNFA and IL-1 from culture media of isolated EC
from day 1-9 using ELISA. The aim of this step to determine whether
LPS increase expression of TNFA from isolated EC. In addition, qPCR
and Western blot to determine the expression of of TNFA receptors in
vitro.
5) Identify the relationship between bovine single nucleotide
polymorphisms (SNPs) in candidate immune and angiogenesis-related
genes and susceptibility to uterine inflammatory disease.
At the level of the investigations conducted and results in this thesis
established that endometritis during postpartum adversely affected fertility in
dairy cows and luteal angiogenesis. Angiogenesis plays a key role in the
growth of tumour and its induced by the same cells and factors involved in
the physiological ovarian angiogenesis (Tamanini and De Ambrogi 2004).
Therefore, the roles of LPS and the association between LPS and luteal
endothelial and vascular smooth cells may provide useful treatment for
further research into ovarian cancer. The types of approaches outlined above
might lead to the possibly new findings which will help to understand the
impact of LPS on luteal cells
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Appendices
Appendix I: Preparation of solutions
Immunohistochemistry
Phosphate buffer saline (PBS)
1x PBS solution was prepared by adding 10 L of distilled water to the following:
Amounts (g) Name of chemical product
85 Sodium chloride (NaCl)
2.5 Potassium dihydrogen phosphate (KH2PO4)
17.8 Sodium phosphate dibasic dihydrate
(Na2HPO4.2H2O)
The pH was then adjusted to 7.4
10mM Citrate buffer (Antigen retrieval)
Two solutions were prepared as follows:
Solution Chemical Amount
(g)
Volume of distilled
water
A Citric acid 4.2 200 ml
B Sodium citrate 14.7 500ml
16ml of solution A was mixed with 84ml of solution B and the volume
was then made up to 1 L.
The pH was then checked to be 6 and adjusted as appropriate
0.4mg/ml trypsin and 0.25mg/ml CaCl2 (antigen retrieval)
This was prepared by adding 120mg of trypsin and 75mg of anhydrous CaCl2 to
300ml of 1XPBS.
Acetone/Methanol Fixative
This was prepared by adding 5ml of acetone to 5ml of methanol
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Peroxidase Block
This was prepared by adding 2ml of Hydrogen peroxide (H2O2) to 18ml of
methanol
20% (V/V) normal goat serum
1ml of normal goat serum (Sigma) was diluted in 4 ml of 1XPBS solution. The
normal goat serum was then dispensed into 1ml aliquots and stored at -20°C.
Primary Antibodies
VWF antibody
Polyclonal Rabbit anti-human VWF (5 g/ml, A0082, Dako). Prior to use the
antibody was diluted 1:1000 in 2% NGS (f.c. 5 µg/ml) as follow:
5µl of VWF into 100µl of normal goat serum, and volume made up to 5ml with
PBS
Rabbit anti-human cleaved caspase3 (Cell Signalling, cat no 9661)
Dilute caspase3 antibody 1 in 300 (diluted 3.3µl into 1ml 1x PBS)
Secondary Antibodies
Biotinylated Goat anti-rabbit (Vectastain kit)
Biotinylated goat anti-rabbit was diluted 33µl in 100µl of normal goat serum+
PBS
Immunofluorescence
Primary antibodies
Mouse anti-human Ki67 (Clone MM1, Vector KP452)
This antibody was diluted 1:80 (12.5µl of Ki67 into 1ml of 1XPBS).
Biotinylated Griffonia (Bandeiraea) simplicifolia lectin I isolectin B4 (Vector, cat
no B1205)
Isolectin (500g/ml) was diluted by 1/25 to concentration of 20g/ml in 1× PBS
buffer and to this other primary antibodies were added.
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Rabbit anti-human caspase 3
Caspase 3 was diluted 1/300 (3.3μl in 1ml of 1XPBS).
Secondary antibodies
Avidin labelled with fluorescein DCS and Texas Red anti-mouse IgG
Avidin-FITC was diluted 1/100 to a working concentration of 20g/ (Diluted by
adding 10μl into 990μl of 1XPBS to give final volume 1ml of 1XPBS). 
Texas Red anti-mouse IgG
Texas red anti-mouse IgG was diluted 1/100 (f.c. 10g/ml) in 1× PBS Buffer (It
was diluted as follows 10μl of Texas red anti-mouse IgG into 990μl of 1XPBS to 
give final volume 1ml).
Texas Red avidin and FITC anti-rabbit IgG 1/75
Texas-Red avidin was dilute 1/100 (added 10μl into 990μl of 1XPBS) 
FITC anti-rabbit IgG
FITC anti-rabbit IgG was diluted 1/75 (13μl into 987μl of 1XPBS) 
Haematoxylin & Eosin staining of paraffin embedded sections
1%Acidified IMS (fume hood)
It was prepared as follows:
280ml Industrial Methylated Spirit (IMS)
4ml HCL
116ml dH20
Ammoniated Water
It was prepared as follows:
300ml dH20
3ml of Ammonia Solution
1.5% Eosin Stain
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It was prepared as follows:
3g Eosin Powder
60µl Acetic acid
300ml dH20
H&E Procedure
1- Xylene (2 x 5 mins)
2- 100% IMS (5 mins)
3- 95% IMS (5 mins)
4- 70% IMS (5 mins)
5- Harris's haematoxylin (Filtered ) (2 min)
6- Tap water until runs clear
7- 1% acid IMS (2 dips)
8- Rinse in tap water
9- Ammoniated water (2 Dips)
10-Rinse in tap water
11-Eosin (1.5% (w/v; filtered) (5 min)
12-Tap water until runs clear
13-70% IMS (2 min)
14-90 % IMS (2 min)
15-100% IMS (2 min)
16-Xylene (2  5 mins)
17-Mount in DPX mountant, add coverslip and allow to air dry
Tissue culture
Fibronectin (1mg/ml)
For 12 wells was prepared as follows:
Added 200l of 1mg/ml Fibronectin into 20ml of sterile distilled water.
Dissociation solution (make up just before culturing)
40 ml DMEM/Ham’s media (with no FCS/BSA)
0.8 ml of 100 mg/ml Collagenase I (Dissolved 1g pot in 10ml DMEM/Ham’s media
stored at -20C)
250 l DNase I (dissolve one vial (5mg) in 1 ml)
500 ng/ml LH
From 250 l aliquot of 1000 g/ml LH
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Dilute 1:2000 i.e. 20 l in 40 ml media  500 ng/ml LH solution (100x) Sterile
filter
Cell culture medium
500 ml of Endothelial cell media (ECM-complete, Lonza)
The following products were added:
5 ml of 500 ng/ml LH
5 ml of 100 ITS
5 ml of 100 pen/strep
500 l hEGF
500 l GA-1000
500 l heparin
500 l R3-IGF-1
500 l Absorbic acid
200 l Hydrocortisone
10 ml FBS (Fetal bovine serum)
Western blot
Tissue lysis buffer
0.5g of Dithiothreitol (DTT, Sigma)
0.5ml of 10% Sodium dodecyl sulphate (SDS)
1 tablet of protease inhibitor cocktail (Roche)
50 ml PBS
25x tissue lysis buffer
0.5g DTT
0.5ml of 10% SDS
1 tablet of protease inhibitor cocktail (Roche)
1.5ml of 1xPBS
Store in 400µl aliquot and dilute with 960µl of 1xPBS
10% Ammonium per sulphate (APS)
This was prepared as follow: 100µg added into 1 ml of dH2O
10% (w/v) Sodium dodecyl sulphate (SDS) solution
10g into 100ml dH2O
Blotting buffer
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50ml of 1XTGS (Tris Glycine SDS, Biorad, cat no 191-0772)
450ml dH2O
Transfer buffer
Transfer buffer was prepared as follow:
100ml of 10x Tris Glycine (TG)
200ml methanol
700ml dH2O
Ponceau S stain
0.1g Ponceau s
5ml acetic acid
95ml dH2O
Blocking solution (Phosphate Suffered Saline with Tween® 20)
1ml of Tween20
1000ml 1xPBS
Primary Antibodies
Steroidogenic enzymes protein (STAR, Abcam, ab96637, Rabbit)
It was diluted 1:3000 (added 1.33 µl of STAR into 4ml blocking solution)
3beta-Hydroxysteroid dehydrogenase (HSD3B, Richard Parker, Rabbit)
It was diluted 1:200 (added 10µl of HSD3B (diluted already 1:20) into 4ml
blocking solution)
Cholesterol side-chain cleavage enzyme (CYP11A, Abcam, ab75497)
It was diluted 1:1000 (added 4µl of CYP11A into 4ml blocking solution)
Histone 3 (H3, Abcam, ab1791, Rabbit)
It was diluted 1:1000 (added 4µl of H3 into 4ml blocking solution)
α-smooth muscle actin (α-SMA, mouse, Sigma, A2547) 
It was diluted 1:1000 (added 4µl of α-SMA into 4ml blocking solution) 
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Secondary Antibodies
Goat anti-rabbit HRP (Sigma Cat NO. A9169)
It was diluted 1/8000 in blocking solution (5 µl in 40ml blocking solution)
Sheep anti-mouse HRP (Amersham, Cat NO. NXA931)
It was diluted 1/50000 in blocking solution (1µl in 50ml blocking solution)
Appendix II
Lipopolysaccharide receptors sequences and primer
sites
There are 3 LPS receptors genome sequences from bovine (Bos-Taurus) with
their accession numbers obtained from National Centre for Biotechnology
Information (http://www.ncbi.nlm.nih.gov/). The top red and bottom green
highlighted fragments were used for designing forward and reverse primers,
respectively, to amplify the large amplicon of each gene. The forward primer site
used only to sequence the middle part of TLR4, CD14, MD-2 and Suz14 (House
keeping gene) are highlighted with yellow.
Toll like receptor4 (TLR4), accession number, NM_174198.6, size 224 bp
AGATAAATATCAGAGAAACGAAAGTCCAGAAAGCTAAGGCTGCCCCTCTCACTTCCTCTCCTCCCGTAACCCAG
CACTGCTTTGAATAGGGGCAGTGCCCTGGGGCACCAAGCCGGGGAGAGACGACACTACAGTGCCTCGGAGGC
TGCCCTGGCCGGCACAGACAGAGGGTTATGCTTTCACAGAGCCACTTCTGGTCACAGAAAATGCCAGGATGAT
GGCGCGTGCCCGCCTGGCTGCGGCTCTGATCCCAGCCACGGCCATCCTCTCCTGCCTGAGAACCGAGAGTTGG
GACCCTTGCGTACAGGTTGTTCCTAACATTAGTTACCAGTGCATGGAGCTGAATCTCTACAAAATCCCCGACAAC
ATCCCCATATCAACCAAGATGCTGGACCTGAGCTTTAACTACCTGAGACATTTAGGCAGCCATAACTTCTCCAGC
TTCCCAGAACTGCAAGTGCTGGATTTATCCAGATGTGAAATTAAGATTATTGAAGACGACACATTTCAGGGCCTA
AACCACCTCTCCACCTTGATACTGACGGGAAACCCTATCCAGAGTTTAGCCTGGGGAGCCTTTTCTGGGCTATC
AAGTTTACAGAAGCTGGTGGCCGTGGAGACAAACCTAGTCTCTCTAAATGACTTCCCCATTGGACATCTCAAAA
ACTTGAAAGAGCTTAATGTGGCTCACAATTTTATCCATTCCTTCAAGTTACCTGAATATTTTTCTAACCTGCCCAA
CCTGGAGCACTTGGATCTTTCTAACAACAAAATCCAAAATATTTATTATGAAGATGTGAAAGTTCTACATCAAATG
CCCCTACTCAACCTCTCTTTAGATTTGTCCTTGAACCCTTTAGACTTTATTGAACCAGGTACCTTTAAAGAAATTA
Cluster Differentiation 14 (CD14), accession number, 41386759
, size 230 bp
ATGGTGTGCGTGCCCTACCTGCTGCTGCTGCTGCTGCCGTCACTGCTGCGTGTGTCTGCGGACACAACAGAAC
CCTGCGAGCTGGACGACGACGATTTCCGTTGTGTCTGCAACTTCACGGATCCGAAGCCTGACTGGTCTAGCGC
CGTTCAGTGTATGGTTGCCGTCGAGGTGGAGATCAGTGCCGGCGGCCGCAGCCTGGAACAGTTTCTCAAGGGA
GCCGACACCAACCCGAAGCAGTATGCTGACACAATCAAGGCTCTGCGCGTTCGGCGACTCAAGCTGGGCGCTG
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CACAGGTTCCTGCTCAGCTTCTGGTCGCCGTTCTGCGCGCGCTCGGGTACTCTCGTCTCAAGGAACTGACGCTT
GAGGACCTGGAGGTAACCGGCCCAACGCCCCCGACGCCTCTGGAAGCCGCTGGGCCTGCGCTCACCACCCTC
AGTCTCCGTAACGTATCGTGGACAACAGGAGGTGCCTGGCTCGGCGAACTGCAGCAGTGGCTCAAGCCTGGGC
TCAGGGTGCTGAACATTGCCCAAGCACACTCGCTTGCCTTTCCGTGCGCAGGGCTCTCCACCTTCGAGGCGCTC
ACCACCCTAGACCTGTCTGACAATCCCAGTCTCGGCGACACGGGGCTGATGGCAGCTCTCTGTCCGAACAAGTT
CCCGGCCCTCCAATATCTAGCGCTACGCAACGCGGGGATGGAGACGCCGAGCGGCGTGTGCGCGGCGCTGGC
GGCAGCGAGGGTGCAGCCCCAAAGCCTGGACCTCAGCCACAACTCGCTGCGCGTCACCGCCCCGGGTGCTAC
CCGATGTGTCTGGCCCAGTGCACTAAGGTCTCTCAATTTGTCGTTCGCTGGGCTGGAGCAAGTGCCTAAGGGA
CTGCCCCCTAAGCTCAGCGTGCTTGATCTCAGCTGCAACAAGCTAAGCAGGGAGCCGCGGCGAGACGAGCTGC
CCGAGGTAAATGACCTGACTCTGGACGGAAATCCCTTTCTGGACCCTGGAGCCCTCCAGCACCAAAATGACCCG
ATGATCTCCGGCGTGGTCCCAGCCTGTGCGCGTTCTGCCTTGACCATGGGGGTGTCAGGAGCCCTGGCGCTGC
TTCAAGGAGCCCGAGGCTTCGCGTA
Lymphocyte antigen 96, (MD-2) accession number: AB072456.1, size
125 bp
GTTTTGGAGAGATTGAATCATGTTTCCATTTGTGCTTTTTTCCACCCTGTTTTCTTCCATATTTACTGAACCTAGG
GAGAATCGTTGGGTCTGCAACTCCTCTGACGCCACCGTTTGGTACGACTACTGTGATAACTTGAAATTTCCTGTT
TCAATACGTTCTGAGCCCTGTATAACATTGAAGGGAAGCCGTGGAATACTCTATCTCTACTACATTCCAAGAAGA
GATATAAGGAGCTTGTATTTCAATATCTATCTATCTACTAAGTCCATGAATTTCCCATTGCGCAAAGAATTTATTT
GCCGAGGATATGATGATGATTTTTCCTTTTGCAGAGCTCTGAAGGGAGAGACTGTGAACACAACAATACAATTC
TCCTTCAGGGGAATACGATTTTCTAAGGGACAGTACAACTGTATTACAGAAGCCATCGAGGGGAACACTGAAGA
AAAGCTCTTTTGCTTGAACTTTACTATCATACATTACCCTGATTTCAATTAG
SUZ12, used as a reference gene, accession number NM_001205587.1,
size 286bp
ATGGCGCCTCAGAAGCACGGCGGTGGGGGAGGGGGCGGCTCGGGGCCCAGCGCGGGGTCCGGGGGAGGCG
GTTTCGGGGGTTCGGCGGCGGTGGCGGCGGCGACGGCGTCGGGCGGCAAATCCGGTGGCGGGGGCTGTGGA
GGCGGCGGCAGTTACTCGGCCTCCTCCTCCTCCTCCGCGGCGGCAGCGGCGGGGGCCGCGGTGTTACCGGTG
AAGAAGCCGAAAATGGAGCACGTCCAGGCTGACCACGAGCTTTTCCTCCAGGCCTTTGAGAAACCAACGCAGA
TCTATAGATTTCTTCGAACACGAAATCTTATAGCGCCAATATTTTTGCATAGAACTCTTACTTACATGTCTCATCG
AAACTCCAGAACAAACATCAAAAGGAAAACATTTAAAGTTGATGATATGTTATCAAAAGTAGAGAAAATGAAAGG
AGAGCAAGAATCTCATAGCTTGTCAGCTCATCTGCAGCTTACATTTACTGGTTTCTTCCACAAAAATGATAAACC
ATCACAAAATTCAGAAAATGAACAAAATTCTGTCACCCTGGAAGTCCTGCTTGTGAAAGTTTGCCACAAAAAAAG
AAAGGATGTAAGTTGTCCGATAAGGCAAGTTCCTACAGGTAAAAAGCAGGTGCCTTTGAATCCTGACCTCAATC
AAACAAAACCTGGAAACTTCCCATCCCTTGCAGTTTCCAGTAATGAATTTGAACCTAGTAACAGCCATATGGTGA
AGTCTTACTCATTGCTATTTAGAGTGACTCGTCCAGGAAGAAGAGAGTATAATGGGATGATTAATGGAGAAACC
AATGAAAATATTGATGTCAATGAAGAACTTCCAGCTAGAAGAAAACGAAATCGTGAAGATGGGGAAAAAACGTT
TGTTGCACAAATGACAGTATTTGATAAAAACAGGCGCTTACAGCTTTTAGATGGGGAATATGAAGTAGCCATGC
AGGAAATGGAAGAATGTCCAATAAGCAAGAAAAGAGCAACATGGGAGACTATTCTTGATGGGAAGAGACTGCC
TCCATTTGAAACATTTTCTCAGGGACCTACATTGCAGTTCACTCTTCGTTGGACAGGAGAGACCAATGATAAATC
TACAGCTCCTATAGCCAAACCTCTTGCCACTAGAAATTCAGAGAGTCTTCATCAAGAAAATAAGCCTGGTTCAGT
AAAACCTACTCAAACTATTGCTGTTAAAGAATCATTGACTACAGATCTGCAAACAAGAAAAGAAAAAGATACTTC
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AAATGAAAACCGACAAAAATTAAGAATATTTTATCAGTTCCTTTATAACAACAATACGAGACAACAAACTGAAGC
AAGAGATGACCTACATTGCCCTTGGTGCACCCTGAACTGCCGCAAACTTTATAGCTTACTTAAACATCTTAAACT
CTGCCATAGCAGATTTATCTTCAATTATGTTTATCATCCAAAAGGTGCTAGGATAGATGTTTCTATCAACGAGTGT
TATGATGGCTCCTATGCAGGAAATCCTCAGGATATTCATCGCCAGCCCGGATTTGCTTTTAGTCGCAATGGACCA
GTAAAGAGAACACCTATCACACACATTCTTGTGTGCAGGCCAAAAAGAACAAAAGCAAGTATGTCTGAATTTCTT
GAATCCGAAGATGGAGAAGTGGAACAGCAGCGAACATACAGTAGTGGACACAACCGCCTCTATTTCCATAGTGA
TACTTGTTTACCTCTCCGTCCACAAGAAATGGAAGTAGATAGTGAAGATGAAAAAGACCCCGAATGGCTAAGAG
AAAAAACCATTACTCAAATTGAGGAATTTTCTGATGTTAATGAAGGAGAGAAAGAAGTGATGAAACTATGGAATC
TCCATGTCATGAAGCATGGGTTTATTGCTGACAATCAAATGAATCATGCCTGTATGCTGTTTGTAGAAAACTATG
GACAGAAAATAATTAAGAAGAATTTATGTCGAAACTTCATGCTTCATCTAGTCAGCATGCATGACTTTAATCTTAT
TAGCATAATGTCAATAGATAAAGCTGTTACCAAGCTCCGTGAAATGCAACAAAAATTAGAAAAAGGAGAATCTGC
TTCCCCTGCAAATGAAGAAGTCACTGAAGAACAAAATGGGACAGCAAATGGATTTAGTGAAATTAACTCAAAAG
AGAAAGCTTTGGAAACAGATGGTGTCTCAGGGGTTTCAAAACAGAGCAAAAAACAAAAACTCTGA
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Reagents
Reagent Supplier
100 bp DNA ladder New England BioLabs,
ABC Elite Kit Vector Laboratories
Ltd Orton Southgate,
Peterborough, UK
Acetone Fisher-Scientific Ltd
Loughborough, Leics, UK
Agarose, powder Sigma-Aldrich (Poole, Dorset,
UK)
Amersham ECL Prime Western
Blotting Detection Reagent
GE Health care (UK)
Ammonia solution Fisher-Scientific
Ltd Loughborough, Leics, UK
Ammonium chloride Sigma-Aldrich (Poole, Dorset,
UK)
Amphotericin-B solution Sigma-Aldrich (Poole, Dorset,
UK)
Anti–mouse IgG antibody,
HRP–linked (for western
blotting)
Sigma-Aldrich (Poole, Dorset,
UK)
Bio-Rad solution
(Protein determinant)
Bio-Rad laboratories
Ltd Hemel Hempstead, UK
Bouins VWR (Lutterworth, Leics, UK)
Bovine serum albumin Sigma-Aldrich (Poole, Dorset,
UK)
Calcium chloride Fisher-Scientific
Ltd Loughborough, Leics, UK
Citric acid VWR (Lutterworth, Leics, UK)
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DAB Vector Laboratories
Ltd Orton Southgate,
Peterborough, UK
DNase type IV Sigma-Aldrich (Poole,Dorset,
UK)
DPX mounting medium VWR (Lutterworth, Leics, UK)
EBM-2 medium Lonza Wokingham
Ltd Loughborough Leics, UK
Epidermal growth factor Lonza, Wheldon Rd, Castleford,
UK
Ethanol Fisher-Scientific
Ltd Loughborough, Leics, UK
Ethidium bromide solution Fisher Scientific
Fetal bovine serum Invitrogen (Paisley, UK)
Fibronectin Sigma-Aldrich (Poole, Dorset,
UK)
Gel Loading Dye, Blue (6X) New England BioLabs
Haematoxylin VWR (Lutterworth, Leics, UK)
Hydrogen peroxide Fisher-scientific
Ltd Loughborough, Leics, UK
Insulin transferrin selenium Sigma-Aldrich (Poole, Dorset,
UK)
E.coli O111:B4, LPS Alpha diagnostic international,
Cat.No. LPS13-1
Methanol Fisher-Scientific
Ltd Loughborough, Leics, UK
Mouse IgG Sigma-Aldrich (Poole, Dorset,
UK)
Sodium chloride Fisher-Scientific
Ltd Loughborough, Leics, UK
Normal goat serum Sigma-Aldrich (Poole, Dorset,
UK)
Nuclease–free water Invitrogen,
Paraffin wax Fisher-Scientific
Ltd Loughborough, Leics, UK
PBS Sigma-Aldrich (Poole, Dorset,
UK)
Penicillin-streptomycin Sigma-Aldrich (Poole, Dorset,
UK)
Phosphate buffered saline
(PBS), 1X liquid
Invitrogen (Paisley, UK)
Potassium bicarbonate Sigma-Aldrich (Poole, Dorset,
UK)
Potassium dihydrogen
phosphate
Fisher-Scientific
Ltd Loughborough, Leics, UK
Progesterone ELISA Ridgeway Science (St Briavels,
Glos, UK)
Protease inhibitor cocktail Roche Products Ltd (Welwyn
Garden City)
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Rabbit IgG Sigma-Aldrich (Poole, Dorset,
UK)
Sodium bicarbonate Sigma-Aldrich (Poole, Dorset,
UK)
Sodium Citrate VWR (Lutterworth, Leics, UK)
Sodium phosphate dibasic di
hydrate
Fisher-Scientific
Ltd Loughborough, Leics, UK
Texas Red avidin and FITC
anti-rabbit IgG
Vector Laboratories Ltd (Orton
Southgate, Peterborough, UK)
Thermo scientific microscope
slides
Fisher-Scientific
Ltd Loughborough, Leics, UK
Toluene Fisher-Scientific
Ltd Loughborough, Leics, UK
Tris Glycine SDS sample buffer
(2X)
Sigma-Aldrich (Poole, Dorset,
UK)
Triton-x100 Fisher-Scientific Ltd
(Loughborough, Leics, UK)
Trypan blue solution Sigma-Aldrich (Poole, Dorset,
UK)
Trypsin from bovine pancreas
TPCK treated
Sigma-Aldrich (Poole, Dorset,
UK)
Tween 20 Fisher Scientific
Vectashield mounting medium
with DAPI
Vector Laboratories Ltd (Orton
Southgate, Peterborough, UK)
Xylene Fisher-Scientific
Ltd Loughborough, Leics, UK
Antibody Source
VWF Dako (Ely, Cambs, UK)
ACTA2 Sigma-Aldrich (Poole, Dorset,
UK)
STAR Abcam, (Cambridge Science
Park, UK)
HSD3B Dr Richard Parker, University of
Alabama
Histone Abcam, (Cambridge Science
Park, UK)
CYP11A Abcam, (Cambridge, UK)
Caspase3 Cell signaling technology (New
England Biolabs Ltd, UK)
Goat anti rabbit IgG HRP Sigma-Aldrich (Poole, Dorset,
UK)
Sheep anti-mouse IgG HRP Sigma-Aldrich (Poole, Dorset,
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UK)
Product Source
12 well tissue culture
plates (NUNC)
Fisher-scientific
Ltd(Loughborough, Leics, UK)
70µm mesh filter Scientific Laboratory Supplies
(Nottingham, UK)
Coverslips for tissue culture Scientific Laboratory Supplies
(Nottingham, UK)
Ministar sterile srynge
filter, 0.2 micron
VWR(Lutterworth, Leics, UK)
Nalgene bottle top
filter units, 0.2 micron
VWR(Lutterworth, Leics, UK)
Sterile scalpel blades
(swann-morton)
Fisher-scientific
Ltd(Loughborough, Leics, UK)
